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Abstract
Investigating the interplay of the immune system, skin barrier, and
microbiome following dermal exposure to triclosan
Rachel Baur
Triclosan is an antimicrobial chemical used in healthcare products that are applied to the skin.
However, exposure to triclosan has been positively associated with food allergy, aeroallergy, and
asthma severity in humans. In mice, dermal triclosan exposure, although not directly sensitizing,
has been shown to augment the allergic response in a model of asthma. Furthermore, exposure to
triclosan on mouse skin has been demonstrated to be immunomodulatory through the activity of
thymic stromal lymphopoietin and S100 calcium-binding protein A8. The skin barrier and
microbiome are known to interact with the immune system and disruptions in barrier integrity
and the microbiome are associated with allergic diseases. However, the impact of dermal
triclosan exposure on the skin integrity, skin microbiome, and its interplay with the immune
system has not been evaluated. In these studies, dermal exposure to triclosan was evaluated using
a mouse model and a model of reconstructed human epidermis. In mice, repeated (7-day) dermal
exposure to 2% triclosan increased transepidermal water loss, altered the expression patterns of
skin barrier genes, and changed the composition of the skin and gut microbiome. In a model of
reconstructed human epidermis, exposure to 0.2% triclosan increased skin permeability, altered
the expression of skin barrier genes, and increased the production of proinflammatory cytokines.
Taken together, these results suggest that exposure to triclosan disrupts the skin barrier integrity
and microbiome and that these alterations may influence immune responses. A better
understanding of immunomodulation and its contribution to the development of allergic disease
is needed to aid in the prevention and treatment of disease.
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Introduction
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Introduction
In the United States, over 32 million workers have the potential for exposure to chemicals
that can cause occupational skin diseases (BLS 2022; NIOSH 2021). The most commonly
reported occupational skin diseases are irritant contact dermatitis (ICD) and allergic contact
dermatitis (ACD) (Aalto-Korte et al. 2020). In one study, 11.7% of all contact dermatitis cases
were reported to be occupationally-related (DeKoven et al. 2021). Certain workers are also atrisk for occupational asthma, which can be caused by the inhalation of respiratory sensitizers
(Dao and Bernstein 2018). In 2020, many of the individuals that developed an occupational
illness worked in health care; 352,900 workers out of the total 661,700 workers that developed
an occupational illness were in the health care and social assistance private sector (BLS 2020).
ACD and asthma are both hypersensitivity reactions that occur following exposure to a contact
or respiratory sensitizer, respectively. These sensitizers can be low molecular weight (LMW)
agents (e.g., chemicals) or high molecular weight (HMW) agents (e.g., proteins) (Anderson et al.
2017; Malo and Chan-Yeung 2009). Health care workers are particularly at-risk for chemical
sensitizer exposure due to their frequent use of disinfecting chemicals (Saito et al. 2015).
However, the mechanisms of sensitization due to chemical exposure are not fully understand.
Multiple factors have been suggested to have a role in the development of allergic diseases,
including activation of the innate immune system, decreased barrier integrity, and changes in the
microbiome (Shane et al. 2019a). More research is needed to better understand the roles of these
additional factors and how they contribute to allergic diseases.

Occupational allergic disease
In 2020, the United States Bureau of Labor Statistics (BLS) reported that 661,700
workers developed a nonfatal occupational illness (BLS 2020). The most common occupational
illness was a respiratory condition (504,800 individuals) followed by other illnesses (124,100
individuals) and skin diseases or disorders (19,800 individuals) (BLS 2020). The majority of
individuals that developed respiratory conditions (308,800 individuals) or occupational skin
diseases or disorders (4,500 individuals) worked in the health care and social assistance private
sector (BLS 2020). This population of workers is large; over 20 million individuals work in the
health care social assistance sector and have the potential for exposure to chemicals that can
cause occupational skin diseases (BLS 2022; NIOSH 2021). Although the specific types of
3

occupational skin diseases are not reported by the BLS, a report using data from the Finnish
Register of Occupational Diseases showed that ICD was the most common type of occupational
skin disease among health care workers (43%), followed by ACD (24%) (Aalto-Korte et al.
2021). Skin infections were also commonly reported (24%); contact urticaria, protein contact
dermatitis, and unspecific dermatitis were less prevalent (< 8% combined) (Aalto-Korte et al.
2021). In addition to health care workers, occupational contact dermatitis has been frequently
reported among hairdressers, cosmetologists, and food service workers (Warshaw et al. 2013;
Warshaw et al. 2012).
Occupational skin diseases have historically been the second most common occupational
disease (BLS 2019); however, occupational respiratory conditions have recently increased (BLS
2020). Although COVID-19 accounts for many of the occupational respiratory conditions
developed in 2020, previous studies have shown that occupational asthma is a common
occupational respiratory condition, particularly among health care workers (Walters et al. 2013).
Exposures that occur during work can also worsen pre-existing asthma in individuals; this
condition is referred to as work-aggravated asthma (Dao and Bernstein 2018). Work-related
asthma, which includes both occupational asthma and work-aggravated asthma, has also been
reported among workers in manufacturing and professional cleaning (Casey et al. 2015;
Lipinska-Ojrzanowska et al. 2017).
Asthma and ACD are both allergic diseases that are the result of a hypersensitivity
reaction to a sensitizer. Hypersensitivity reactions are classified into four types (I-IV) based on
their reactions during the elicitation phase. Asthma, allergic rhinitis, anaphylaxis, and urticaria
are considered type I (immediate) reactions whereas ACD is considered type IV (delayed)
(Anderson et al. 2017). The classification of these hypersensitivity reactions was originally
proposed by Coombs and Gell in 1963 (Coombs and Gell 1963). Type I (immediate)
hypersensitivity reactions involve the antibody immunoglobulin E (IgE), mast cells, B cells, and
type 2 helper T (Th2) cells (Anderson et al. 2017). In contrast, type IV hypersensitivity reactions
are T cell mediated and involve proinflammatory cytokines (Anderson et al. 2017). These
hypersensitivity reactions both have two phases: sensitization and elicitation. Sensitization
occurs upon the first exposure to a sensitizer. Sensitizers can be classified as LMW agents, for
example chemicals, or HMW agents, for example proteins (Anderson et al. 2017; Malo and
4

Chan-Yeung 2009). Common contact sensitizers that contribute to occupational ACD include
plastics and resins (e.g., epoxy chemicals, acrylates, isocyanates), rubber, preservatives (e.g.,
isothiazolinones, formaldehyde), and metals (e.g., nickel, cobalt, chrome) (Aalto-Korte et al.
2020). Among health care workers, the most common contact sensitizers include rubber
chemicals, acrylates, isothiazolinones, formaldehyde, and disinfectants (Aalto-Korte et al. 2021).
LMW agents that have been shown to cause occupational asthma include drugs, wood dust,
chemicals, metals, and biocides (Pralong et al. 2012). Interestingly, there is overlap between
contact and respiratory sensitizers, despite the difference in hypersensitivity reaction
classification for ACD and asthma. Classifying sensitizers, especially LMW agents, can be
difficult with the current classification scheme, and more research is needed to better understand
the mechanisms of occupational allergic diseases (Anderson et al. 2017).

Antimicrobial chemical exposure and allergic disease
Certain disinfectants have been shown to be sensitizers that can cause occupational
allergic disease (e.g., ACD, asthma) (Aalto-Korte et al. 2021; Pralong et al. 2012). Health care
workers frequently use disinfectants such as quaternary ammonium compounds and orthophthalaldehyde (OPA) in their jobs (Saito et al. 2015). However, some of these antimicrobial
chemicals have been identified as sensitizers. Quaternary ammonium compounds are a group of
chemicals frequently used to disinfect surfaces and examples include didecyldimethylammonium
chloride (DDAC) and benzalkonium chloride (BAC). Exposure to DDAC has been reported to
cause ACD and urticaria (Table 1.1) (Dejobert et al. 1997; Dibo and Brasch 2001; Houtappel et
al. 2008; Mowitz and Ponten 2015; Ruiz Oropeza et al. 2011). In mice, dermal exposure to
DDAC has been demonstrated to be an irritant (0.5%, 1%) and sensitizer (0.25%, 0.5%, 1%)
(Anderson et al. 2016b). DDAC exposure increased the frequency of activated CD8+ T cells in
the mouse dLNs, but not IgE-specific B cells nor IgE antibody in the serum, suggesting that
DDAC sensitization occurs through a T cell mediated response (Table 1.1) (Anderson et al.
2016b). BAC has also been identified as a contact sensitizer in humans with ACD and rates
among health care workers are reported to be 7.5%, compared to 2.3% among non-health care
workers (Suneja and Belsito 2008). However, in mice, dermal exposure to BAC was shown to be
irritating but not strongly sensitizing (Manetz and Meade 1999). Both DDAC and BAC have
been identified as respiratory sensitizers in individuals with occupational asthma (Table 1.1)
5

(Migueres et al. 2021). In this study, 22 out of 871 individuals in the cohort were identified to
have occupational asthma due to a quaternary ammonium compound (Migueres et al. 2021).
Thus, exposure to quaternary ammonium compounds on the skin is an area of concern for human
health, particularly for health care workers who frequently use these antimicrobial chemicals.
In addition to quaternary ammonium compounds, other antimicrobial chemicals have
been identified as sensitizers as well. Glutaraldehyde, a high-level disinfectant used on heatsensitive medical equipment, has been shown to be a contact sensitizer with particularly high
positive sensitization rates among health care workers (Shaffer and Belsito 2000; Suneja and
Belsito 2008; Warshaw et al. 2008). Rates of glutaraldehyde as the causative agent of ACD have
been reported at 13.2% among health care workers, compared to 0.88% in non-health care
workers (Suneja and Belsito 2008). Another high-level disinfectant, OPA, has been proposed as
a safer alternative to glutaraldehyde (Walsh et al. 1999). However, OPA has also been identified
as a sensitizer and has been associated with anaphylaxis and asthma (Table 1.1) (Fujita et al.
2006; Sokol 2004; Suzukawa et al. 2007). In mice, dermal exposure to OPA has been
demonstrated to be an irritant (0.75% OPA) and sensitizer (0.1%, 0.75% OPA) (Anderson et al.
2010). Additionally, mice dermally exposed to OPA had a significantly higher frequency and
number of IgE+ B cells and serum IgE antibody, suggesting an IgE mediated response following
OPA exposure (Table 1.1) (Anderson et al. 2010). These studies together demonstrate that
certain antimicrobial chemicals are sensitizers and that their mechanisms differ depending on the
agent.
Table 1.1. Select antimicrobial chemicals that are associated with allergic diseases.
Classification of each chemical in humans and in mice: sensitizer (T cell mediated, IgE
mediated), irritant, or adjuvant.
Classification

Classification

in Humans

in Mice

ACD, urticaria, asthma

Sensitizer

Sensitizer (T cell)

BAC

ACD, asthma

Sensitizer

Irritant

OPA

Anaphylaxis, asthma

Sensitizer

Sensitizer (IgE)

Triclosan

Food allergy, aeroallergy,
asthma exacerbation

None

Adjuvant

Antimicrobial chemical

Associated allergic disease(s)

DDAC
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In addition to directs effects on the immune system, some antimicrobial chemicals, such
as triclosan, have been shown to be immunomodulatory. 5-chloro-2-(2,4-dichlorophenyoxy)
phenol, referred to as triclosan (Figure 1.1), is a low molecular weight (289.5 g/mol)
antimicrobial chemical that was first used in surgical scrubs in healthcare settings in 1972,
followed by incorporation into consumer products, including soaps, deodorants, toothpastes, and
mouthwashes (Fang et al. 2010; Jones et al. 2000). Exposure to triclosan has been associated
with food allergy, aeroallergy, and asthma exacerbation (Table 1.1) (Savage et al. 2014; Savage
et al. 2012). Although triclosan itself has not been identified as a sensitizer in mice (Anderson et
al. 2016a), animal studies have demonstrated that exposure to triclosan impacts the normal
immune response. Dermal exposure to triclosan has been demonstrated to augment the allergic
response in a mouse model of asthma (Anderson et al. 2013). Additionally, exposure to triclosan
has been shown to enhance allergic responses in mouse models of peanut allergy (Tobar et al.
2016) and house dust mites (Hirota et al. 2019). Together, these studies demonstrate that
exposure to triclosan impacts the immune response and plays a role in the development of
allergic disease, potentially acting as an adjuvant (Table 1.1). However, these mechanisms have
not been thoroughly investigated.

Figure 1.1. Structure of triclosan.

Relevance of dermal triclosan exposure
Exposure to triclosan has been found to be widespread, suggested by the 2003-2004
National Health and Nutrition Examination Survey (NHANES) that found detectable levels of
triclosan in the urine of 75% of the United States population (Calafat et al. 2008). Over the last
50 years, researchers have found that exposure to triclosan is associated with disease (Anderson
et al. 2019; Weatherly and Gosse 2017). Specifically, triclosan has been shown to be an
endocrine-disrupting compound and exposure may impact reproduction and early development
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(Weatherly and Gosse 2017). Additionally, exposure to triclosan has been associated with
allergic diseases (Savage et al. 2012). Due to this, in 2016, the United States Food and Drug
Administration (FDA) banned the use of triclosan in consumer soaps (FDA 2016). However,
triclosan is still used in some formulations of products (Consumer product information database).
Most commonly, triclosan is used in concentrations ranging 0.1% to 0.3%, but has been used in
some products up to 2% triclosan. Exposure to triclosan can occur by the dermal or oral routes,
because triclosan is used in skin and oral care products. Health care workers using triclosancontaining soap have been shown to have higher levels of urinary triclosan, demonstrating that
triclosan is absorbed through the skin (MacIsaac et al. 2014). Furthermore, animal studies have
shown that triclosan is absorbed through mouse skin and have demonstrated that triclosan is
excreted through feces and urine (Fang et al. 2016). Additionally, triclosan has been detected in
multiple animal tissues following dermal exposure, including the plasma, bladder, gall bladder,
liver, digestive tract, and lungs (Fang et al. 2016). In humans, triclosan has been detected in the
liver and adipose tissue (Geens et al. 2012). Together these studies show that triclosan can be
absorbed through the skin, passed through tissues in the body, and excreted from the body.
Additionally, exposure to triclosan on the skin could impact both the site of exposure as well as
other tissues and systems within the body. Thus, investigating the impact of dermal triclosan
exposure on immune and allergic disease is important and relevant.

Mechanisms of allergic disease
Introduction
Understanding the mechanisms of allergic disease development is important for the
prevention and treatment of disease. It is well-established that two phases must occur in order for
an allergic disease to develop: sensitization and elicitation. For sensitization to occur, a dendritic
cell (DC) must take-up a sensitizing antigen in a barrier site, migrate to the draining lymph node
(dLN), and present the antigen to a T cell. DCs interact with naïve T cells in the dLNs and based
on these interactions and the cytokine milieu, T cells undergo differentiation to specific cell
subsets (Table 1.2). Allergic reactions have classically been divided into four types (Coombs and
Gell 1963). Urticaria, hay fever, and asthma are examples of a type 1 (immediate) reaction and
ACD is an example of a type IV (delayed) hypersensitivity reaction (Coombs and Gell 1963).
The type I hypersensitivity reaction is characterized by antibody and histamine involvement
8

whereas the type IV hypersensitivity reaction does not involve antibody (Coombs and Gell
1963). In a type I/IgE-mediated allergic disease, T cells differentiate to CD4+ Th2 cells and
interact with B cells in the dLNs, leading to class switching to IgE (Hammad and Lambrecht
2015). B cells can then migrate to barrier sites and produce IgE that binds to mast cells. During
the elicitation phase, antigen cross-links with IgE and mast cells are degranulated, releasing
histamine and other inflammatory factors that produce the clinical symptoms of an allergic
disease. In a type IV/T cell-mediated allergic disease, the sensitization phase involves the T cells
differentiating to CD4+ type 1 helper T (Th1) cells and migrating back to the skin. Upon
elicitation, the effector T cells in the skin produce cytokines such as interferon-γ (IFN-γ) and
lead to the release of additional proinflammatory cytokines by keratinocytes, including
interleukin (IL)-1β and tumor necrosis factor (TNF)-α (Kaplan et al. 2012). Additional immune
cells are recruited and CD8+ cytotoxic T cells are involved in tissue damage. Recently,
researchers have identified more complexity and overlap, particularly in the context of chemical
allergy, between these two traditional classification schemes.
Mixed immune responses
In addition to the role that Th2 and Th1 cells play in allergic disease, other helper T cell
subsets have been shown to be involved in inflammatory skin and allergic diseases (Shane et al.
2019a). Type 17 helper T (Th17) cells, which are distinguished by their production of IL-17A
(Table 1.2), are known to be involved in the development of psoriasis and may also be involved
in atopic dermatitis (AD) and ACD (Shane et al. 2019a; Silvestre et al. 2018). In mice with a
deficiency in the skin barrier, IL-17 was elevated following skin exposure to a sensitizer (Oyoshi
et al. 2009). Additionally, IL-17 and Th17 cells may contribute to certain types of asthma
(Hammad and Lambrecht 2021). More recently, type 22 helper T (Th22) cells have been
identified as a T cell subset that produces IL-22 and plays a role in skin disease, particularly
psoriasis and AD (Fujita 2013). IL-22 has been shown to influence responses in the skin
including expression of skin barrier genes and antimicrobial proteins (Gutowska-Owsiak and
Ogg 2013). Exposure to antimicrobial chemicals (Table 1.1) on mouse skin has also been shown
to increase the expression of Il22 in the skin, suggesting that Il22 may play an important role in
the response to dermal chemical exposure (Anderson et al. 2020). These newly identified T cell
subsets and their potential for involvement in disease suggest that the mechanisms contributing
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to inflammatory skin and allergic diseases are more complex than the traditional Th1 vs. Th2
paradigm.
Table 1.2. The most common helper T cell subsets. The transcription factors involved in T cell
differentiation and the primary cytokines produced by each of these main T cell subsets are also
shown. Additional helper T cell subsets have been identified, but their main transcription factor
and role in health and disease have not been well-established.
T Cell Subset

Transcription Factor

Distinguishing Cytokines

Th1

Tbet

IFN-γ

Th2

Gata3

IL-4, IL-5, IL-13

Th17

Rorγt

IL-17

Th22

Ahr

IL-22

Although LMW antigens have typically been thought to invoke T cell-mediated
responses, this strict classification has been challenged. Dermal exposure to the sensitizing
antimicrobial chemicals didecyldimethylammonium bromide (DDAB) and DDAC has been
shown to result in mixed-type reactions in mice (Shane et al. 2019b; Shane et al. 2017).
Exposure to DDAB on mouse skin has been demonstrated to increase the frequency of both
activated CD4+ and CD8+ T cells, suggesting involvement of Th2 and Th1 responses,
respectively (Shane et al. 2017). Dermal exposure to DDAC has been demonstrated to increase
Th1, Th2, and Th17 cytokines (e.g., IFN-γ, IL-4, IL-5, IL-13, IL-17A) in the dLNs of mice,
increase the frequency of IgE+ B cells, and increase activation marker expression on type 2
innate lymphoid cells (ILC2s), cells which are thought to be involved in Th2 allergic responses
(Shane et al. 2019b). In humans, DDAC exposure has been shown to cause ACD (considered a T
cell mediated allergic disease) in addition to urticaria and asthma (IgE mediated allergic
diseases) (Table 1.1) (Dejobert et al. 1997; Dibo and Brasch 2001; Houtappel et al. 2008;
Migueres et al. 2021; Mowitz and Ponten 2015; Ruiz Oropeza et al. 2011). These studies
highlight the potential for chemical exposures to result in mixed-type immune responses and
suggest that mechanisms of chemical allergy are more complex than previously realized.
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Immunomodulatory responses to non-sensitizers
In addition to these mixed immune responses following sensitizing chemical exposure,
exposure to non-sensitizing chemical adjuvants may impact the tissue microenvironment,
promote mixed or Th2 responses, and exacerbate allergic diseases. Exposure to triclosan and
parabens has been associated with food sensitization, aeroallergy, and asthma exacerbation
(Quiros-Alcala et al. 2019; Savage et al. 2014; Savage et al. 2012), all considered Th2 allergic
diseases. Additionally, formaldehyde exposure has been positively associated with asthma in
children (McGwin et al. 2010). However, these chemicals may not be directly sensitizing. For
example, triclosan has not been identified as a sensitizer in mice (Anderson et al. 2016a).
Instead, triclosan may act as an adjuvant by promoting a Th2-skewed immune response. In mice,
dermal exposure to triclosan (0.75%, 1.5%, 3%) has been demonstrated to exacerbate airway
hyperreactivity in a mouse model of asthma (Anderson et al. 2013). Additionally, in that study,
dermal exposure to triclosan increased the serum levels of allergen-specific IgE and expression
of the Th2 cytokine Il13 in the lungs compared to ovalbumin alone, further supporting the
involvement of a Th2-skewed response (Anderson et al. 2013). In a follow-up study, dermal
exposure to triclosan impacted immune responses in both the skin microenvironment and dLNs
(Figure 1.2) (Marshall et al. 2015). In the skin, repeated dermal exposure to triclosan (3%)
increased the levels of a Th2-skewing cytokine thymic stromal lymphopoietin (TSLP) and
proinflammatory cytokines (IL-1β, TNF-α); however, the Th2-releated cytokines IL-25 and IL33 and proinflammatory cytokine IL-1α were decreased with triclosan exposure (Marshall et al.
2015). In the dLNs, repeated exposure to triclosan increased levels of Th2 cytokines (IL-4, IL13), a Th17 cytokine (IL-17A), a Th22 cytokine (IL-22), and a Th1 cytokine (IFN-γ) (Marshall
et al. 2015). Changes in immune cell composition also occurred in the dLNs; dermal exposure to
triclosan increased the frequency and number of B cells and DCs while CD4+ and CD8+ T cells
were decreased in frequency but increased in number (Marshall et al. 2015). Importantly,
GATA3+ T cells and OX40 expressing CD4+ T cells were increased with exposure to triclosan,
supporting a Th2-skewed immune response (Marshall et al. 2015). The Th2-related cytokine
TSLP was shown to play an important role in this Th2-skewing response; blockage of TSLP
reduced GATA-3 and OX40 expression on T cells (Marshall et al. 2015). In another study, the
Th2 immune response was also confirmed; gene expression of the Th2 cytokine Il4 was
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increased in both the skin and dLNs of mice following dermal exposure to triclosan (Anderson et
al. 2020). Together these studies suggest that dermal triclosan exposure is immunomodulatory
and impacts both the skin microenvironment and dLNs. These studies also suggest that triclosan
augments the allergic response through a Th2-mediated immune reaction.

Figure 1.2. Schematic showing the effects due to dermal triclosan exposure on BALB/c mice.
Dermal exposure to triclosan increases proinflammatory and Th2-related cytokines in the skin.
Triclosan exposure also increases the number of immune cells and proinflammatory/Th2/Th17
cytokines in the dLNs. Figure from (Marshall et al. 2015).
In addition to triclosan, paraben exposure has been associated with food sensitization,
aeroallergy, and asthma exacerbation (Quiros-Alcala et al. 2019; Savage et al. 2014; Savage et
al. 2012). However, sensitization to parabens is rare, with rates reported between 0.6% and 3% in
North America (Hafeez and Maibach 2013), suggesting that parabens may also act as adjuvants
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in allergic disease. In mice, dermal exposure to butyl paraben has been shown to exacerbate the
ear swelling response in a model of contact hypersensitivity (Matsuoka et al. 2018).
Additionally, exposure to butyl paraben was demonstrated to increase the frequency of allergenspecific DCs and the production of IL-4 and IFN-γ in the dLNs (Matsuoka et al. 2018). In
another study using a mouse model of asthma, subcutaneous exposure of ethyl paraben in dams
increased the number of eosinophils, allergen-specific IgE, and IL-5 cytokine production in the
female mouse offspring, although airway hyperreactivity was not significantly impacted (Junge
et al. 2022). Although these studies have limitations (e.g., differences in dose, duration, and route
of exposure), these studies suggest that parabens may also act as adjuvants in allergic disease
through immunomodulation, including Th2-skewed immune responses.
Formaldehyde may also act as an adjuvant in respiratory allergic diseases such as asthma.
Although formaldehyde is a known and prevalent contact sensitizer, recently estimated to occur
at a rate of 7.4% in individuals in North America (DeKoven et al. 2021), reports of formaldehyde
as a respiratory sensitizer are not as common (Burge et al. 1985). However, exposure to
formaldehyde has been positively associated with asthma exacerbation in humans (Lam et al.
2021), suggesting that formaldehyde exposure augments respiratory allergic disease. In mice,
exposure to gaseous formaldehyde has been shown to increase the airway hyperreactivity
response in a model of asthma (Liu et al. 2011). The authors of this study also showed that
formaldehyde elevated the number of eosinophils and levels of IL-4 and IL-6, but not IFN-γ, in
the lungs compared to allergen exposure alone (Liu et al. 2011), suggesting dominance of a Th2
response. Taken together, these studies suggest that certain chemical exposures may result in
mixed or Th2-skewed immune responses, rather than the traditional Th1-skewed response of a T
cell-mediated reaction, and highlight the need for further investigations into the mechanisms of
immunomodulation resulting from exposure to chemicals.
Immune cells
In addition to T cells, DCs play a central role in the development of an allergic disease.
Specifically, DCs transfer antigen from a barrier site to a dLN. In the dLN, the DC interacts with
a T cell by presenting an antigen on the major histocompatibility (MHC) complex to the T cell
receptor (TCR) on the T cell. The MHC-TCR interaction is central to antigen presentation.
However, other interactions are important in the specific response that occurs along with antigen
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presentation. For example, OX40L expression on DCs is involved in promoting Th2 responses
(Hammad and Lambrecht 2015). As mentioned previously, exposure to 3% triclosan on mice has
been demonstrated to increase the frequency and number of DCs in the dLNs (Figure 1.2)
(Marshall et al. 2015), suggesting that there is an increased potential for DC-T cell interactions in
the LNs, a key step in sensitization. Furthermore, T cells had increased OX40 expression
following dermal triclosan exposure, suggesting an increase in the OX40L-OX40 interaction
which promotes Th2 responses (Marshall et al. 2015). Together these results show that triclosan
exposure on the skin influences responses in the dLNs by promoting Th2 immune responses.
However, less is known about the reactions occurring in the skin microenvironment. Among
these reactions with potential influence on Th2 immune responses include cytokines, barrier
integrity, and the microbiome.
Cytokines
The signals in the microenvironment of the barrier tissue are a critical component in
determining the subsequent type of immune skewing. Cytokines are an important contributor of
immune system activation because they facilitate the crosstalk between cell types. Cytokines that
are involved in the early steps of Th2-skewing include TSLP, IL-25, and IL-33 (Dainichi et al.
2018). TSLP, IL-25, and IL-33 are produced by epithelial cells such as keratinocytes and signal
to immune cells in the skin, including DCs and ILC2s (Celebi Sozener et al. 2020; Dainichi et al.
2018). TSLP has been well-studied in the context of Th2-skewed skin diseases such as AD
(Hammad and Lambrecht 2015; Soumelis and Liu 2020). Although a sensitizing antigen has not
been found for AD, this inflammatory skin disease is typically considered a Th2-skewed disease.
Additionally, AD is often considered the precursor to food allergy and asthma development,
called the atopic march, suggesting that these Th2-skewed diseases (food allergy, asthma) are
linked (Goleva et al. 2019). In mice, overexpression of Tslp in the skin has been shown to cause
AD-like disease and promote Th2 immune responses (Yoo et al. 2005). Furthermore, elevated
levels of TSLP in early childhood have been correlated with increased risk for development of
AD (Kim et al. 2016). TSLP has also been shown to promote Th2 responses by increasing
OX40L on DCs (Ito et al. 2005). Together these studies show that TSLP is a key cytokine in
promoting Th2 immune responses.
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TSLP has been shown to be a key component in the response to triclosan exposure.
Dermal exposure to 3% triclosan has been demonstrated to increase TSLP protein levels in
mouse skin, but not IL-25 or IL-33 (Figure 1.2) (Marshall et al. 2015). Furthermore, blocking
TSLP was shown to reduce the Th2-skewing responses (Marshall et al. 2015), confirming the
important role of TSLP following exposure to triclosan. These studies suggest a link between
TSLP and Th2 immune responses in the context of triclosan exposure on the skin. In addition to
triclosan, repeated dermal exposure to other antimicrobial chemicals (BAC, DDAC, OPA) used
by health care workers has been shown to increase expression of Tslp in the skin of mice
(Anderson et al. 2020). Together, these results demonstrate the importance of TSLP in the
response to chemical exposure and support a role for TSLP in the Th2-skewing responses.
T cell subsets also produce specific cytokines that are involved in the immune response
(Table 1.2). The Th2 cytokines (IL-4, IL-5, IL-13) play a central role in diseases such as AD and
asthma (Dainichi et al. 2018; Hammad and Lambrecht 2015). Dermal exposure to triclosan has
been shown to upregulate Il4 gene expression in both the skin and dLNs of mice in both a dose
and time-dependent manner (Anderson et al. 2020). Additionally, exposure to triclosan on mouse
skin has been demonstrated to increase IL-4 protein levels in skin and IL-4 and IL-13 protein
levels in dLNs (Marshall et al. 2015), further supporting the Th2 immune skewing following
triclosan exposure. However, it is important to note that other cytokines (IL-17A, IL-22, IFN-γ)
were also increased in the dLNs, suggesting mixed/complex immune responses as well (Figure
1.2) (Marshall et al. 2015). Repeated exposure to triclosan (0.75%, 1.5%, 3%) also increased the
expression of Il22 in mouse skin (Anderson et al. 2020). IL-22 has been shown to be involved in
the pathology of certain skin diseases, such as psoriasis (Fujita 2013). Taken together these
studies show the importance of cytokine signaling in the skin and dLNs and that exposure to
triclosan can increase the production of certain cytokines in the skin, potentially altering
signaling pathways and increasing the risk or severity of allergic diseases.
Innate immune responses
Activation of the innate immune system to facilitate sensitization can occur through
danger associated molecular patterns (DAMPs) binding to pattern recognition receptors (PRRs).
Activation of PRRs results in specific downstream responses and is dependent on the DAMPs
and PRRs involved. The DAMPs S100 calcium-binding protein A8 (S100A8) and S100A9 are
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related to Th2 diseases. For example, individuals with AD and mouse models of AD have both
been shown to have elevated levels of S100A8 and S100A9 (Kim et al. 2021a). S100A8 and
S100A9 form a heterodimer, called calprotectin, and are involved in Toll-like receptor 4 (TLR4)
signaling. The downstream responses due to TLR4 activation, such as increased production of
proinflammatory cytokines (IL-6, IL-12, TNF-α), play a role in the process of sensitization
(Koppes et al. 2017). Interestingly, repeated dermal exposure to triclosan on mice has been
shown to increase the expression of S100a8 and S100a9 as well as Tlr4 in the skin (Marshall et
al. 2017), suggesting that triclosan exposure contributes to Th2 immune responses through the
action of S100A8/S100A9 signaling. Inflammasome activation is also an important component
of the innate immune system and may play a role in sensitization (Koppes et al. 2017). Dermal
exposure to triclosan has been shown to activate the NLR family pyrin domain containing 3
(NLRP3) inflammasome and increase IL-1β production (Weatherly et al. 2020), suggesting that
triclosan exposure initiates innate immune responses also through inflammasome activation.
Both TLR4 signaling and NLRP3 inflammasome activation are contributors in the innate
immune responses and may be ways that triclosan contributes to increased potential for
sensitization and severity of allergic disease.
Recently, innate immune cells have become an area of interest because of their presence
in barrier sites and potential role in allergic disease. Specifically, innate lymphoid cells (ILCs)
have been shown to have a role in mediating allergic diseases (Kobayashi et al. 2020). ILCs are
grouped into three subpopulations (ILC1s, ILC2s, and ILC3s) and each have been identified in
the skin (Kobayashi et al. 2020). ILC2s have been shown to be elevated in patients with AD and
are thought to play a role in wound healing and promoting Th2 diseases through the production
of Th2 cytokines (IL-4, IL-5, IL-9, IL-13) (Kobayashi et al. 2020). Additionally, TSLP is known
to be involved in activating ILC2s (Kobayashi et al. 2020). Dermal exposure to the antimicrobial
chemical DDAC has been shown to activate ILC2s in mouse skin, suggesting the involvement of
these innate immune cells in response to chemical exposures on the skin (Shane et al. 2019b).
However, the impact of dermal triclosan exposure on ILC2s has not been investigated.
In conclusion, studies have shown that dermal exposure to triclosan impacts the immune
responses in both the skin and dLNs through cytokine signaling (e.g., TSLP),
S100A8/S100A9/TLR4 signaling, and inflammasome activation. These factors are known to
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play a role in increasing sensitization potential, suggesting that exposure to triclosan augments
allergic disease through these immune responses. However, disruptions in the integrity of the
skin barrier and microbiome have also been linked with allergic diseases, but they have not been
examined following triclosan exposure on the skin. Thus, there is a critical need to examine the
effects of dermal triclosan exposure on the skin barrier and microbiome so that the mechanisms
by which triclosan modulates the immune system and promotes disease are better understood.

The skin barrier
Introduction
The skin is the largest organ in the body, plays an essential role as a physical barrier, and
is a critical component of the innate immune system. The physical barrier of the skin acts as an
initial defense against foreign molecules and pathogens. However, decreased integrity of the skin
may lead to or contribute to disease potentially through alterations in immune responses, skin
permeability, and increased absorption of allergens. Breakdown of the skin barrier is associated
with Th2 diseases including AD (Kelleher et al. 2015), food allergy (Kelleher et al. 2016), and
aeroallergen sensitization (Boralevi et al. 2008) and this suggests that the skin plays an important
role in Th2 diseases. Therefore, investigating the interplay of the skin barrier and Th2 immune
responses may improve the understanding of mechanisms of sensitization. Additionally, this
knowledge could be utilized for the prevention or treatment of allergic diseases.
The outer layer of the skin, the epidermis, is primarily comprised of keratinocytes that
undergo a process of proliferation and terminal differentiation in order to create the skin barrier
(Figure 1.3). The skin renewal process takes ~28 days in humans and ~8-10 days in mice (De
Vuyst et al. 2017). The skin barrier is comprised of the stratum corneum and tight junctions
(Goleva et al. 2019). Key components of the stratum corneum are the cornified envelopes and
lipids. The epidermal differentiation complex (EDC) is a region of the genome that encodes
genes involved in formation of the cornified envelope. The EDC encodes the single genes
involucrin (IVL) and loricrin (LOR) as well as several gene clusters: small-proline rich (SPR)
proteins 1-4, late cornified envelope (LCE) proteins 1-5, S100 genes, and S100 fused-type
protein (SFTP) genes (Toulza et al. 2007; Wu et al. 2009). The seven SFTP genes are
profilaggrin (FLG), filaggrin 2 (FLG2), trichohyalin (TCHH), TCHH-like 1, hornerin (HRNR),
repetin (RPTN), and cornulin (CRNN) (Hsu et al. 2011; Wu et al. 2009). The most well-studied
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EDC genes are IVL, LOR, and FLG. IVL is expressed in the stratum spinosum and is a precursor
to the cornified envelope (Goleva et al. 2019). LOR is expressed later on during keratinocyte
differentiation in the stratum granulosum (Goleva et al. 2019). IVL and LOR form crosslinks with
transglutaminase-1 and together they make-up the cornified envelope in the stratum corneum
(Goleva et al. 2019). FLG is expressed as profilaggrin and broken down into filaggrin
monomers, which are also components of the cornified envelope (Figure 1.3) (Goleva et al.
2019). A more recently discovered gene, FLG2, is thought to play a similar role as FLG in
supporting the cornified envelope and in maintaining skin integrity (Figure 1.3) (Albérola et al.
2019; Pendaries et al. 2015). SPR proteins and TCHH are also involved in maintaining the
structure of the cornified envelope (Candi et al. 2005). The fifteen S100 genes encoded in the
EDC in humans have functions that extend beyond skin integrity (Lesniak and Graczyk-Jarzynka
2015). Some of the S100 genes are involved in normal keratinocyte function (e.g., S100A10,
S100A11) and others are upregulated following pathogen or allergen exposure and have
antimicrobial and cell signaling roles (e.g., S100A7, S100A8, S100A9, S100A12) (Lesniak and
Graczyk-Jarzynka 2015). EDC genes are therefore important in maintaining skin integrity and
promoting normal keratinocyte functions.
The importance of EDC genes is further supported by the correlations present between
EDC gene mutations and disease. Loss-of-function mutations in EDC genes such as FLG
(Drislane and Irvine 2020) or FLG2 (Margolis et al. 2014) are a risk factor for AD and allergic
diseases. Additionally, individuals with AD have been found to have reduced expression of FLG
and FLG2 in their skin (Pellerin et al. 2013). FLG mutations are also associated with the skin
condition ichthyosis vulgaris (Cabanillas and Novak 2016) and FLG2 mutations are associated
with peeling skin syndrome (Alfares et al. 2017; Bolling et al. 2018). These results demonstrate a
connection between EDC genes and disease, including allergic diseases, which suggests an
interplay between EDC genes and the immune system.
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Figure 1.3. Structure of the epidermis. The epidermis is comprised of four layers: stratum
corneum, stratum granulosum, stratum spinosum, and stratum basale. Keratinocytes proliferate in
the stratum basale and express keratin 14 (Krt14). As keratinocytes move to the stratum
spinosum, they undergo a process of terminal differentiation and switch expression to keratin 10
(Krt10). Keratinocytes form tight junctions, a component of the skin barrier, in the stratum
granulosum (shown as the black line) and express genes such as tight junction protein 1 (Tjp1).
Differentiating keratinocytes also express genes involved in forming the cornified envelope,
another component of the skin barrier, including Flg and Flg2.
Methods to study skin responses
Methods in the clinic, in animal models, and in vitro have been developed to investigate
the role of the skin barrier in microbial infection, wound healing, AD, psoriasis, and more. For
example, trans-epidermal water loss (TEWL) is a non-invasive measurement that measures water
evaporation from the skin; increased TEWL levels indicate decreased integrity of the skin barrier
(Fluhr et al. 2006). This measurement is a useful tool to measure barrier integrity both in humans
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and in animal models. Genes involved in skin integrity (e.g., FLG, FLG2, IVL, LOR) can also be
examined at the gene and protein level to provide information regarding skin responses. Changes
in expression may indicate disruption of homeostasis and may be a mechanism by which the
barrier integrity is disrupted. Hairless mice (e.g., SKH1) are useful in skin studies such as wound
healing and skin cancer research where large areas of visible skin are needed for investigation
(Benavides et al. 2009). Importantly, these mice, specifically the outbred SKH1 strain, are
immunocompetent (Schaffer et al. 2010). Keratinocytes, the most abundant cell type in the
epidermis, can be investigated in vitro through culture techniques. While cultured keratinocytes
are useful in many circumstances, 3D skin models provide a useful way to look at multiple
differentiated layers in the context of an intact skin barrier. Reconstructed human epidermis
(RHE) and full thickness skin are types of 3D skin models that can be used to study the skin
barrier and diseases associated with the skin (Niehues et al. 2018; Rademacher et al. 2018). RHE
is comprised of keratinocytes to create the epidermal layer and full thickness skin is constructed
with both keratinocytes and fibroblasts to create the epidermal and dermal layers (Rademacher et
al. 2018). Importantly, these 3D skin models are maintained at the air-liquid interface to mimic
the skin environment (Figure 1.4A) (Frankart et al. 2012) and all four skin layers including an
intact stratum corneum are present in the epidermis (Figure 1.4B). Specific genes in these in
vitro skin models have been successfully knocked out and used to evaluate potential gene
function (Mildner et al. 2006). Additionally, barrier integrity can be evaluated by measuring the
passage of molecules (e.g., Lucifer Yellow) through the tissue (Mildner et al. 2010; Pendaries et
al. 2014). These various methods (in vivo and in vitro) are useful ways to investigate the skin
microenvironment and skin barrier in the context of various diseases. The skin is a common
route of chemical exposure; therefore, these methods can also be used in the investigation of
dermal exposure to chemicals, such as triclosan.
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Figure 1.4. The 3D skin model. (A) RHE tissue inserts are maintained at the air-liquid interface
by suspending the tissue inserts over culture media. The culture media provides the nutrients and
growth factors needed for the tissues to thrive. (B) Hematoxylin & eosin stain of an RHE tissue.
All four layers including the stratum corneum are present.
Filaggrin and allergic disease
FLG mutations are associated with Th2 diseases including AD (Kelleher et al. 2015) and
food allergy (Kelleher et al. 2016). FLG is also downregulated in the skin of individuals with
AD, independent of FLG mutations (Drislane and Irvine 2020). Due to the well-established link
between FLG mutations and AD (Cabanillas and Novak 2016), animal models and RHE 3D
human skin models have been used for mechanistic studies. Flaky tail mice, which have a lossof-function mutation in Flg and transmembrane protein 79 (Tmem79), develop exacerbated
responses to chemicals and allergens (Fallon et al. 2009; Oyoshi et al. 2009; Scharschmidt et al.
2009). Flaky tail mice also have been shown to have elevated TEWL levels (Moniaga et al.
2010); however, not all studies have observed this (Fallon et al. 2009) or it has been
demonstrated only in aged flaky tail mice (Scharschmidt et al. 2009). Flg knockout mice also
have exacerbated responses to chemicals and allergens (Kawasaki et al. 2012). A skewing
towards Th2 responses further promotes the uptake of allergens in the flaky tail mouse model
(Sehra et al. 2016). Additionally, BALB/c mice, which have a Th2 bias, with a Flg mutation
develop skin inflammation as well as lung inflammation and increased airway hyperreactivity
with age (Saunders et al. 2016). Together these results suggest the importance of Flg in
preventing chemical and allergen sensitization and suggest a link between the skin barrier and
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lung inflammation. This finding correlates also with the atopic march in humans when AD in
early childhood has been shown to precede the development of food allergy and asthma later on.
FLG knockdown in human skin models has been shown to increase permeability to the
molecule Lucifer Yellow, suggesting that FLG is important for normal skin barrier function
(Mildner et al. 2010; Pendaries et al. 2014). However, other studies show conflicting results (van
Drongelen et al. 2013). Additionally, 3D skin models constructed with keratinocytes derived
from patients with FLG mutations have not been shown to have a disrupted skin barrier (Niehues
et al. 2017). Despite these conflicting results, it is generally recognized that FLG plays a role in
maintaining the skin barrier and that loss-of-function mutations in FLG contribute to Th2
diseases (Cabanillas and Novak 2016). However, many questions still remain regarding the
immune mechanisms that relate skin barrier disruption resulting from chemical exposure.
FLG2 mutations have also been associated with AD (Margolis et al. 2014). Furthermore,
individuals with AD have been shown to have reduced FLG2 protein in their skin (Broccardo et
al. 2011; Pellerin et al. 2013). These results suggest that FLG2 also plays a role in Th2 diseases;
however, the role of FLG2 is not well understood. Although FLG2 and FLG are both expressed
by keratinocytes, they may have unique roles potentially due to different timing in production
(Makino et al. 2014; Wu et al. 2009). In a RHE model, FLG2 knockdown has been demonstrated
to disrupt the skin thickness, morphology, pH, and processing patterns of FLG (Pendaries et al.
2015). FLG2 has also been shown to be involved in cell-cell adhesions between keratinocytes
(Mohamad et al. 2018) and a portion of FLG2 is structurally involved in cornified envelopes
(Albérola et al. 2019). Flg2 is also expressed in mouse skin, although its function is unknown
(Hansmann et al. 2012). Taken together, these results suggest that FLG2 is involved in skin
integrity and that altered expression patterns may play a role in disease.
Tight junctions and allergic disease
Tight junctions between keratinocytes in the stratum granulosum are also important in
skin barrier and function (Figure 1.3) (Goleva et al. 2019; Kirschner et al. 2013). Tight junctions
are made up of transmembrane proteins and cytosolic scaffold proteins (Goleva et al. 2019).
Transmembrane proteins include junctional adhesion molecules, occludin, and claudins. The
cytosolic scaffold proteins, zonulae occludens (also known as tight junction proteins (TJPs)),
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connect to the actin cytoskeleton of a cell. Regulation of these tight junction genes is critical for
formation and maintenance of the skin barrier. One way that tight junctions are regulated is
through activation of PRRs expressed on keratinocytes (Kuo et al. 2013). For example, activation
of Toll-like receptor 2 (TLR2) on keratinocytes can lead to enhanced barrier function through
tight junctions (Kuo et al. 2013). Knockout of the transmembrane protein claudin-1 in mice
results in premature death and these mice have a disrupted skin barrier (Furuse et al. 2002),
demonstrating the key role of this protein in the skin. Although the role of tight junctions in
allergic diseases has not been well-studied, individuals with AD have been shown to have
decreased levels of claudin-1 (De Benedetto et al. 2011), suggesting that dysfunction of tight
junctions plays a role in Th2 diseases.
Keratins and allergic disease
Intermediate filaments are also critical in the skin because of their involvement with both
skin structure and metabolism (Pan et al. 2013). Intermediate filaments are comprised of keratins
and there are 54 known human keratins: 28 type I keratins and 26 type II keratins (Pan et al.
2013). Keratins are regulated as pairs and form heterodimer complexes to make intermediate
filaments through the pairing of a type I and type II keratin (Moll et al. 2008). The specific
keratins that are expressed vary depending on the tissue type and stage of development. In the
epidermis, KRT14 and KRT5 are expressed by keratinocytes in the basal layer whereas KRT10
and KRT1 are expressed by keratinocytes in the differentiation stage (Figure 1.3) (Moll et al.
2008). However, upon stress or damage, activated keratinocytes upregulate expression of
KRT6a, KRT16, and KRT17 and these keratins are involved in the wound healing response
(Moll et al. 2008; Zhang et al. 2019). Genetic mutations in certain keratins result in skin fragility
disorders such as KRT5/KRT14 causing epidermolysis bullosa simplex or KRT1/KRT10 causing
epidermolytic hyperkeratosis (Pan et al. 2013). KRT10 is essential to skin barrier integrity and
function because homozygous KRT10 knockout mice die within a few hours of birth and have
increased levels of TEWL (Jensen et al. 2000; Porter et al. 1996). These findings demonstrate the
critical role that keratins play in skin integrity.
Although limited, some studies have suggested that there are interactions between
keratins and the immune response (Goleva et al. 2019; Pan et al. 2013). Dysregulation of keratins
and Th2 immune responses have been correlated; individuals with AD have been shown to have
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decreased levels of KRT1 and KRT10 (Totsuka et al. 2017). Furthermore, stimulation with Th2
cytokines (IL-4, IL-13) has been shown to decrease KRT1 and KRT10 expression in cultured
human keratinocytes (Totsuka et al. 2017), demonstrating an impact of Th2 cytokines on these
skin barrier genes. Lack of keratin in the skin is also linked with elevated TSLP production
(Kumar et al. 2016). In contrast, KRT6 and KRT16 have been shown to be upregulated in the skin
of individuals with AD and animal models of AD (Kim et al. 2021b). Taken together, these
results show correlation between changes in the immune response and dysregulation of keratins,
but the mechanisms related to their influence on Th2 diseases is unknown.
Disrupting skin integrity
Although mutations of skin barrier genes such as FLG and their resulting impacts have
been well-studied, the impact of environmental exposures on skin integrity and disease is an
emerging area of research (Akdis 2021). Exposure to detergents, cigarettes, ozone, diesel
exhaust, nanoparticles, microplastics, and more have been shown to damage epithelial barriers of
the skin, lungs, and/or gut (Celebi Sozener et al. 2020). Specifically, detergents decreased barrier
integrity of bronchial epithelial cells (Wang et al. 2019) and keratinocytes (Xian et al. 2016)
through decreased tight junction integrity. Additionally, exposure to particulate matter on
cultured keratinocytes and mouse skin has been demonstrated to decrease barrier integrity and
decrease FLG expression (Kim et al. 2021a). The sensitizer para-phenylenediamine has also been
shown to alter the expression of FLG and FLG2, specifically in individuals with ACD (Meisser
et al., 2020), demonstrating a compound effect with chemical exposures and allergic skin
disease. Although mechanisms relating chemical exposures and Th2 skin diseases are not wellunderstood, skin damage has been shown to activate the immune response through the release of
Th2-related cytokines (TSLP, IL-33, IL-25) and these cytokines are involved in the activation of
DCs and ILC2s (Celebi Sozener et al. 2020; Dainichi et al. 2018). Although the impact of
triclosan exposure on the skin barrier specifically has not been examined, exposure to triclosan
altered metabolic pathways and lipid levels, increased ROS production, and increased
proinflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α) by cultured keratinocytes (Liang et al.
2021). Understanding the impact of triclosan exposure on skin integrity is relevant because
health care workers may be particularly vulnerable to breakdown of the skin barrier due to wet
work and the potential for chemical exposures. Health care workers have been shown to have
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elevated TEWL levels compared to controls, indicating decreased skin barrier integrity (Visscher
et al. 2010). Taken together, exposure to chemicals and other environmental pollutants may
contribute to disease through skin barrier damage or altered keratinocyte function.
Disruption of the intact skin barrier may also increase the risk of sensitization by
increasing skin permeability and absorption of chemicals and allergens. The permeability of
sucrose, caffeine, and hydrocortisone has been shown to be increased in mice with decreased
barrier integrity (Tsai et al. 2001). Additionally, pyrimethanil, pyrene, and oxybenzone
absorption is increased in individuals with FLG mutations or lower copy number variants of FLG
(Rietz Liljedahl et al. 2021). In mouse models of skin sensitization to protein allergens such as
ovalbumin, skin barrier disruption is a necessary step for sensitization to occur (Nakajima et al.
2012). Together these studies show that decreased barrier integrity increases chemical and
allergen absorption through the skin. This may be one mechanism by which disruptions in the
skin barrier contribute to sensitization and the development of disease.
Interplay of the skin barrier and immune responses
Environmental exposures, skin barrier disruption, and altered immune responses are all
closely connected. Although decreased barrier integrity alone does not directly lead to AD and
allergic diseases, the combination of decreased skin integrity with an altered immune response is
a strong risk factor for sensitization and allergic disease. The development of certain animal
models for AD reflects this. Animal models for AD can be grouped into (1) spontaneous
development of AD-like disease, (2) genetic mutations, or (3) topical application of a sensitizer
that leads to an AD-like disease (Jin et al. 2009). One animal model of AD combines disrupting
the skin barrier with application of an allergen (Jin et al. 2009). Additionally, dermal exposure to
a hapten such as oxazolone or trinitrocholorobenzene (TNCB) has been demonstrated to alter
barrier integrity and immune responses, resulting in features that resemble AD-like disease (Jin
et al. 2009). Specifically, dermal exposure to 1% TNCB for 36 days has been demonstrated to
produce characteristics of AD including redness and scaling, epidermal hyperplasia, increased
number of CD4+ T cells and mast cells, increased serum IgE, increased TEWL, and decreased
skin hydration (Matsumoto et al. 2004). However, it has been noted that these AD models may
be more reflective of ACD rather than true AD (Gilhar et al. 2021). Regardless, these animal
models, although less useful for understanding AD in humans, are informative regarding
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chemical exposures and their interactions with the skin barrier and immune system. Taken
together, these results suggest a close connection between chemical exposure, decreased barrier
integrity, and activation of the immune system.
Cytokines have a wide range of influence on keratinocytes and their function (GutowskaOwsiak and Ogg 2013; Jiang et al. 2020). For example, TSLP-stimulated keratinocytes in vitro
have been shown to have reduced levels of FLG (Kim et al. 2015a), suggesting that cytokines
such as TSLP may impact barrier integrity. Additionally, IL-22 (Gutowska-Owsiak et al. 2011)
and Th2 cytokines (IL-4, IL-13) (Howell et al. 2009) have been demonstrated to decrease FLG
expression in cultured human keratinocytes. Interestingly, flaky tail mice with a mutation in the
skin barrier gene Flg have increased expression of Tslp (Moniaga et al. 2013). Together these
studies suggest interactions between the immune response and skin barrier. However, the
question of whether it is skin barrier disruption or an altered immune response that occurs first in
the context of human disease (e.g., AD) remains unanswered.
Conclusion
The skin is a dynamic tissue comprised of multiple layers of proliferating and
differentiating keratinocytes that produce cytokines and interact with immune cells. Cornified
envelopes, lipids, tight junctions, and keratins are all important in maintaining the structure and
function of the skin. Disruptions in any of these components may lead to decreased integrity of
the skin and impact immune responses. Although genetic mutations can decrease skin barrier
integrity, environmental exposures can also contribute. While decreased skin integrity alone is
insufficient for sensitization, the combination of a decreased barrier with changes in the immune
system may increase the risk of sensitization. Together, studies have demonstrated crosstalk
between the skin barrier and the immune response and have showed that alterations in one can
impact the other. Additional research is needed to investigate mechanisms of decreased barrier
integrity and its relationship with the immune response. This knowledge may expand options for
the prevention and treatment of allergic diseases.
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The microbiome
Introduction
The microbiome, comprised of microorganisms that live in and on the body, has emerged
as an important player in human health. Commensal microorganisms interact closely with tissues
and are important in the development and regulation of the immune system (Belkaid and
Harrison 2017). The microbiome is regulated by host factors, such as physical barriers and
antimicrobial peptides, and by interactions with other microorganisms. These interactions are
critical for maintaining homeostasis. When homeostasis is disrupted, called dysbiosis, this may
result in or contribute to the development of disease. Dysbiosis has been associated with many
diseases including AD, asthma, and food allergy (Lunjani et al. 2018). Diet, lifestyle, and
environmental exposures have been shown to shape the microbiome and changes in these factors
may contribute to dysbiosis and the development of disease.
Commensal microorganisms are acquired upon birth, established primarily during the
first 3 years of life, and are found throughout the body, including the oral cavity, colon, vagina,
and skin (Gilbert et al. 2018; Peroni et al. 2020). These microorganisms include bacteria, viruses,
fungi, protozoa, and archaea (Peroni et al. 2020). However, bacteria have been the most widely
studied microorganism, particularly in the gut. In the gut, Bacteroides and Firmicutes are the
most abundant phyla (Peroni et al. 2020). Specific examples of beneficial gut bacteria include
Bacteroides fragilis, Alistipes shahii, segmented filamentous bacteria, Clostridium leptum,
Roseburia, and Anaerostipes (Figure 1.5) (Belkaid and Harrison 2017; Peroni et al. 2020). In
contrast, the most abundant bacterial phyla on the human skin, in order of relative abundance, are
Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes (Grice et al. 2009). Examples
include Corynebacterium, Propionibacterium, Cutibacterium acnes, and Staphylococcus
epidermidis (Figure 1.5) (Belkaid and Harrison 2017; Flowers and Grice 2020; Peroni et al.
2020). Interestingly, the abundance of each species on the skin is dependent on the conditions of
the body site (sebaceous, moist, or dry) (Grice et al. 2009). Fungi of the Malassezia species are
also present on the skin (Byrd et al. 2018). Although establishment of the microbiome occurs
during early childhood, the microbiome can also be shaped later-on in life by diet, antibiotic
usage, occupation, pet ownership, exercise, sleep, and stress (Gilbert et al. 2018). These factors
may contribute to dysbiosis and disease.
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Figure 1.5. Diagram of bacterial classification. Select genera/species are included based on their
presence and beneficial role in the human microbiome (Belkaid and Harrison 2017; Flowers and
Grice 2020; Gilbert et al. 2018; Peroni et al. 2020). Classification ranks are from the most recent
update (April 2020) in the NCBI taxonomy database (Schoch et al. 2020).
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Bisphenol A, phthalates, perfluorochemicals, heavy metals, pesticides, and more have
also been shown to alter the gut microbiome (Chiu et al. 2020). Additionally, exposure to
antimicrobial chemicals, such as triclosan, may disrupt the microbiome (Yee and Gilbert 2016).
Triclosan exposure has been shown to disrupt the microbiome of humans (Bever et al. 2018),
fish (Gaulke et al. 2016; Narrowe et al. 2015), mice (Gao et al. 2017; Yang et al. 2018), rats (Hu
et al. 2016), and an in vitro model of the human gut (Mahalak et al. 2020). Although the impact
of triclosan on the skin has not been specifically studied, exposure to other antimicrobials on the
skin has been explored. Specifically, topical application of antibiotics has been demonstrated to
disrupt the skin microbiome in mice (SanMiguel et al. 2017) and topical application of
antiseptics has been shown to disrupt the skin microbiome in humans (SanMiguel et al. 2018).
However, more studies are needed to understand the specific impacts of chemical exposures,
specifically antimicrobials, on the microbiome and the consequences of dysbiosis on disease.
The microbiome’s influence on the immune system
During homeostasis, the microbiome has been shown to develop and regulate the immune
system systemically and locally (Belkaid and Harrison 2017). Metabolites from bacteria, such as
short chain fatty acids (SCFAs), can impact hematopoiesis and migrate to various tissues within
the body, having systemic effects (Belkaid and Harrison 2017). The microbiota is also important
for promoting regulatory T cells (Tregs), which control inflammatory processes within the body.
Locally, the microbiota can influence innate lymphoid cells, such as ILC3s, γδ T cells, and
mucosal associated invariant T cells (Belkaid and Harrison 2017). Furthermore, epithelial cells at
barrier sites sense the presence of microorganisms through TLRs, NOD-like receptors, and
SCFA receptors, resulting in signals that reinforce and maintain the integrity of the barrier
(Belkaid and Harrison 2017). Although many of these findings are from studies of the gut
microbiome, the skin microbiome has been shown to be important in the regulation of the
immune system as well, such as promoting Tregs in the skin (Flowers and Grice 2020).
Staphylococcus epidermidis, an abundant member of the skin microbiome, produces SCFAs,
enhances TLR2 regulatory signaling pathways, and helps to protect the skin from potential
pathogens, such as S. aureus (Stacy and Belkaid 2019). Together these findings support an
important role of the microbiome in the development and maintenance of the immune system.
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However, dysbiosis has been associated with AD, food allergy, and asthma (Peroni et al.
2020). The microbiome has been suggested to regulate Th2 immune responses, and dysbiosis
may diminish these regulatory mechanisms and promote the development of allergic disease
(McCoy et al. 2018). Mice lacking a microbiome, called germ-free mice, have been shown to
have exacerbated airway hyperreactivity in a model of asthma or exacerbated responses in a
model of food allergy (Herbst et al. 2011; Stefka et al. 2014). However, recolonization with
microorganisms reduces these responses, suggesting that the microbiome plays a role in
regulating immune responses. Less work has focused on the skin microbiome specifically.
However, the skin microbiome remains important because dysbiosis of the skin microbiome is
associated with AD (Nakatsuji and Gallo 2019; Paller et al. 2019). Specifically, individuals with
AD have been shown to have reduced diversity of microorganisms on the skin, called alpha
diversity, and over 90% of patients are thought to have an overgrowth of the pathogen S. aureus
(Lunjani et al. 2018). While the role of S. aureus on the skin is an active area of investigation,
the roles of other species of microorganisms on the skin are often overlooked.
The skin microbiome
As mentioned, the skin microbiome has been shown to be important in the maintenance
of the immune system (Flowers and Grice 2020; Stacy and Belkaid 2019). However, disruptions
in the skin microbiome are associated with diseases involving the immune system. One wellstudied association is skin dysbiosis and AD (Nakatsuji and Gallo 2019). Skin dysbiosis may
result from exposure to antimicrobials and this is an emerging area of research. In mice,
application of a triple-antibiotic ointment on the mouse skin was shown to decrease alpha
diversity and specifically increased the abundance of Enterobacteriaceae and Ruminococcaceae,
while Lachnospiraceae was decreased in abundance following antibiotic ointment exposure
(SanMiguel et al. 2017). In another study, researchers from this lab also showed that, in humans,
topical application of the antiseptics alcohol and povidone-iodine altered the composition of
bacteria on the skin (SanMiguel et al. 2018). These studies suggest that antimicrobials disrupt the
skin microbiome. However, the impact of this type of disruption on human health and disease
has not been studied. Additional studies are needed to explore the impact of exposure to other
antimicrobials on the skin microbiome and their potential to promote disease.
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In addition to crosstalk between the microbiome and immune system, the microbiome has
also been shown to interact with the skin barrier (Baldwin et al. 2017). Germ-free mice have
been shown to have altered expression patterns of skin barrier genes and increased keratinocyte
proliferation (Meisel et al. 2018), suggesting that the microbiome plays a role in regulating the
skin barrier. The microbiome may also play a role in skin barrier repair through activation of the
aryl hydrocarbon receptor (AHR) in keratinocytes (Uberoi et al. 2021). In humans, individuals
with loss-of-function FLG mutations have been shown to have an altered microbiome (Baurecht
et al. 2018). Additionally, Flg deficient mice have an altered microbiome (Archer et al. 2019).
Together these studies demonstrate that there is crosstalk between microorganisms and the skin
barrier. Additionally, these studies suggest that the crosstalk works in both directions.
Methods to investigate the microbiome
Although the impact of the microbiome in human disease is recognized, methods of
investigation are an emerging area of research. Traditionally, culture techniques have been used
in the lab to investigate microorganisms. However, cultures do not provide a complete picture of
microorganisms, because many microorganisms do not grow in the media used in a laboratory
setting. Recent advances in technology have enabled more thorough investigations of
microorganisms. Sequencing is particularly useful for surveying the microorganisms, such as
bacteria, present in an environment. The 16S ribosomal RNA (rRNA) gene has been widely used
to investigate bacteria because this gene is conserved among bacteria but also contains
hypervariable regions to distinguish between species (Byrd et al. 2018). Similarly, internal
transcribed spacer 1 gene sequencing is commonly used for analysis of fungi in an environment
(Byrd et al. 2018). Through sequencing, a more complete picture of microorganisms present in
an environment can be achieved.
Collection method, site of collection, and sequencing technique can all impact
microbiome research results (Meisel et al. 2016). Skin swabs are the most commonly used
collection method for surveys of the skin microbiome. In human skin microbiome studies, the
body site of microbial collection (e.g., sebaceous, moist, dry) impacts the results due to the
preference of certain microorganisms for particular microenvironments (Grice et al. 2009). For
example, Propionibacteria are abundant in sebaceous/oily sites whereas Corynebacteria are more
abundant in moist skin environments (Grice et al. 2009). Sequencing technique has also been
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shown to impact results (Meisel et al. 2016). The 16S rRNA gene has 9 hypervariable regions
V1-V9 and typically the V1-V3 or V4 regions are used for microbiome surveys. The
hypervariable region chosen can influence results though; for example, V1-V3 has been shown
to capture more of the skin bacterial species compared to the V4 region alone (Meisel et al.
2016). Animal models are frequently used in research; however, the composition of the mouse
skin microbiome differs from the human skin microbiome (Figure 1.6). Propionibacterium
(phylum Actinobacteria), Corynebacterium (phylum Actinobacteria), and Staphylococcus
(phylum Firmicutes) are some of the most abundant bacterial genera found on the human skin
(Grice et al. 2009). In comparison, mice have relatively lower levels of Propionibacterium and
Corynebacterium and instead have higher levels of species from the phylum Bacteroidetes and
phylum Firmicutes (Figure 1.6) (Gimblet et al. 2017; SanMiguel et al. 2017). Species from the
phylum Proteobacteria are found on both human and mouse skin, although the types of bacteria
from this phylum differ at the species level. The differences in microbiome composition can be
partially

explained

by

differences

in

skin

properties.

For

example,

on

humans,

Propionibacterium (phylum Actinobacteria) grows well in skin areas abundant with sebum, but
mice have less abundance of sebum on the skin and, therefore, Propionibacterium is less
abundant on mouse skin (Byrd et al. 2018). The similarities and differences between humans and
mice should be considered when translating research findings. Taken together, these results show
that sequencing is a valuable tool for microbiome surveys and that experimental design and
techniques selected also impact findings.
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Figure 1.6. Comparison of bacterial composition on human and mouse skin. Example bacterial
compositions are shown in relative abundance (%) and are based on data reported in previous
skin microbiome studies. Human: (Grice et al. 2009). Mouse: (Gimblet et al. 2017).
Triclosan as an antimicrobial agent
Relatively few studies have investigated the effect of triclosan and the microbiome.
Triclosan exhibits its antimicrobial activity by targeting bacterial fatty acid synthesis.
Specifically, triclosan targets the bacterial enoyl ACP reductase enzyme FabI, an enzyme
involved in fatty acid synthesis (Heath et al. 1999; McMurry et al. 1998). However, bacteria can
acquire resistance to triclosan through mutations in FabI and other genes (Rozman et al. 2021).
Additionally, some species of bacteria have intrinsic resistance to triclosan by encoding
isozymes of the enoyl ACP reductase enzyme: FabK (Heath and Rock 2000) or FabV (Huang et
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al. 2016). Pseudomonas aeruginosa is particularly resistant to the effects of triclosan (Huang et
al. 2016). Resistance to triclosan can also occur through the upregulation of efflux pumps (Khan
et al. 2018). Therefore, exposure to disinfectants commonly used, such as triclosan, is a concern
because their effectiveness may wane when they are abundantly used.
Various techniques in vitro and in vivo are used to investigate the activity and
effectiveness of antimicrobial agents such as triclosan. The minimum inhibitory concentration
(MIC) is a widely used value to determine the effectiveness of an antimicrobial. The MIC for
triclosan is 0.25 µg/mL for Escherichia coli and 0.01 µg/mL for Staphylococcus aureus (Heath
and Rock 2000). Although MIC values can be useful to determine the concentrations needed to
target certain microorganisms, they also have limitations. The FDA has recommended that
clinical outcome studies be used to evaluate reduction of infection, rather than reduction of
microorganism abundance, as a measure of antimicrobial agent effectiveness (FDA 2016).
Focusing on reducing the number of microorganisms, which includes both pathogens and
commensals, may not result in a net reduction of infection, the intended goal of disinfectant and
antiseptic use. Commensal microorganisms play an important role in colonization resistance;
thus, depleting commensal microorganisms may lead to a reduction in the natural competition
against pathogens. Triclosan has been associated with colonization of the pathogen S. aureus
(Syed et al. 2014), suggesting that exposure to triclosan may not reduce infection rates, because
S. aureus is a key pathogen of the skin. However, studies investigating reduction of infection are
limited. One study investigating total bacterial abundance showed that triclosan-containing soap
did not perform any better than regular hand soap in reducing the abundance of bacteria on the
skin (Kim et al. 2015b). This result suggests that the addition of triclosan to hand soap may have
no added benefit. However, exposure to triclosan has been suggested to impact commensal
microorganisms (Yee and Gilbert 2016), supporting the idea that exposure to triclosan may
reduce abundance of certain microorganisms, such as commensals, but not necessarily
pathogens. Overall, data is limited showing the effectiveness of triclosan as a disinfectant in
consumer and occupational settings. Additionally, antibiotic resistance is a growing concern, and
widespread triclosan use may also contribute to the resistance of bacteria to antibiotics (Lu et al.
2018; Westfall et al. 2019).
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Conclusion
The microbiome has emerged as an important component of human health, yet the
underlying mechanisms between dysbiosis and immune related diseases have not been fully
explored. Although the connection between AD and S. aureus is well-established, other skin
microorganisms and their influence on the immune system following antimicrobial exposure and
potential impact on allergic disease is not well studied. Not only are there interactions between
the skin microbiome and immune system, but the skin microbiome and skin barrier have
significant crosstalk as well. Exposure to antimicrobials such as triclosan may contribute to
dysbiosis and disease; however, the impact of triclosan exposure on the skin microbiome has not
fully been evaluated.

Conclusions
Antimicrobial chemicals are frequently used as disinfectants and antiseptics by healthcare
workers, leading to increased risk of exposure and potential for occupational disease. The
antimicrobial chemical triclosan had been increasingly used in consumer and healthcare products
until the ban by the FDA in 2016 from use in consumer soaps. However, triclosan is still used at
high concentrations in clinical product formulations and select consumer products. Although
triclosan specifically targets bacteria, these bacteria may be commensals or pathogens, which
may not confer an overall benefit if rates of infection are not reduced through the use of
triclosan. Furthermore, triclosan exposure may have negative impacts on human health,
including allergic diseases, which could further negate any beneficial effects of using this agent
as a disinfectant or antiseptic. The mechanisms by which triclosan exposure modulates the
immune system include increased TSLP production, S100A8/S100A9/TLR4 signaling, and
NLRP3 inflammasome activation. However, dermal exposure to triclosan on the skin barrier
integrity and skin microbiome composition, which have both been identified as important in
regulating the immune system, have not been evaluated. Although an increasing number of
studies have demonstrated that triclosan exposure disrupts the microbiome (Jackson-Browne et
al. 2019; Yee and Gilbert 2016), the impact of triclosan exposure on the skin microbiome and its
interplay with the skin barrier integrity and immune system has not been explored. This is an
important area of research that is lacking. Overall, there is a need to better understand the impact
of exposure to antimicrobial chemicals on the skin and their effects on human health.
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Abstract
Triclosan is an antimicrobial chemical used in healthcare settings that can be absorbed
through the skin. Exposure to triclosan has been positively associated with food and aeroallergy
and asthma exacerbation in humans and, although not directly sensitizing, has been demonstrated
to augment the allergic response in a mouse model of asthma. The skin barrier and microbiome
are thought to play important roles in regulating inflammation and allergy and disruptions may
contribute to development of allergic disease. To investigate potential connections of the skin
barrier and microbiome with immune responses to triclosan, SKH1 mice were exposed dermally
to triclosan (0.5-2%) or vehicle for up to 7 consecutive days. Exposure to 2% triclosan for 5-7
days on the skin was shown to increase trans-epidermal water loss levels. Seven days of dermal
exposure to triclosan decreased filaggrin 2 and keratin 10 expression, but increased filaggrin and
keratin 14 protein along with the danger signal S100a8 and interleukin-4. Dermal exposure to
triclosan for 7 days also altered the alpha and beta diversity of the skin and gut microbiome.
Specifically, dermal triclosan exposure increased the relative abundance of the Firmicutes
family, Lachnospiraceae on the skin but decreased the abundance of Firmicutes family,
Ruminococcaceae in the gut. Collectively, these results demonstrate that repeated dermal
exposure to the antimicrobial chemical triclosan alters the skin barrier integrity and microbiome
in mice, suggesting that these changes may contribute to the increase in allergic immune
responses following dermal exposure to triclosan.
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Introduction
Triclosan is an antimicrobial chemical that was first used in surgical scrubs in healthcare
settings in 1972, followed by incorporation into consumer products, including soaps, deodorants,
toothpastes, and mouthwashes (Fang et al. 2010; Jones et al. 2000). While the FDA banned the
use of triclosan in consumer soaps in 2016 (FDA 2016), triclosan is still used in some
formulations of products used in healthcare settings. Triclosan exposure has been associated with
negative health effects, including effects on the immune system (Anderson et al. 2019;
Weatherly and Gosse 2017). Positive associations have been documented between triclosan
exposure and food allergy, aeroallergy, and asthma exacerbation in humans (Savage et al. 2014;
Savage et al. 2012). Although triclosan itself was not identified as a sensitizer in mice (Anderson
et al. 2016), dermal exposure to triclosan was demonstrated to augment the allergic response in a
mouse model of asthma (Anderson et al. 2013) through a thymic stromal lymphopoietin (TSLP)mediated pathway (Marshall et al. 2015). Additionally, exposure to triclosan was reported to
enhance allergic responses in mouse models of peanut allergy (Tobar et al. 2016) and house dust
mites (Hirota et al. 2019). Together these results demonstrate that exposure to triclosan is
immunomodulatory and suggest that triclosan contributes to the development of allergic disease.
Exposure to triclosan primarily occurs through the skin or by ingestion, because triclosan
is used in skin and mouthcare products. Healthcare workers using triclosan-containing soap were
shown to have higher levels of urinary triclosan, showing that triclosan is absorbed through the
skin (MacIsaac et al. 2014). In addition to being the largest organ in the body, the skin plays an
essential role as a physical barrier and is very immunologically active. Disruptions in the
integrity of the skin barrier or mutations in related genes have been associated with inflammatory
and allergic diseases, including atopic dermatitis (AD) (Kelleher et al. 2015), food allergy
(Kelleher et al. 2016), and aeroallergen sensitization (Boralevi et al. 2008). Additionally,
alterations in the skin barrier may increase the permeability of the skin (Rietz Liljedahl et al.
2021), increasing the sensitization potential of chemicals or allergens. There are many mediators
in the skin that could influence immune function. Keratinocytes, the most abundant cell type of
the epidermis, undergo a dynamic process of proliferation and terminal differentiation, ending in
production of cornified envelope proteins and lipids, which are key components of the skin
barrier (Goleva et al. 2019). Tight junctions between keratinocytes also contribute to the skin
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barrier and function (Goleva et al. 2019). The epidermal differentiation complex is a region of
the genome that encodes cornified envelope proteins, including filaggrin (Flg), filaggrin 2
(Flg2), involucrin (Ivl), and loricrin (Lor) (Toulza et al. 2007; Wu et al. 2009). FLG loss-offunction mutations are associated with increased rates of AD and allergic disease (Drislane and
Irvine 2020). However, additional investigations into the mechanisms between skin barrier
integrity and subsequent immune response are needed.
While associations between skin integrity and allergic disease have been established, the
contribution of the skin microbiome is just beginning to emerge. The microbiome has recently
been identified as an important component of human health and is involved in the development
and regulation of the immune system (Belkaid and Harrison 2017). Disruption of the healthy
microbiome, called dysbiosis, is associated with inflammatory and allergic diseases. The
microbiome has been suggested to regulate T helper cell type 2 (Th2) immune responses,
therefore dysbiosis may diminish the regulatory mechanisms and promote allergic disease
development (McCoy et al. 2018). Many factors, including chemical exposure, have been shown
to cause microbiome dysbiosis (Chiu et al. 2020; Gilbert et al. 2018; Jackson-Browne et al. 2019;
Yee and Gilbert 2016). While a large amount of research has made associations between the gut
microbiome and human health, relatively few studies have focused on the contribution of the
skin microbiome. Of those limited studies, application of topical antibiotics has been shown to
disrupt the skin microbiota in mice (SanMiguel et al. 2017) and topical application of antiseptics
disrupted the skin microbiota in humans (SanMiguel et al. 2018). However, the impact of dermal
exposure to the antimicrobial chemical triclosan on the skin microbiota of mice has not been
investigated. In an effort to better understand the role of skin integrity and microbiome on the
immune system, this study investigated the impact of repeated dermal exposure to triclosan on
various factors related to barrier function and the contribution of commensal bacteria in mice.

Materials and Methods
Animals
Female SKH1 mice (6-7 weeks old, Charles River) were purchased and allowed to acclimate for
at least one week. SKH1 mice are the most commonly used hairless mouse strain and have
previously been used to assess the skin microbiome (SanMiguel et al. 2017). Mice were
randomly assigned to an exposure group and identified with tail markings made with a
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permanent marker. Mice were housed (3-5/cage; same exposure group) in ventilated plastic
shoebox cages with autoclaved bedding and crinkle nest material. Harlan NIH-31 modified 6%
irradiated rodent diet and tap water were available ad libitum. Housing facilities were maintained
with a 12-hour light/dark cycle. Specific measures were taken to control microorganisms: a
dedicated bioexclusion room with limited access was used for the study, all equipment was
wiped down with 70% ethanol prior to use, and animal cages were changed twice per week. All
procedures were conducted under a class II type B2 biological safety cabinet (Baker
SterilchemGARD). All animal experiments were performed in the AAALAC International
accredited National Institute for Occupational Safety and Health (NIOSH) animal facility in
accordance with an animal protocol approved by the CDC-Morgantown Institutional Animal
Care and Use Committee.
Triclosan Exposures
Triclosan (CAS# 3380-34-5) was purchased from Calbiochem (EMD Millipore Corp.). Acetone
(CAS# 67-41-1) was purchased from Sigma-Aldrich. Mice (5-6/group) were exposed once per
day for 7 consecutive days to acetone (vehicle control) or to triclosan (0.5%, 2%) dissolved in
acetone (w/v) on the entire dorsal back skin (100 µL/mouse). An additional unexposed (naïve)
control group was included for the microbiome experiments. The concentrations were selected
based on previous study findings where immune changes were observed following 0.75-3%
triclosan and determined to be non-toxic (Anderson et al. 2013). Due to the larger application
area and potential strain sensitivity, slightly lower concentrations were used (0.5%, 2%) in the
present study. Acetone was selected as the vehicle based on solubility and historical control data
for triclosan studies (Anderson et al. 2013; Anderson et al. 2016; Marshall et al. 2015).
Endpoints were evaluated following exposures up to 7 days because previous kinetic studies
have demonstrated that multiple immune changes occurred during this triclosan exposure
duration in mice (Anderson et al. 2020).
TEWL Measurements
Trans-epidermal water loss (TEWL) was determined daily prior to exposure (0%, 0.5%, 2%)
using a VapoMeter (Delfin) and small adapter on mouse dorsal skin per manufacturer’s
instructions.
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Euthanasia and Skin Collection
Animals were euthanized by CO2 inhalation 24 hours after the final exposure. Back skin (1 cm2)
was fixed in 4% paraformaldehyde or 10% formalin for immunofluorescence or histology,
respectively. Back skin (1 cm2) was collected for western blot into tubes containing a steel bead
and 750 µL T-PER with Halt Protease and Phosphatase Inhibitor cocktail and 0.5 M EDTA.
Samples were processed on a TissueLyser II and supernatant was collected and frozen at -80 °C
until analyzed. Back skin (1 cm2) was collected for gene expression into tubes containing 500 µL
RNAlater (Invitrogen) and frozen at -80 °C until processed.
Histology
Formalin-fixed paraffin-embedded mouse skin (5 µm) was mounted on slides and stained with
hematoxylin and eosin following standard procedures (1 slide/animal). Slides were brightfield
imaged on an Olympus VS120 slide scanner at 40X. Epidermal thickness was measured using
ImageJ from 1 random view/slide and 3 measurements per view were taken and averaged. For
histopathology, prepared slides were transferred to Vet Path Services, Inc. ProvantisTM pathology
software v10.1.0.1 was utilized for data capture. Stained histologic sections were examined by
light microscopy and observations were entered into ProvantisTM by the non-blinded Study
Pathologist. Histologic sections were of adequate size and quality for detailed evaluation.
Histopathology grades were assigned as grade 1 (minimal), grade 2 (mild), grade 3 (moderate),
grade 4 (marked), or grade 5 (severe) based on an increasing extent of change, unless otherwise
specified.
Immunofluorescence Imaging
Fixed mouse skin was cryopreserved in 30% sucrose, frozen in optimal cutting temperature
compound, cryosectioned (5 µm), and mounted on slides. Skin sections (1 section/animal for
each protein of interest) were washed with PBS, blocked with blocking buffer (3% bovine serum
albumin with 0.1% Triton in PBS) at room temperature for 1 hour, and stained with primary
antibody diluted in blocking buffer at 4 °C overnight. The following primary antibodies were
used: FLG (1:200; BioLegend 905804), FLG2 (1:200; NBP1-91901), keratin 10 (KRT10)
(1:400; ab76318), and keratin 14 (KRT14) (1:500; NBP2-67585). Slides were washed, stained
with secondary antibody (Alexa Fluor 594, 1:300) at room temperature for 1 hour, washed, and
stained with DAPI Fluoromount-G. Images were acquired at 20X using an Olympus VS120
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Slide Scanner. Negative controls with secondary antibody only were included for each sample
and consistently showed low background fluorescence (Supplemental Figure 2.1). Distribution
(µm) was measured using ImageJ from 1 random view/slide and 3 measurements per view were
taken and averaged.
Protein Analysis
Total protein was quantified using the BCA protein assay (Pierce) per manufacturer’s
instructions. Select proteins of interest were quantified using a capillary immunoassay. Optimal
sample and antibody concentrations were determined using a linear range finding assay. Samples
were prepared in sample buffer and fluorescent master mix, then denatured at 95 °C for 5
minutes. Samples, antibodies (FLG, 0.4 mg/mL; FLG2, 0.4 mg/mL; KRT10, 0.2 mg/mL;
KRT14, 0.4 mg/mL), and reagents were loaded and run on a Wes machine (ProteinSimple) using
total protein 12-230 kDa assay with 18 sec. stacking matrix load time and 30 min. separation
time. The ProteinSimple Anti-Rabbit and Total Protein Detection Modules were used. Peaks
were automatically detected and manually inspected to confirm a peak signal-to-noise (S/N) ratio
above 10 and peak height/baseline ratio above 3. Area under the curve was calculated for total
protein and protein of interest using Compass software (ProteinSimple). Protein of interest was
normalized to total protein. Proteins evaluated include FLG (1:50; BioLegend 905804), FLG2
(1:50; Bethyl A305-861A-M), KRT10 (1:150; ab76318), and KRT14 (1:50; ab197893).
Gene Expression Analysis
Total RNA was isolated from skin using the RNeasy kit per manufacturer’s instructions
(Qiagen). A QIAcube (Qiagen) automated RNA isolation machine was utilized in conjunction
with the RNA isolation kit. The concentration and purity of the RNA were determined using a
NanoDrop Spectrophotometer (Thermo Scientific). Reverse transcription was performed using a
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) per manufacturer’s
instructions. TaqMan Fast Universal PCR Master Mix (Applied Biosystems), cDNA, and genespecific primers (TaqMan Gene Expression Assays) were combined and real-time quantitative
PCR (qPCR) was performed per manufacturer’s instructions. MicroAmp Fast Optical 96-Well
Reaction Plates were analyzed on a 7500 Fast Real-Time PCR System (Applied Biosystems)
using cycling conditions per manufacturer’s instructions. Actb (Mm01205647_g1) was used as
the reference gene. Data was collected and relative fold change compared to acetone (vehicle
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control) was calculated using the cycle threshold (Ct) and the 2-ΔΔCt method. Genes evaluated
include Flg (Mm01716522_m1), Flg2 (Mm02744902_g1), Ivl (Mm00515219_s1), Lor
(Mm01962650_s1), Krt10 (Mm03009921_m1), Krt14 (Mm00516876_m1), tight junction
protein

1

(Tjp1)

(Mm00493699_m1),

occludin/ELL

domain

containing

1

(Ocel1)

(Mm01349279_m1), integrin subunit beta like 1 (Itgbl1) (Mm01200043_m1), S100a8
(Mm00496696_g1), Tslp (Mm01157588_m1), e-cadherin (Cdh1) (Mm01247357_m1), Toll-like
receptor 4 (Tlr4) (Mm00445273_m1), interleukin 4 (Il4) (Mm00445259_m1), and interleukin 22
(Il22) (Mm00444241_m1). For Il4 and Il22, the Ct was undetected in some vehicle control
samples, and for these undetected samples the Ct was set at 40 to calculate fold change.
Bacterial Collection and Isolation
To collect commensal skin bacteria, a sterile foam tipped applicator (Puritan) was moistened
with sterile 1X DPBS (Mediatech, Inc.) and then used to swab the dorsal skin of the mouse. Mice
were swabbed prior to exposure (day 0), throughout exposure (day 1 and 3), one-day after the
last exposure (day 7), and one-week after the last exposure (day 13). These timepoints were
selected based on previous results showing immune alterations following up to 7 days of
triclosan exposure on mouse ears (Anderson et al. 2020). The swab was placed into a sterile 2.0
mL Safe-Lock Eppendorf tube and stored at -80 °C until processed. Microbial DNA was isolated
as previously described (Meisel et al. 2016), with several modifications. Briefly, cells were lysed
by adding 300 µL Yeast Cell Lysis Solution from the MasterPure Yeast DNA Purification Kit
(Epicentre) and 0.5 µL Ready-Lyse Lysozyme Solution (Epicentre) to each sample. Samples
were incubated, mechanically lysed using 0.5 mm glass bead tubes (Qiagen), and then incubated
a second time as previously described. Samples were placed on ice for 5 minutes. Protein was
precipitated out of samples using 150 µL Protein Precipitation Reagent from the MasterPure
Yeast DNA Purification Kit (Epicentre) and samples were vortexed for 10 seconds. Samples
were centrifuged at maximum speed for 10 minutes, supernatant was transferred to a new tube,
and 500 µL isopropanol (CAS# 67-63-0) was added to supernatant. Samples were transferred to
PureLink Genomic DNA columns (Invitrogen) and centrifuged. Purification steps were followed
as per manufacturer’s instructions, with 50 µL elution volume. To collect gut bacteria, fecal
pellets were collected into sterile 2.0 mL Safe-Lock tubes (Eppendorf) following euthanasia and
stored at -80 °C until processed. Fecal matter was weighed and recorded prior to isolation. Gut
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microbial DNA was isolated from the fecal matter using the DNeasy PowerSoil Kit (Qiagen) as
per manufacturer’s instructions, with the following exception. Samples were vortexed vertically
on a vortex mixer for 15 minutes. DNA was eluted with 100 µL of the elution buffer and frozen
at -80 °C until sequenced. DNA concentration was determined using a Qubit 2.0 Fluorometer
(Invitrogen) and DNA quality was checked on agarose gels.
Microbiota Sequencing
For the skin microbiota, the library was constructed using the 16S MetaVx Library Preparation
(GENEWIZ, Inc.). Amplicons were constructed with 50 ng DNA or maximum volume for
samples with low quantity. The bacterial 16S ribosomal RNA gene V3-V4 region was amplified
using forward primers containing the sequence “CCTACGGRRBGCASCAGKVRVGAAT” and
reverse primers containing the sequence “GGACTACNVGGGTWTCTAATCC”. For the gut
microbiota, the V3-V4 region was amplified using forward primers containing the sequence
“CCTACGGGNGGCWGCAG”

and

reverse

primers

containing

the

sequence

“GACTACHVGGGTATCTAATCC.” Samples had unique barcodes for identification.
Indexes/adaptors were added to the ends by PCR. Libraries were validated with Agilent 2100
Bioanalyzer (Agilent Technologies) and quantified using Qubit 2.0 Fluorometer or qPCR. DNA
libraries were run on an Illumina MiSeq. Sequencing was performed with a 2 x 250 paired-end
configuration. 16S rRNA gene sequencing reads have been deposited in the NCBI Sequence
Read Archive under BioProject ID PRJNA734311.
Microbiome Sequencing Analysis
Paired-end sequencing reads were demultiplexed and analyzed by QIIME2 (Quantitative Insights
Into Microbial Ecology) (Bolyen et al. 2019). Briefly, DADA2 (Callahan et al. 2016) was used
to trim, denoise, and join to generate counts on unique sequences (termed as features) in each
sample. Taxonomy assignment of the features was done with a naïve Bayesian classifier against
SILVA 132 database (Quast et al. 2013) at 99% similarity. For phylogenetic diversity analyses,
features assigned to the kingdom Bacteria were used and singleton features were removed. Alpha
(Shannon’s diversity index) and beta diversity metrics (weighted UniFrac distance) were
computed and principal coordinates analysis (PCoA) plots using Emperor (Vázquez-Baeza et al.
2013) were generated for each of the beta diversity metrics.
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Statistical Analysis
One-way analysis of variance (ANOVA) was conducted for all experiments containing 3 or more
groups followed by a Dunnett’s Multiple Comparison Test. For TEWL and skin microbiome
analysis, a repeated measures ANOVA was conducted followed by a Dunnett’s Multiple
Comparison Test compared to day 0. Unpaired t-tests were conducted for experiments with two
groups. Mann-Whitney test was conducted for KRT14 protein analysis due to unequal variance.
Statistical analysis was conducted using GraphPad Prism (v. 5.0). All differences were
considered significant at p < 0.05.

Results
Repeated exposure to triclosan disrupts the skin barrier integrity
TEWL is a validated measurement for evaluating skin barrier integrity (Fluhr et al. 2006).
Exposure to 2% triclosan significantly increased TEWL starting at day 5 and continued to
increase through day 7 (Figure 2.1A). Seven days of dermal exposure to 2% triclosan also
increased the epidermal thickness of mouse dorsal skin (Figure 2.1B-E). Additionally, exposure
to 2% triclosan resulted in dermal infiltration of neutrophils and mononuclear cells (6/6
moderate), epidermal hyperplasia (6/6 moderate), and epidermal hyperkeratosis (5/6 minimal,
1/6 mild). Vehicle treated mice had minimal (3/3) to mild (3/3) dermal infiltration and no
epidermal hyperplasia or hyperkeratosis. Minimal to mild dermal infiltration are part of the
expected background findings in the skin of the SKH1 hairless mouse strain (Benavides et al.
2009). Mixed infiltrates in the dermis consisted of neutrophils and mononuclear cells, which
were primarily localized to the deep dermis and dermal adipose layer in association with hair
follicles and shafts. In some instances of moderate infiltration, inflammatory cells extended to
involve the superficial dermis. No changes in TEWL or skin thickness were observed following
exposure to 0.5% triclosan, therefore only 2% triclosan was evaluated in subsequent studies.
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Figure 2.1. Repeated dermal exposure to triclosan disrupted the skin barrier integrity of mice.
(A) Trans-epidermal water loss (TEWL) of mouse skin throughout exposure to either vehicle or
triclosan (0.5%, 2%). Points represent individual mice and bars represent mean of 5 mice/group.
*p < 0.05, **p < 0.01, ***p < 0.001 vs. day 0, by repeated measures ANOVA with Dunnett’s
Multiple Comparison Test. Representative H&E images of dorsal skin following exposure to
vehicle (B), 0.5% triclosan (C), or 2% triclosan (D). Scale bar = 50 µm. (E) Epidermal thickness
following dermal exposure to vehicle or triclosan (TCS, 0.5%, 2%). Points represent individual
mice and bars represent the mean (± SEM) of 5 mice/group. ***p < 0.001 vs. vehicle, by oneway ANOVA with Dunnett’s Multiple Comparison Test.
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Dermal exposure to triclosan results in divergent filaggrin responses
Dermal exposure to 2% triclosan for 7 days increased the distribution of the FLG layer in
the epidermis in the dorsal skin of mice (Figure 2.2A-C). Additionally, 7 days of exposure to 2%
triclosan on mouse skin significantly increased FLG protein levels (Figure 2.2D-E). Total protein
was used as the loading control and was not changed between exposure groups (Supplemental
Figure 2.2). The gene expression of Flg remained unchanged in the skin following 7 days of
dermal 2% triclosan exposure (Figure 2.2F).
Similar to FLG, FLG2 distribution was increased in the epidermal layer (Figure 2.2G-I).
Although 7 days of dermal exposure to 2% triclosan did not significantly change FLG2 protein
levels (Figure 2.2J-K), there was a decreasing trend in FLG2 protein in the 2% triclosan
exposure group (44,286 ± 9,483) compared to vehicle control (113,788 ± 41,019). Dermal
exposure to 2% triclosan significantly decreased the gene expression of Flg2 in mouse skin
(Figure 2.2L).
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Figure 2.2. Seven days of dermal exposure to triclosan increased the filaggrin (FLG) protein and
decreased the gene expression of filaggrin 2 (Flg2) in mouse skin. Representative images of FLG
(red) and DAPI (blue) (A-B) and FLG2 (red) and DAPI (blue) (G-H) staining in the skin
following 7 days of dermal exposure to vehicle or 2% triclosan on mice. Scale bar = 50 µm. Line
indicates basement membrane. Distribution (µm) of FLG (C) and FLG2 (I) in epidermis. Points
represent individual mice and bars represent the mean (± SEM) of 4-5 mice/group. *p < 0.05 and
**p < 0.01, by unpaired t-test. Immunoblot of FLG (D) and FLG2 (J) in skin following 7 days of
dermal exposure to vehicle or 2% triclosan. Each lane represents an individual mouse. Area
under the curve of FLG (E) and FLG2 (K) normalized to total protein. Points represent
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individual mice and bars represent the mean (± SEM) of 4-5 mice/group. **p < 0.01, by unpaired
t-test. Fold change in gene expression of Flg (F) and Flg2 (L) in skin compared to vehicle
control following 7 days of dermal exposure to vehicle or 2% triclosan on mice. Points represent
individual mice and bars represent the mean (± SEM) of 6 mice/group. **p < 0.01 vs. vehicle, by
unpaired t-test.
Dermal triclosan exposure induces differential keratin expression
Seven days of dermal exposure to 2% triclosan increased KRT10 distribution in the skin
(Figure 2.3A-C). Although triclosan exposure did not significantly impact KRT10 protein
expression (Figure 2.3D-E), the gene expression of Krt10 in mouse dorsal skin was significantly
decreased (Figure 2.3F). Seven days of dermal exposure to 2% triclosan also increased the
distribution of KRT14 in the skin (Figure 2.4A-C) and the KRT14 protein level was significantly
increased following 2% triclosan exposure (Figure 2.4D-E). Additionally, dermal exposure to
2% triclosan for seven days significantly increased the gene expression of Krt14 in mouse dorsal
skin (Figure 2.4F). No significant changes in gene expression of Ivl, Lor, Tjp1, Ocel1, or Itgbl1
following 7 days of dermal 2% triclosan exposure were observed (Supplemental Figure 2.3).

Figure 2.3. Seven days of dermal exposure to triclosan decreased the gene expression of keratin
10 (Krt10) in mouse skin. Representative images of KRT10 (red) and DAPI (blue) staining in the
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skin following 7 days of dermal exposure to vehicle (A) or 2% triclosan (B) on mice. Scale bar =
50 µm. Line indicates basement membrane. (C) Distribution (µm) of KRT10 in epidermis. Points
represent individual mice and bars represent the mean (± SEM) of 4-5 mice/group. **p < 0.01,
by unpaired t-test. (D) Immunoblot of KRT10 in skin following 7 days of dermal exposure to
vehicle or 2% triclosan. Each lane represents an individual mouse. (E) Area under the curve of
KRT10 normalized to total protein. Points represent individual mice and bars represent the mean
(± SEM) of 5 mice/group. (F) Fold change in gene expression of Krt10 in skin compared to
vehicle control following 7 days of dermal exposure to vehicle or 2% triclosan on mice. Points
represent individual mice and bars represent the mean (± SEM) of 6 mice/group. *p < 0.05 vs.
vehicle, by unpaired t-test.

Figure 2.4. Seven days of dermal exposure to triclosan increased the expression of keratin 14
(KRT14) in mouse skin. Representative images of KRT14 (red) and DAPI (blue) staining in the
skin following 7 days of dermal exposure to vehicle (A) or 2% triclosan (B) on mice. Scale bar =
50 µm. Line indicates basement membrane. (C) Distribution (µm) of KRT14 in epidermis. Points
represent individual mice and bars represent the mean (± SEM) of 4-5 mice/group. *p < 0.05, by
unpaired t-test. (D) Immunoblot of KRT14 in skin following 7 days of dermal exposure to
vehicle or 2% triclosan. Each lane represents an individual mouse. (E) Area under the curve of
KRT14 normalized to total protein. Points represent individual mice and bars represent the mean
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(± SEM) of 5 mice/group. **p < 0.01 vs. vehicle, by Mann-Whitney test. (F) Fold change in
gene expression of Krt14 in skin compared to vehicle control following 7 days of dermal
exposure to vehicle or 2% triclosan on mice. Points represent the individual mice and bars
represent the mean (± SEM) of 6 mice/group. **p < 0.01 vs. vehicle, by unpaired t-test.
Triclosan exposure on the skin increased expression of danger signals and cytokines
Previously, we have shown that 7 days of triclosan exposure on BALB/c mouse ears
alters the expression of S100a8, Il4, Il22, Tslp, Cdh1, and Tlr4 (Anderson et al. 2020). Based on
the kinetics from that study, the expression of these danger signals and cytokines were evaluated
in SKH1 mice. Seven days of dermal exposure to 2% triclosan significantly increased the
expression of the danger signal S100a8 and Th2 cytokine Il4 in hairless SKH1 mouse back skin
(Figure 2.5A-B). However, no significant changes in the expression of Il22, Tslp, Cdh1, Tlr4 in
the skin were observed (Figure 2.5C-F).

Figure 2.5. Seven days of dermal exposure to triclosan increased the expression of genes
involved in the immune response. Fold change in expression compared to vehicle control of (A)
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S100a8, (B) Il4, (C) Il22, (D) Tslp, (E) Cdh1, and (F) Tlr4 following 7 days of dermal exposure
to vehicle or 2% triclosan on mice. Points represent the individual mice and bars represent the
mean (± SEM) of 6 mice/group. *p < 0.05, **p < 0.01 vs. vehicle, by unpaired t-test.
Dermal triclosan exposure alters the skin microbiota
Seven days of dermal exposure to 2% triclosan significantly increased the alpha diversity,
the diversity of microorganisms within each sample, at day seven of the skin microbiota on mice
(Figure 2.6A). This change in alpha diversity was restored similar to baseline levels one week
after the final triclosan exposure (day 13). No significant difference between the naïve and
vehicle groups was observed. Seven days of triclosan exposure also altered the beta diversity, the
diversity between samples, compared to naïve and vehicle (Figure 2.6B). The composition of the
skin microbiota was altered on day 7 following triclosan exposure with a greater abundance of
Firmicutes compared to naïve and vehicle (Figure 2.6C). Specific changes in taxons within the
Firmicutes phylum following 7 days of triclosan exposure included a significant increase in
abundance of Lachnospiraceae (Figure 2.6D) and Clostridiales vadinBB60 group (Figure 2.6E).
Relative abundance of Ruminococcaceae followed a similar trend but was less impressive
(Figure 2.6F). The abundance of Enterobacteriaceae (phylum Proteobacteria) was modestly
decreased following 7 days of dermal triclosan exposure (Figure 2.6G). The differences in
relative abundance were restored similar to baseline levels by day 13. Together, these results
show that 7 days of dermal exposure to 2% triclosan altered the composition of the skin
microbiota on mice.
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Figure 2.6. Seven days of dermal exposure to triclosan altered the composition of the skin
microbiota on mice. (A) Shannon index as a measure of alpha diversity of skin microbiota
throughout 7 days of vehicle or 2% triclosan exposure on mouse skin or one-week after the final
triclosan exposure ended (day 13). An additional untreated (naïve) group was included. Points
represent mean (± SEM) of 6 mice/group. *p < 0.05 vs. day 0, by repeated measures ANOVA
with Dunnett’s Multiple Comparison Test. (B) Weighted UniFrac as a measure of beta diversity
of skin microbiota on day 7. Points represent individual mice. (C) Relative abundance of taxa on
day 7. Bars represent mean of 6 mice/group. Relative abundance of Lachnospiraceae (D),
Clostridiales vadinBB60 group (E), Ruminococcaceae (F), and Enterobacteriaceae (G). Points
represent mean (± SEM) of 6 mice/group. *p < 0.05, ***p < 0.001 vs. day 0, by repeated
measures ANOVA with Dunnett’s Multiple Comparison Test.
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Dermal triclosan exposure alters the gut microbiota
Seven days of dermal exposure to 2% triclosan significantly decreased the alpha diversity
of the gut microbiota in mice (Figure 2.7A). Beta diversity was also shifted between vehicle and
2% triclosan groups (Figure 2.7B). The composition of the gut microbiota was altered following
7 days of dermal exposure to triclosan with an increase in phylum Bacteroidetes and decrease in
phylum Firmicutes relative abundance (Figure 2.7C). Specifically, 7 days of 2% triclosan
exposure significantly decreased the relative abundance of Ruminococcaceae (phylum
Firmicutes) (Figure 2.7D). However, no remarkable change between Lachnospiraceae and
Clostridiales vadinBB60 group were observed (Figure 2.7E-F). Within the phylum
Bacteroidetes, relative abundance of Muribaculaceae was unchanged with triclosan exposure
(Figure 2.7G), but the abundance of Rikenellaceae was increased (Figure 2.7H) and abundance
of Tannerellaceae was decreased (Figure 2.7I) following 7 days of 2% triclosan exposure on
mice. Together, these results show that 7 days of dermal exposure to 2% triclosan altered the
composition of the gut microbiota in mice.
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Figure 2.7. Seven days of dermal exposure to triclosan altered the composition of the gut
microbiota in mice. (A) Shannon index as a measure of alpha diversity of gut microbiota
following 7 days of dermal exposure to vehicle or 2% triclosan. Points represent individual mice
and bars represent mean (± SEM) of 6 mice/group. *p < 0.05 vs. vehicle, by unpaired t-test. (B)
Weighted UniFrac as a measure of beta diversity of gut microbiota on day 7 following vehicle or
2% triclosan exposure. Points represent individual mice. (C) Relative abundance of taxa on day 7
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following vehicle or 2% triclosan exposure. Bars represent mean (± SEM) of 6 mice/group.
Relative abundance of Ruminococcaceae (D), Lachnospiraceae (E), Clostridiales vadinBB60
group (F), Muribaculaceae (G), Rikenellaceae (H), and Tannerellaceae (I) following 7 days of
dermal exposure to vehicle or 2% triclosan. Points represent individual mice and bars represent
mean (± SEM) of 6 mice/group. **p < 0.01, ***p < 0.001 vs. vehicle, by unpaired t-test.

Discussion
Absorption of chemicals through the skin is a major occupational concern as the CDC
estimates that over 13 million workers in the United States are potentially exposed to chemicals
with the capacity to be absorbed through the skin (Anderson and Meade 2014; Council 2019).
Many chemicals have been identified to have effects on the immune system and lead to
occupational diseases (Kasemsarn et al. 2016). Investigations are needed to better understand the
initiating factors and mechanism of immune dysfunction, occupational disease, and the
relationship with the skin barrier integrity and skin microbiome (Council 2019).
The results of this study show that repeated dermal exposure to the immunomodulatory
chemical triclosan alters the integrity of the skin barrier, skin microbiota, and gut microbiota in
mice. Healthcare workers, who are typically exposed to high levels of antimicrobial chemicals
and have higher rates of allergic disease (Kadivar and Belsito 2015; Prodi et al. 2016), have been
demonstrated to have high levels of TEWL and skin barrier disruption (Visscher et al. 2010).
The findings described in this manuscript support a link between higher rates of allergic disease
and skin barrier disruption following triclosan exposure (Figure 2.1).
Exposure to chemicals such as detergents have been shown to influence epithelial barriers
(Celebi Sozener et al. 2020), and damage to or alterations in the skin barrier are associated with
the development of skin diseases (Kasemsarn et al. 2016). While the relationship between AD
and FLG has been well established (Cabanillas and Novak 2016), studies investigating the
influence of dermal chemical exposure on FLG are lacking. Contradictory to its role in AD, FLG
expression was increased in the present study following dermal triclosan exposure (Figure 2.2).
The skin microenvironment plays an important role in regulating expression of skin barrier genes
such as FLG and it is well established that certain cytokines (IL-4, IL-13, IL-22) negatively
modulate the expression of FLG (Gutowska-Owsiak et al. 2011; Howell et al. 2009). In contrast,
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aryl hydrocarbon receptor (AhR) signaling has been shown to promote the expression of FLG in
the skin (Hidaka et al. 2017; van den Bogaard et al. 2013). Although Il4 was concurrently
expressed in the skin (Figure 2.5) with FLG protein after triclosan exposure, it is possible that
exposure to triclosan may also activate other pathways, such as AhR (Szychowski et al. 2016),
resulting in competing pathways in the regulation of FLG following triclosan exposure. This is
an area of research that requires additional investigation.
Although not as well documented as FLG, FLG2 mutations have also been associated
with AD (Margolis et al. 2014), supporting the reduced Flg2 expression reported in this study
(Figure 2.2). FLG2 contributes to the cornified envelope (Albérola et al. 2019) and plays a role
in cell-cell adhesion (Mohamad et al. 2018), suggesting a contribution to skin integrity. Although
FLG and FLG2 have been shown to have similar expression patterns in cultured human
keratinocytes (Wu et al. 2009), other work highlights the differential regulation of FLG and
FLG2 (Gutowska-Owsiak et al. 2011; Hansmann et al. 2012). The mechanism behind differential
regulation of these genes due to chemical exposure is unclear, but it is possible that increased
FLG may compensate for decreased FLG2 in an effort to restore skin barrier integrity.
Additionally, timing may be an influencing factor as expression differences were only
investigated at the peak of TEWL (7 days post exposure).
In addition to FLG, keratinocytes are critical in the formation of an intact skin barrier.
Keratinocytes produce keratins, which are involved in cell structure and metabolism (Pan et al.
2013). Decreased levels of KRT10 in the skin have been positively associated with AD, and Th2
cytokines have been shown to negatively regulate KRT10 (Totsuka et al. 2017), suggesting that
KRT10 plays a role in inflammatory and allergic diseases. Consistent with these findings, our
results show decreased Krt10 gene expression along with increased Il4 expression, following
triclosan exposure (Figure 2.3F, Figure 2.5B). Krt10 plays a critical role in the skin as
homozygous Krt10 deficient mice die shortly following birth (Jensen et al. 2000; Porter et al.
1996), and is expressed by keratinocytes in the differentiation phase (Moll et al. 2008). Increased
epidermal thickness (Figure 2.1) along with decreased Krt10 further supports impairment of
keratinocyte differentiation and is consistent with other studies in the literature (Fang et al.
2015). In contrast to KRT10, a marker of keratinocyte proliferation, KRT14, was increased
following triclosan exposure (Figure 2.4), suggesting effects on keratinocyte proliferation also
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consistent with the literature (Wu et al. 2015) and histopathology (Figure 2.1). Due to the
important role that keratins play in skin structure and integrity, alterations in the normal keratin
expression patterns, increased proliferation but delayed differentiation, following triclosan
exposure may be a contributing factor to the disruptions observed in skin barrier integrity.
While an intact skin barrier requires a physiological keratinization process, it also
depends upon a normal skin microbiome. In these studies, seven days of dermal exposure to
triclosan increased the alpha diversity of the skin microbiota on mice, demonstrating that
triclosan exposure leads to dysbiosis of the skin microbiome (Figure 2.6). Furthermore, the
abundance of Firmicutes, specifically the families Lachnospiraceae and Clostridiales vadinBB60
group, was enriched. While Lachnospiraceae in the gut are considered beneficial (Sorbara et al.
2020), the role for Lachnospiraceae on the skin has not been defined. However, Lachnospiraceae
have previously been identified on the skin of mice (Gimblet et al. 2017) and topical exposure to
antibiotics was shown to reduce the abundance of Lachnospiraceae on mouse skin (SanMiguel et
al. 2017). The skin microbiome is critical for maintaining homeostasis of the skin, supporting
barrier integrity, and resisting colonization of pathogens (Baldwin et al. 2017; Byrd et al. 2018).
Mice lacking a microbiome have been shown to have altered expression of skin barrier genes
(Meisel et al. 2018). Dysbiosis of the skin microbiota is also thought to contribute to
inflammatory and allergic skin diseases (Belkaid and Tamoutounour 2016). The skin
microbiome has been demonstrated to interact with and influence the integrity of the skin barrier
and subsequently the development of skin diseases (Baldwin et al. 2017). The return of the
microbiota similar to the untreated mice 7 days after the last application of triclosan
demonstrates that these changes in the microbiota are reversible, aligning with previous findings
in fish where the gut microbiota was restored 1-2 weeks post a 7-day triclosan exposure
(Narrowe et al. 2015). Our results demonstrate changes in the skin microbiota following dermal
triclosan exposure and suggest that these changes may influence the skin barrier and immune
responses.
Interestingly, in contrast to the skin, the alpha diversity of the gut microbiota was
decreased in mice, suggesting divergent impacts on the microbiome due to triclosan exposure
(Figure 2.7). Specifically, dermal exposure to triclosan reduced the abundance of
Ruminococcaceae (phylum Firmicutes) in the gut. Decreased abundance of genera in the
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Lachnospiraceae and Ruminococcaceae families in the gut have been associated with increased
rates of allergic disease (Simonyté Sjodin et al. 2019), suggesting that these commensal
microorganisms are involved in regulating allergic immune responses. Previous studies have
shown that oral or environmental exposure to triclosan alters the gut microbiota in humans
(Bever et al. 2018), rats (Hu et al. 2016), mice (Gao et al. 2017; Yang et al. 2018), and fish
(Gaulke et al. 2016; Narrowe et al. 2015). Specifically, exposure to triclosan either through
drinking water or diet was shown to decrease the alpha diversity of the gut microbiota of mice
(Gao et al. 2017; Yang et al. 2018). Triclosan has also been shown to be absorbed through mouse
skin and excreted through feces (Fang et al. 2016). These results align with the result of our
study and expand the findings by demonstrating that exposure to triclosan on the skin impacts
the gut microbiome. In the present study, in addition to exposure through the skin, there is the
potential for oral exposure due to group housing and grooming practices. The skin and gut have
different microbial compositions and thus are likely to respond uniquely to antimicrobial
chemical exposures and thus is an area of research that requires additional investigation.
Additionally, disruption of the skin barrier may influence the absorption of triclosan, resulting in
a greater impact on the skin microbiota and gut microbiota. Together, these differences in
diversity and relative abundance of commensal microorganisms demonstrate a disruption in
homeostasis of the microbiota due to triclosan exposure.
While the observed changes in skin integrity and microbiome were not evident until
seven days post exposure, early immune changes have been reported in the skin following
triclosan exposure. Our laboratory has previously shown that triclosan induces expression of
Tslp, S100a8, Il4, Il22 and decreases expression of Cdh1, in some cases as early as one day post
triclosan exposure in BALB/c mice (Anderson et al. 2020). Additionally, certain chemokines
including Cxcl1 and Cxcl2, were upregulated in the skin as early as one day following dermal
triclosan exposure, supporting an early and direct influence on keratinocytes (Weatherly et al.
2020). While changes in certain Th2 cytokines including Tslp were not observed in the present
study, it is important to note that BALB/c mice, which have a Th2 bias, were not used in the
studies described in this manuscript. Additionally, although SKH1 mice are immunocompetent
(Benavides et al. 2009), their immune system is not as well characterized and investigations of
allergic responses following triclosan exposure are lacking in this strain. However, triclosan
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exposure increased Il4 expression in this study and collectively these findings suggest that
immunological changes may be a prerequisite for effects on skin integrity and the microbiome,
but additional research is required.
In summary, these results demonstrate that repeated dermal exposure to triclosan disrupts
the skin barrier integrity and microbiome of mice. Taken together, these findings suggest that an
altered skin barrier and/or skin microbiome may contribute to changes in the immune system,
lower the protection from exposures on the skin, and thus contribute to an increased
susceptibility to occupational or allergic diseases. Early changes in the immune system due to
chemical exposure may further promote disruptions in the barrier integrity and microbiome,
resulting in a positive feedback loop. Investigating the impact of dermal exposure to
antimicrobial chemicals, such as triclosan, is important to improve risk assessment of
occupational exposures and contribute to an improved understanding of mechanisms of
sensitization and allergic disease.
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Abstract
Triclosan is an antimicrobial chemical incorporated into products that are applied to the
skin of healthcare workers. Exposure to triclosan has previously been shown to be
immunomodulatory and associated with allergic disease. Additionally, we have shown that
exposure to triclosan dermally activates the NLRP3 inflammasome and disrupts the skin barrier
integrity in mice. The skin is the largest organ of the body and plays an important role as a
physical barrier and regulator of the immune system. Alterations in the barrier and immune
regulatory functions of the skin have been demonstrated to increase the risk of sensitization and
development of allergic disease. In this study, the impact of triclosan exposure on the skin barrier
and keratinocyte function was investigated using a model of reconstructed human epidermis. The
apical surface of reconstructed human epidermis was exposed to triclosan (0.05-0.2%) once for
6, 24, or 48 hours or daily for 5 consecutive days. Exposure to triclosan increased epidermal
permeability and altered the expression of genes involved in formation of the skin barrier.
Additionally, exposure to triclosan altered the expression patterns of several cytokines and
growth factors. Together, these results suggest that exposure to triclosan impacts skin barrier
integrity and function of human keratinocytes and suggests that these alterations may impact
immune regulation.

Key Words: triclosan, keratinocytes, skin, barrier function, permeability
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Introduction
Triclosan is an antimicrobial chemical that has been used in healthcare settings and in
consumer products such as soaps, deodorants, toothpastes, and mouthwashes, since 1972 (Fang
et al. 2010; Jones et al. 2000). Although the use of triclosan has been banned from consumer
soaps (FDA 2016), triclosan is still used in certain formulations of products used in healthcare
settings (Consumer product information database). Exposure to triclosan is associated with food
allergy, aeroallergy, and asthma exacerbation (Savage et al. 2014; Savage et al. 2012), and
dermal exposure has been demonstrated to be immunomodulatory in mice (Anderson et al. 2013;
Anderson et al. 2016). Additionally, topical triclosan exposure has been shown to disrupt the
barrier integrity and alter the expression of genes involved in the skin barrier in mice (Baur et al.
2021).

Together,

these

results

demonstrate

that

dermal

exposure

to

triclosan

is

immunomodulatory and may be influenced by mediators such as skin barrier integrity.
The skin, comprised of the epidermis and dermis, is the first line of defense against
environmental exposures and influences immune responses. Distinct features of the physical skin
barrier, such as lipids, cornified envelopes in the stratum corneum, and tight junctions in the
stratum granulosum, limit or prevent the passage of certain molecules, such as high molecular
weight proteins, through the skin (Goleva et al. 2019). When barrier integrity or permeability are
disrupted, chemicals and/or proteins are more likely to be absorbed through the skin (Rietz
Liljedahl et al. 2021), and may lead to increased allergic sensitization. Additionally, disruptions
in skin integrity are associated with allergic diseases (Kelleher et al. 2015; Kelleher et al. 2016).
Due to the use of triclosan in skin products, the skin is a primary route of exposure through
which triclosan can be absorbed (MacIsaac et al. 2014). Thus, investigating the skin barrier
integrity and response of keratinocytes, the most abundant cell type in the epidermis, to triclosan
exposure is critical to understanding the immunomodulatory effects and associations with
increased sensitization potential.
Keratinocytes are key players in the structural integrity of the skin and they are involved
in sensing and reacting to the environment (Hammad and Lambrecht 2015). Cytokine signaling
is a key mechanism that keratinocytes interact with immune cells, both by producing cytokines
and responding to cytokines via cytokine receptors (Hammad and Lambrecht 2015; Jiang et al.
2020). Certain cytokines that are produced by epithelial cells including keratinocytes, such as
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thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, can communicate with
immune cells and skew immune responses towards T helper cell type 2 (Th2) responses, leading
to increased risk of sensitization (Goleva et al. 2019; Hammad and Lambrecht 2015). Dermal
exposure to triclosan has been shown to increase levels of Tslp, as well as other signaling
molecules such as S100 calcium-binding protein A8 (S100a8), IL-1 beta (Il1b), chemokine (CX-C motif) ligand (Cxcl)1, and Cxcl2 in mouse skin (Anderson et al. 2020; Weatherly et al.
2020). Additionally, triclosan exposure on mouse skin has been shown to alter expression of
filaggrin and keratin genes, demonstrating an impact on keratinocytes (Baur et al. 2021).
Exposure to triclosan on human keratinocytes in vitro has been shown to alter metabolic
pathways and increase proinflammatory cytokines (Liang et al. 2021). However, the impact of
triclosan exposure on human keratinocyte response and the skin barrier is not well understood.
3D skin models have been successfully employed to evaluate the skin barrier and to
explore mechanisms of skin disease (Niehues et al. 2018). One type of 3D skin model,
reconstructed human epidermis (RHE), represents a particularly useful approach to explore the
skin barrier and keratinocyte function independent from immune cells and the microbiome. RHE
is comprised of a functional barrier with an intact stratum corneum, proliferating and
differentiating primary human keratinocytes, and has similarities in the multi-layered structure of
intact human skin (Frankart et al. 2012). In this study, the impact of triclosan exposure on RHE
barrier and keratinocyte response was evaluated by assessing barrier permeability and expression
of barrier genes, cytokines, and growth factors.

Materials and Methods
RHE Tissue
EpiDermTM (MatTek) tissues were equilibrated per manufacturer’s instructions. Briefly,
tissue inserts were placed at 4 °C for 2 hours upon arrival, then transferred to 6-well plates
containing 0.9 mL/well of pre-warmed Dulbecco’s Modified Eagle’s Medium (DMEM,
hydrocortisone free) containing epidermal growth factor, insulin, other proprietary stimulators of
epidermal differentiation, gentamicin (5 µg/mL), amphotericin B (0.25 µg/ml), phenol red, and
proprietary lipid precursors (MatTek). Tissues were incubated at 37 °C with 5% CO2 overnight
to equilibrate. The following morning, tissues were washed with 100 µL pre-warmed Dulbecco’s
phosphate-buffered saline (DPBS) and either (1) media was replaced with 0.9 mL fresh pre83

warmed DMEM media/well (5-day experiments) or (2) tissues were transferred to 12-well
hanging-top lids (MatTek) with plates containing 5 mL of pre-warmed DMEM media/well (6h,
24h, and 48h experiments). For the 5-day experiment, media was replaced daily throughout the
experiment, prior to each exposure.
Triclosan Exposures
Triclosan (CAS # 3380-34-5) was purchased from EMD Millipore Corp. Acetone was
selected as the vehicle based on solubility and previous use in evaluating triclosan exposure on
EpiDerm tissues (Marshall et al. 2015). Acetone (CAS # 67-41-1) was purchased from SigmaAldrich. EpiDerm tissues (3/group) were exposed on the apical side to 30 µL acetone (vehicle)
or triclosan (0.05-0.2%) dissolved in acetone (w/v) once for 6, 24, or 48 hours or once/day (30
µL/day) for 5 consecutive days. Experiments were independently performed twice for each
timepoint and endpoint. An additional experiment was performed to compare no exposure vs.
acetone control. Tissues were incubated at 37 °C with 5% CO2 during the exposure. The
concentrations were selected based on triclosan concentrations in product formulations (0.10.3%) and a previous toxicity assessment of EpiDerm tissues to triclosan where ≥ 0.188%
triclosan was determined to be toxic (Marshall et al. 2015).
LDH Release Assay
Culture media (10 µL) was collected after 6, 24, or 48 hours of the single exposure or
each day of the 5-day exposure and transferred to a clear flat-bottomed 96-well plate. The LDHCytotoxicity Colorimetric Assay Kit II (BioVision) was used to perform the lactate
dehydrogenase (LDH) release assay per manufacturer’s instructions. Absorbance (450 nm) was
measured using a µQuant (BioTek) or Varioskan Lux (Thermo Scientific) microplate
spectrophotometer in duplicate for each sample. Values were averaged and fold change
compared to vehicle control was calculated.
Gene Expression Analysis
EpiDerm tissues were washed with 100 µL pre-warmed DPBS immediately prior to
nucleic acid extraction. EpiDerm tissues were disrupted and homogenized in 700 µL QIAzol
(QIAGEN) using a steel bead and TissueLyser II or with a pellet pestle homogenizer.
Homogenates were centrifuged at 15,000 g for 10 minutes at 4 °C. Total RNA was isolated from
lysates using the miRNAeasy kit (Qiagen) per manufacturer’s instructions, with a final elution
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volume of 30 µL per sample. The RNA purity and yield were determined on a NanoDrop
Spectrophotometer (Thermo Scientific). Reverse transcription was performed using the HighCapacity cDNA Reverse Transcription Kit (Applied Biosystems) per manufacturer’s
instructions. TaqMan Fast Universal PCR Master Mix (Applied Biosystems), cDNA, and genespecific primers (TaqMan Gene Expression Assays) were combined, and real-time quantitative
PCR was performed per manufacturer’s instructions. Gene expression was analyzed on a 7500
Fast Real-Time PCR System (Applied Biosystems), StepOnePlus (Applied Biosystems), or
QuantStudio3 (Applied Biosystems) using cycling conditions per manufacturer’s instructions.
GAPDH (Hs02786624_g1) was used as the reference gene. Data was collected and relative fold
change compared to the acetone vehicle was calculated using the cycle threshold (Ct) and the 2ΔΔCt

method. Data from one tissue insert (5-day exposure) was identified to be an outlier

(Grubbs’ test) and excluded from analysis. Genes evaluated include filaggrin (FLG)
(Hs00856927_g1), FLG2 (Hs00418578_m1), involucrin (IVL) (Hs00846307_s1), loricrin (LOR)
(Hs01894962_s1), tight junction protein 1 (TJP1) (Hs01551861_m1), occludin (OCLN)
(Hs00170162_m1), keratin (KRT) 10 (KRT10) (Hs00166289_m1), KRT14 (Hs00265033_m1), ecadherin (CDH1) (Hs01023895_m1), TSLP (Hs00263639_m1), S100A8 (Hs00374264_g1), IL1A
(Hs00174092_m1), IL1B (Hs01555410_m1), tumor necrosis factor (TNF) (Hs00174128_m1),
CXCL1 (Hs00236937_m1), CXCL2 (Hs00601975_m1), and CXCL8 (Hs00174103_m1).
Cytokine Release
Culture media was collected and frozen at -80 °C. Media was evaluated with a custom
human premixed multi-analyte kit (LXSAHM; R&D Systems) and analyzed on a MagPix
(Luminex) per manufacturer’s instructions. Analytes measured: epidermal growth factor (EGF),
IL1α, IL6, IL18, IL33, S100A8, TNF alpha (TNF-α), vascular endothelial growth factor
(VEGF), granulocyte macrophage colony-stimulating factor (GM-CSF), IL1β, IL8, IL31, IL36β,
transforming growth factor alpha (TGFα), TSLP.
Permeability Assay
EpiDerm tissues were washed with 100 µL pre-warmed DPBS immediately prior to the
permeability assay. Tissues were exposed on the apical side to 40 µL of 1 mM Lucifer Yellow
CH dilithium salt (Sigma) dissolved in DPBS and incubated at 37 °C with 5% CO2 for 2 hours.
Media (100 µL/replicate) was collected and fluorescence intensity was measured in triplicate in
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96-well black flat-bottomed plates (Greiner Bio-One) read on a Synergy (BioTek) or Varioskan
Lux (Thermo Scientific) microplate reader (excitation 428 nm, emission 536 nm). Fluorescence
intensity was averaged per sample and fold change in fluorescence intensity compared to vehicle
control was calculated.
Histology
Following the permeability assay, EpiDerm tissues were washed with 100 µL prewarmed DPBS immediately prior to collection. Formalin-fixed paraffin-embedded tissues were
sectioned (5 µm) and mounted on slides and stained with hematoxylin and eosin following
standard procedures (1 slide/tissue). Slides were brightfield imaged on an Olympus VS120 slide
scanner or Olympus AX70 microscope. Epidermal thickness was measured from 3 random
views/slide and 3 measurements/view were taken and averaged.
Statistical Analysis
The 3 replicate samples from 2 independent experiments were averaged for each
treatment combination resulting in a sample size of 2/group. Dependent measures were analyzed
using mixed-model analysis of variance (ANOVA), with each analysis incorporating experiment
as a random factor. Two-way factorial ANOVA’s with repeated measures were utilized when
time and exposure were included as independent variables and repeated measures were a factor.
Simple two-way factorial ANOVA’s were utilized when time and exposure were included as
independent variables. One-way ANOVA’s were utilized when only exposure was included as
an independent variable. In some cases, data were log transformed to reduce heterogenous
variance and meet the assumptions of the analysis. Post-hoc comparisons were carried out using
Fishers LSD test. All differences were considered significant at p < 0.05. All analyses were
carried out using SAS version 9.4 (SAS Institute, Cary, NC).

Results
Exposure to triclosan altered expression of barrier genes
Single exposure to triclosan for 6 (0.1% and 0.2% triclosan), 24 (0.1% and 0.2%
triclosan), and 48 (0.1% and 0.2% triclosan) hours increased LDH levels, a marker of
cytotoxicity, in culture media in a dose dependent manner (Figure 3.1A). Additionally, RNA
yield from tissues was reduced following 6 and 24 hours of 0.2% triclosan exposure and
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following 48 hours of 0.1% and 0.2% triclosan (Supplemental Figure 3.1A). Select genes known
to be involved in barrier integrity and previously investigated in mice (Baur et al. 2021) were
then evaluated. Exposure to triclosan for 6 (0.2%) and 24 hours (0.05%, 0.1%, and 0.2%)
significantly increased expression of FLG (Figure 3.1B) and 24 hours of 0.2% triclosan exposure
significantly increased FLG2 expression (Figure 3.1C). However, the increase in FLG and FLG2
did not persist at the 48-hour timepoint. Exposure to 0.2% triclosan for 6 hours increased KRT10
expression (Figure 3.1D). KRT14 was decreased at 24 hours (0.1%) (Figure 3.1E). Exposure to
triclosan for 6 (0.1% and 0.2%) and 24 hours (0.2%) increased expression of TJP1 (Figure 3.1F)
and OCLN (0.1% and 0.2% at 6 hours, 0.1% and 0.2% at 24 hours) (Figure 3.1G). Furthermore,
exposure to 0.2% triclosan increased expression of IVL, LOR and CDH1 at multiple timepoints
(Supplemental Figure 3.1B-D). Together, these data demonstrate that in vitro triclosan exposure
alters the expression of select skin barrier genes in EpiDerm.
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Figure 3.1. Exposure to triclosan induced toxicity and altered expression of barrier genes in
EpiDerm tissues. (A) Fold change in optical density (OD) (450 nm) compared to vehicle control
in culture media to detect LDH release following 6, 24, and 48 hours of 0% triclosan (acetone
vehicle) or 0.05-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group. *p < 0.05
vs. 0% triclosan. Fold change in gene expression compared to vehicle control of (B) FLG, (C)
FLG2, (D) KRT10, (E) KRT14, (F) TJP1, and (G) OCLN following 6, 24, and 48 hours of 0%
triclosan (vehicle) or 0.05-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group.
*p < 0.05 vs. 0% triclosan.
Exposure to triclosan increased expression of cytokines and tissue permeability
Single exposure to 0.2% triclosan for 6 hours significantly increased the gene expression
of TSLP (Figure 3.2A) while exposure to 0.2% triclosan for 6 and 24 hours significantly
increased the expression of IL1A (Figure 3.2B). Twenty-four hours of 0.2% triclosan and 48
hours of 0.1% triclosan exposure significantly increased expression of IL1B (Figure 3.2C).
Exposure to triclosan for 6 hours (0.1% and 0.2%), 24 hours (0.2%), and 48 hours (0.1% and
0.2%) also increased TNF expression (Figure 3.2D). Triclosan exposure increased the expression
of chemokines CXCL1 (Figure 3.2E) (6 hours, 0.1% and 0.2%), CXCL2 (Figure 3.2F) (6 hours,
0.1% and 0.2%; 24 hours, 0.2%; 48 hours, 0.2%), and CXCL8 (Figure 3.2G) (6 hours, 0.1% and
0.2%; 24 hours, 0.2%). Exposure to 0.05% triclosan for 24 hours decreased CXCL1 expression.
Exposure to triclosan had no significant impact on S100A8 expression (Figure 3.2H).
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Figure 3.2. Exposure to triclosan on EpiDerm tissues altered the gene expression of cytokines.
Fold change in gene expression compared to vehicle control of (A) TSLP, (B) IL1A, (C) IL1B,
(D) TNF, (E) CXCL1, (F) CXCL2, (G) CXCL8, and (H) S100A8 following 6, 24, and 48 hours of
0% triclosan (acetone vehicle) or 0.05-0.2% triclosan. Bars represent the mean (± SEM) of 2
samples/group. *p < 0.05 vs. 0% triclosan.
To evaluate cytokines at the protein level, media was collected following triclosan
(0.05%, 0.1%, 0.2%) exposure on EpiDerm tissues for 24 and 48 hours. Corresponding with
changes in gene expression, 24 (0.1% and 0.2%) and 48 hours (0.1% and 0.2%) of triclosan
exposure significantly increased release of IL1α in the media (Table 3.1). In contrast, no
significant changes in CXCL8 levels in the culture media were observed (Table 3.1). Additional
cytokines and growth factors known to be produced by keratinocytes were evaluated following
triclosan exposure. Exposure to 0.1% and 0.2% triclosan for 24 hours and 48 hours significantly
increased levels of IL36 and triclosan exposure (0.05%, 0.1%, and 0.2%) for 24 hours increased
VEGF levels (Table 3.1). Additionally, exposure to 0.1% triclosan for 48 hours increased VEGF.
Exposure to triclosan did not alter levels of EGF in the culture media. TSLP, TNFα, S100A8,
IL1β, IL18, IL31, IL33, GMCSF, TGFα, and IL6 levels were near or below the limit of detection
(results not shown).
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Table 3.1
Exposure Duration

24 hours

48 hours

Triclosan (w/v)

0%

0.05%

0.1%

0.2%

0%

0.05%

0.1%

0.2%

IL1α

19.4 ± 2.2

29.3 ± 3.6

39.7 ± 2.8
*

54.0 ± 9.1
*

26.2 ±11.1

32.4 ± 11.9

61.0 ± 26.2
*

71.8 ± 14.7
*

IL36

49.5 ± 3.2

59.1 ± 3.3

70.4 ± 10.7
*

99.3 ± 6.0
*

78.7 ± 9.8

84.1 ± 5.8

114.3 ± 9.8
*

145.9 ± 19.3
*

CXCL8

72.7 ± 7.7

54.5 ± 1.5

59.9 ± 6.2

46.9 ± 5.6

100.4 ± 38.3

93.8 ± 29.0

115.7 ± 54.7

66.3 ± 25.8

VEGF

79.8 ± 20.6

102.0 ± 20.9
*

121.2 ± 18.4
*

129.1 ± 9.6
*

112.8 ± 32.7

136.2 ± 27.0

154.0 ± 27.8
*

142.7 ± 38.0

EGF

28.5 ±21.1

31.0 ± 19.9

28.6 ± 19.0

31.7 ± 22.7

39.6 ± 3.8

44.1 ± 0.3

42.9 ± 6.0

43.4 ± 3.6

Cytokines and growth factors (pg/mL) released following 24 and 48 hours of triclosan exposure on EpiDerm. Numbers represent
mean (± SEM) of 2 samples/group. *p < 0.05 vs. 0% triclosan.
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To investigate the impact of triclosan exposure on keratinocyte function, permeability of
a fluorescent molecule through the EpiDerm tissue was assessed following 24 and 48 hours of
exposure to the mid (0.1%) and high (0.2%) concentrations of triclosan. Exposure to triclosan on
EpiDerm tissues for 24 (0.1% and 0.2%) and 48 hours (0.1%) significantly increased tissue
permeability (Figure 3.3A). However, epidermal thickness was decreased only at 24 hours
(Figure 3.3B) and minimal changes in morphology (Figure 3.3C-F) following 0.2% triclosan
exposure were identified. Taken together, these results demonstrate that a single exposure to
triclosan increases expression of select cytokines and growth factors in EpiDerm and increases
tissue permeability.
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Figure 3.3. Exposure to triclosan on EpiDerm tissues altered barrier permeability. (A) Fold
change in fluorescence intensity compared to vehicle control following 24 and 48 hours of 0%
triclosan (vehicle) or 0.1-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group.
*p < 0.05 vs. 0% triclosan. (B) Epidermal thickness (µm) following 24 and 48 hours of 0%
triclosan (acetone vehicle) or 0.2% triclosan. Bars represent the mean (± SEM) of 2
samples/group. *p < 0.05 vs. 0% triclosan. Representative hematoxylin and eosin images of
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EpiDerm tissues following 24 hours of exposure to acetone vehicle (C) or 0.2% triclosan (D) and
48 hours of exposure to acetone vehicle (E) or 0.2% triclosan (F). Scale bar = 20 µm.
Repeated exposure to triclosan had minimal impacts on expression of skin barrier genes
To evaluate the impact of repeated daily exposures to triclosan, as has previously been
investigated in mice (Baur et al. 2021), EpiDerm tissues were exposed daily for 5 consecutive
days to triclosan (0.1% and 0.2%). Exposure to triclosan (0.1 and 0.2%) for 1-5 days
significantly increased LDH release in media (Figure 3.4A). Additionally, RNA yield was
reduced after 5 days of triclosan (0.1% and 0.2%) exposure (Supplemental Figure 3.2A). Daily
exposure of EpiDerm tissues to triclosan for a period of 5 days had no significant impact on the
expression of FLG, FLG2, KRT10, KRT14, TJP1, nor OCLN (Figure 3.4B-G). Additionally, no
significant change in expression of IVL nor CDH1 was observed following triclosan exposure,
but 0.2% triclosan significantly decreased LOR expression (Supplementary Figure 3.2B-D).
Together, these data demonstrate that repeated exposure to triclosan on EpiDerm tissues had
minimal impacts on the expression of skin barrier genes.
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Figure 3.4. Repeated exposure to triclosan increased toxicity in EpiDerm tissues. (A) Fold
change in optical density (OD) (450 nm) compared to vehicle control in culture media to detect
LDH release following 5 days of 0% triclosan (acetone vehicle) or 0.1-0.2% triclosan. Bars
represent the mean (± SEM) of 2 samples/group. *p < 0.05 vs. 0% triclosan. Fold change in gene
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expression compared to vehicle control of (B) FLG, (C) FLG2, (D) KRT10, (E) KRT14, (F)
TJP1, (G) OCLN following 5 days of 0% triclosan (acetone vehicle) or 0.1-0.2% triclosan. Bars
represent the mean (± SEM) of 2 samples/group.
Repeated exposure to triclosan changed expression of cytokines and growth factors
Repeated daily exposure of EpiDerm tissues to triclosan had no significant impact on
TSLP nor CXCL2 gene expression (Figure 3.5A and 3.5C). Exposure to triclosan for 5 days
significantly increased the gene expression of TNF (Figure 3.5B, 0.2%) and CXCL8 (Figure
3.5D, 0.1% and 0.2%). In contrast, triclosan exposure for 5 days significantly decreased gene
expression of S100A8 (Figure 3.5E, 0.2%).
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Figure 3.5. Repeated exposure to triclosan on EpiDerm tissues changed expression of immunerelated genes. Fold change in gene expression compared to vehicle control of (A) TSLP, (B)
TNF, (C) CXCL2, (D) CXCL8, and (E) S100A8 following 5 days of 0% triclosan (acetone
vehicle) or 0.1-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group. *p < 0.05
vs. 0% triclosan.
Media was collected daily prior to each exposure, up to 5 days of exposure, to investigate
changes in cytokine excretion over time. Exposure to triclosan (0.2%) increased IL1α production
as early as 1-day post exposure (Table 3.2), as shown previously with single triclosan exposure
(Table 3.1). IL1α continued to increase at 2 days of triclosan exposure before plateauing at days
3-5. Exposure to 0.2% triclosan significantly increased IL36 through 5 days of exposure (Table
3.2). After repeated triclosan (0.1% and 0.2%) exposure, EGF levels were significantly increased
(Table 3.2). In contrast, repeated exposure to triclosan decreased the levels of CXCL8 and VEGF
in the culture media (Table 3.2). TSLP, TNFα, S100A8, IL1β, IL18, IL31, IL33, GMCSF,
TGFα, and IL6 levels were low or undetectable (results not shown). Exposure to acetone alone
compared to no exposure controls increased the production of IL1ɑ (days 1-5), IL36 (days 4-5),
and CXCL8 (days 1-5) (Supplemental Table 3.1). No changes were observed between acetone
and no exposure controls for VEGF and EGF (Supplemental Table 3.1). To assess skin barrier
function, the permeability assay was performed after 5 days of repeated triclosan exposure.
Exposure to triclosan for 5 days did not significantly increase tissue permeability (Figure 3.6).
Together, these data demonstrate that repeated exposure to triclosan on EpiDerm tissues alters
the expression patterns of cytokines and growth factors in the absence of permeability
alterations.
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Table 3.2
Cytokine

IL1α

IL36

CXCL8

VEGF

EGF

Triclosan (w/v)

1 day

2 days

3 days

4 days

5 days

0%

74.3 ± 12.9

94.2 ± 33.6

136.8 ± 10.7

140.6 ± 13.8

163.2 ± 29.8

0.1%

181.9 ± 98.0 *

167.9 ± 78.5

211.9 ± 9.7

200.2 ± 8.7

186.8 ± 27.4

0.2%

254.0 ± 119.8 *

198.5 ± 74.5 *

249.9 ± 10.0

184.6 ± 21.9

154.3 ± 30.7

0%

127.3 ± 80.8

74.8 ± 53.4

59.5 ± 30.7

51.6 ± 26.9

50.1 ± 21.4

0.1%

240.1 ± 157.8

179.5 ± 107.2

211.7 ± 38.0 *

218.4 ± 23.3 *

222.9 ± 42.0 *

0.2%

371.0 ± 243.0 *

236.2 ± 126.7 *

298.2 ± 45.3 *

257.4 ± 45.7 *

212.1 ± 50.8 *

0%

332.2 ± 188.3

230.7 ± 100.0

269.7 ± 20.8

246.9 ± 29.5

243.2 ± 30.0

0.1%

372.9 ± 237.9

181.5 ± 93.4

127.0 ± 8.4

71.0 ± 4.1

42.5 ± 3.0 *

0.2%

361.0 ± 240.4

152.6 ± 88.4

88.6 ± 13.5

43.7 ± 1.7 *

27.2 ± 0.9 *

0%

336.6 ± 115.9

274.0 ± 129.9

40.8

310.8 ± 45.5

326.8 ± 74.3

0.1%

563.8 ± 203.9

456.0 ± 205.0

487.0 ± 110.5

302.4 ± 139.2

186.5 ± 130.3 *

0.2%

498.3 ± 224.1

312.9 ± 165.3

178.9 ± 47.0 *

68.5 ± 19.5 *

38.9 ± 13.3 *

0%

21.2 ± 3.9

17.9 ± 6.8

22.6 ± 0.9

23.0 ± 1.3

21.4 ± 2.4

0.1%

24.0 ± 9.1

22.7 ± 9.5

33.1 ± 0.1

40.1 ± 1.6 *

44.2 ± 3.2 *

0.2%

25.2 ± 10.2

30.2 ± 11.4

48.7 ± 3.5 *

54.3 ± 7.1 *

56.6 ± 10.8 *

Cytokines and growth factors (pg/mL) released following 5 days of triclosan exposure on EpiDerm. Numbers represent mean (± SEM)
of 2 samples/group. *p < 0.05 vs. 0%.
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Figure 3.6. Repeated exposure to triclosan on EpiDerm tissues had no significant impact on
permeability. Fold change in fluorescence intensity compared to vehicle control following 5 days
of 0% triclosan (acetone vehicle) or 0.1-0.2% triclosan. Bars represent the mean (± SEM) of 2
samples/group.

Discussion
In the United States, over 32 million workers are predicted to have the potential for
exposure to chemicals that can be absorbed through the skin and cause occupational skin
diseases (BLS 2022; NIOSH 2021). Investigations into skin exposures are needed, because these
exposures can lead to immunotoxicity and allergic disease (NORA 2019). Triclosan is an
immunomodulatory, antimicrobial chemical and is used in occupational settings that result in
exposure to the skin; however, the direct impacts of triclosan exposure on skin cells and the skin
barrier are not well understood.
In this study, the impact of a single or repeated exposure to triclosan on the skin barrier
and keratinocyte response was investigated using RHE, EpiDerm. A single exposure of triclosan
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on EpiDerm tissues significantly increased the expression of genes involved in skin barrier
function, including FLG, FLG2, and KRT10 (Figure 3.1). However, FLG, FLG2, and KRT10
gene expression were not significantly changed after the repeated exposure (Figure 3.4). These
results partially align with animal studies that demonstrate that exposure to triclosan on SKH1
hairless mouse skin decreased Flg2 and Krt10 gene expression (Baur et al. 2021). While the
importance of FLG in clinical atopic dermatitis has been well reported, investigations using in
vitro models are conflicting. Previous studies have shown that knockdown of FLG in RHE alters
tissue permeability (Mildner et al. 2010; Pendaries et al. 2014), but, in contrast, RHE constructed
with keratinocytes with FLG loss-of-function mutations has not been shown to alter tissue
permeability (Niehues et al. 2017). Although FLG2 knockdown in RHE has not been shown to
alter permeability, other markers of skin integrity including decreased abundance of urocanic
acid, decreased loricrin expression, and disrupted processing of profilaggrin were identified
(Pendaries et al. 2015). However, the role of FLG2 in barrier integrity has been suggested by
other studies (Albérola et al. 2019). Additionally, the impact of chemical exposure on FLG and
FLG2 has not been well investigated. A single exposure to triclosan on EpiDerm tissues also
increased expression of TJP1 and OCLN (Figure 3.1), barrier genes which contribute to the
formation of tight junctions and regulate tissue permeability (Kirschner et al. 2013). Together,
these results demonstrate that triclosan alters the expression of skin barrier genes in vitro and
suggests that integrity of the barrier may be impacted due to changes in these genes.
Additionally, exposure duration and timing may also be a contributing factor.
In this study, TSLP expression was significantly increased in EpiDerm tissues after 6
hours of triclosan exposure (Figure 3.2A), but not after 5 days of repeated exposure (Figure
3.5A). Previously, dermal exposure to triclosan was shown to increase Tslp expression in mouse
skin in Th2 prone BALB/c mice (Anderson et al. 2020). TSLP is produced by keratinocytes and
is involved in Th2 immune responses (Hammad and Lambrecht 2015). Although TSLP
stimulation of keratinocytes was previously shown to decrease expression of FLG (Kim et al.
2015), differences between levels of TSLP added to cultured keratinocytes (over 10 ng/mL)
(Kim et al. 2015) compared to TSLP levels produced by EpiDerm in this study (less than 0.003
ng/mL) may account for the differential responses in FLG. Exposure to triclosan on EpiDerm
tissues also increased IL1A gene expression (Figure 3.2B) and IL1α protein production in media
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(Table 3.1) and repeated exposure to triclosan increased IL1α levels in media (Table 3.2) as early
as 24 hours post exposure. IL1α is one of the first cytokines released following keratinocyte
stimulation, leading to the production of additional proinflammatory cytokines (Jiang et al.
2020). Additionally, IL1α may be involved in repair of the skin barrier (Gutowska-Owsiak and
Ogg 2013). Although the acetone vehicle increased IL1α levels too, compared to no exposure
controls, exposure to triclosan further increased the release of IL1α when compared to acetone
vehicle, demonstrating that exposure to triclosan impacts the release of proinflammatory
cytokines. Together, these results demonstrate that triclosan exposure on EpiDerm tissues has a
direct impact on the keratinocyte proinflammatory and allergic response.
A single exposure to triclosan on EpiDerm tissues increased CXCL1, CXCL2, TNF, and
CXCL8 gene expression (Figure 3.2D-G) suggesting a proinflammatory response. While CXCL8
was elevated at the transcript level, protein levels were not significantly changed. The most
robust change in gene expression occurred at the 6-hour time point, although protein levels were
not evaluated at this time point. By 48 hours, no changes were identified in gene expression
suggesting this finding might be a result of kinetics. The increased expression of CXCL2 and
CXCL1 aligns with increased Cxcl2 and Cxcl1 gene expression in mouse skin following triclosan
exposure (Weatherly et al. 2020). Additionally, in this EpiDerm model, TSLP protein production
was below the limit of detection which could also be due to the lack of immune cells in this
model, since mast cells, basophils, and dendritic cells have also been shown to be a source of
TSLP (Tsilingiri et al. 2017). A single exposure to triclosan on EpiDerm tissues increased
protein production of IL36 and VEGF (Table 3.1) and repeated exposure to triclosan increased
IL36 and EGF protein levels (Table 3.2). Activated IL36 has been shown to downregulate genes
involved in skin integrity (Pfaff et al. 2017). Furthermore, EGF may regulate IL36 (Buhl and
Wenzel 2019). Although VEGF was initially increased following triclosan exposure, production
of VEGF decreased after repeated exposures, along with CXCL8. This suggests that
proinflammatory effects occurred early-on but waned with time, potentially due to cytotoxicity.
Cytotoxicity was observed in this study (Figure 3.1A and 3.4A) and has previously been shown
in mouse keratinocytes (Wu et al. 2015) and EpiDerm tissues (Marshall et al. 2015) following
triclosan exposure. Surprisingly, repeated exposure to triclosan on EpiDerm tissues also
decreased S100A8 gene expression (Figure 3.5E). This differential change in an immune-related
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gene, compared to animal studies (Marshall et al. 2017; Weatherly et al. 2020), may again be due
to differences in cell populations, because no immune cells, such as neutrophils, are present in
EpiDerm tissues, or due to cytotoxic effects. Taken together, changes in the expression patterns
of cytokines and growth factors indicate changes in keratinocyte function following triclosan
exposure in this model of RHE.
Disruptions in skin barrier genes and cytokines can impact skin barrier integrity. A single
exposure to triclosan on EpiDerm tissues increased tissue permeability (Figure 3.3A),
demonstrating a disruption in barrier integrity. Although studies investigating single genes
involved in the skin barrier, such as FLG2 (Pendaries et al. 2015), have not been shown to
directly disrupt tissue permeability, the combination of barrier genes and cytokines changing in
keratinocytes due to triclosan exposure may be responsible for the impact on tissue permeability.
Previously, we have shown that exposure to triclosan on mouse skin disrupts barrier integrity
(Baur et al. 2021), complimenting these in vitro findings on skin integrity. Interestingly, repeated
(5-day) exposure to triclosan had no statistically significant impact on skin permeability nor
expression of skin barrier genes. This result may be due to the overt cytotoxicity observed
following repeated triclosan exposure. Additionally, the length of exposure (5 days) may account
for differences observed, compared to 1 day of exposure. This highlights some of the limitations
of the in vitro model and supports the need for additional kinetic related studies.
In summary, these results show that exposure to triclosan on RHE disrupts expression of
skin barrier genes, increases barrier permeability, and alters keratinocyte function which is
consistent with animal studies and further expands on previous observations by using a human
skin model. Changes in keratinocyte function following exposure to chemicals may be a critical
initiator in recruitment and signaling to immune cells, followed closely by disruption of the skin
barrier, resulting in increased absorbance of chemicals and further exacerbation of the
proinflammatory and allergic response. Studies investigating the response of exposure to
chemicals, including antimicrobials, on the skin are critical for increased understanding of early
changes in the skin and the initiation of sensitization or immune modulation.

103

Acknowledgements
We would like to acknowledge Rosana Schafer and Jennifer Franko for providing laboratory
space and equipment to complete these experiments. We would also like to acknowledge Gordon
Meares, F. Heath Damron, Edwin Wan, Meenal Elliott, and Michelle Witt for access to
equipment to complete these experiments. We would like to acknowledge the WVU Microscope
Imaging Core Facility, Morgantown, WV for support provided to help make this publication
possible and Grant #P20GM103434 which in turn provides financial support to the Core Facility.

Disclosure of Interest
The authors declare no conflicts of interest. The authors alone are responsible for the content of
this manuscript. The findings and conclusions in this report are those of the authors and do not
necessarily represent the official position of the National Institute for Occupational Safety and
Health, Centers for Disease Control and Prevention.

Funding
This work was supported by internal funds from the Health Effects Laboratory Division of the
National Institute for Occupational Safety and Health.

References
Albérola G, Schroder JM, Froment C, Simon M. 2019. The amino-terminal part of human flg2 is
a component of cornified envelopes. J Invest Dermatol. 139(6):1395-1397.
Anderson SE, Baur R, Kashon M, Lukomska E, Weatherly L, Shane HL. 2020. Potential
classification of chemical immunologic response based on gene expression profiles. J
Immunotoxicol. 17(1):122-134.
Anderson SE, Franko J, Kashon ML, Anderson KL, Hubbs AF, Lukomska E, Meade BJ. 2013.
Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of
asthma. Toxicol Sci. 132(1):96-106.
Anderson SE, Meade BJ, Long CM, Lukomska E, Marshall NB. 2016. Investigations of
immunotoxicity and allergic potential induced by topical application of triclosan in mice.
J Immunotoxicol. 13(2):165-172.
Baur R, Gandhi J, Marshall NB, Lukomska E, Weatherly LM, Shane HL, Hu G, Anderson SE.
2021. Dermal exposure to the immunomodulatory antimicrobial chemical triclosan alters
the skin barrier integrity and microbiome in mice. Toxicol Sci.
BLS. 2022. Table b-1a. Employees on nonfarm payrolls by industry sector and selected industry
detail, seasonally adjusted. Washington, DC: U.S. Bureau of Labor Statistics.
Buhl AL, Wenzel J. 2019. Interleukin-36 in infectious and inflammatory skin diseases. Front
Immunol. 10:1162.
Consumer product information database. [accessed 2022]. https://www.whatsinproducts.com/.
104

Fang JL, Stingley RL, Beland FA, Harrouk W, Lumpkins DL, Howard P. 2010. Occurrence,
efficacy, metabolism, and toxicity of triclosan. J Environ Sci Health C Environ Carcinog
Ecotoxicol Rev. 28(3):147-171.
FDA. 2016. Safety and effectiveness of consumer antiseptics; topical antimicrobial drug
products for over-the-counter human use. Final rule. Fed Regist. 81:61106-61130.
Frankart A, Malaisse J, De Vuyst E, Minner F, de Rouvroit CL, Poumay Y. 2012. Epidermal
morphogenesis during progressive in vitro 3d reconstruction at the air-liquid interface.
Exp Dermatol. 21(11):871-875.
Goleva E, Berdyshev E, Leung DY. 2019. Epithelial barrier repair and prevention of allergy. J
Clin Invest. 129(4):1463-1474.
Gutowska-Owsiak D, Ogg GS. 2013. Cytokine regulation of the epidermal barrier. Clin Exp
Allergy. 43(6):586-598.
Hammad H, Lambrecht Bart N. 2015. Barrier epithelial cells and the control of type 2 immunity.
Immunity. 43(1):29-40.
Jiang Y, Tsoi LC, Billi AC, Ward NL, Harms PW, Zeng C, Maverakis E, Kahlenberg JM,
Gudjonsson JE. 2020. Cytokinocytes: The diverse contribution of keratinocytes to
immune responses in skin. JCI Insight. 5(20).
Jones RD, Jampani HB, Newman JL, Lee AS. 2000. Triclosan: A review of effectiveness and
safety in health care settings. American Journal of Infection Control. 28(2):184-196.
Kelleher M, Dunn-Galvin A, Hourihane JO, Murray D, Campbell LE, McLean WHI, Irvine AD.
2015. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2
months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol.
135(4):930-935 e931.
Kelleher MM, Dunn-Galvin A, Gray C, Murray DM, Kiely M, Kenny L, McLean WHI, Irvine
AD, Hourihane JO. 2016. Skin barrier impairment at birth predicts food allergy at 2 years
of age. J Allergy Clin Immunol. 137(4):1111-1116 e1118.
Kim JH, Bae HC, Ko NY, Lee SH, Jeong SH, Lee H, Ryu WI, Kye YC, Son SW. 2015. Thymic
stromal lymphopoietin downregulates filaggrin expression by signal transducer and
activator of transcription 3 (stat3) and extracellular signal-regulated kinase (erk)
phosphorylation in keratinocytes. J Allergy Clin Immunol. 136(1):205-208 e209.
Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner JM. 2013. Contribution of
tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest
Dermatol. 133(5):1161-1169.
Liang Y, Zhang H, Cai Z. 2021. New insights into the cellular mechanism of triclosan-induced
dermal toxicity from a combined metabolomic and lipidomic approach. Sci Total
Environ. 757:143976.
MacIsaac JK, Gerona RR, Blanc PD, Apatira L, Friesen MW, Coppolino M, Janssen S. 2014.
Health care worker exposures to the antibacterial agent triclosan. J Occup Environ Med.
56(8):834-839.
Marshall NB, Lukomska E, Long CM, Kashon ML, Sharpnack DD, Nayak AP, Anderson KL,
Jean Meade B, Anderson SE. 2015. Triclosan induces thymic stromal lymphopoietin in
skin promoting th2 allergic responses. Toxicol Sci. 147(1):127-139.
Marshall NB, Lukomska E, Nayak AP, Long CM, Hettick JM, Anderson SE. 2017. Topical
application of the anti-microbial chemical triclosan induces immunomodulatory
responses through the s100a8/a9-tlr4 pathway. J Immunotoxicol. 14(1):50-59.
105

Mildner M, Jin J, Eckhart L, Kezic S, Gruber F, Barresi C, Stremnitzer C, Buchberger M, Mlitz
V, Ballaun C et al. 2010. Knockdown of filaggrin impairs diffusion barrier function and
increases uv sensitivity in a human skin model. J Invest Dermatol. 130(9):2286-2294.
Niehues H, Bouwstra JA, El Ghalbzouri A, Brandner JM, Zeeuwen P, van den Bogaard EH.
2018. 3d skin models for 3r research: The potential of 3d reconstructed skin models to
study skin barrier function. Exp Dermatol. 27(5):501-511.
Niehues H, Schalkwijk J, van Vlijmen-Willems I, Rodijk-Olthuis D, van Rossum MM,
Wladykowski E, Brandner JM, van den Bogaard EHJ, Zeeuwen P. 2017. Epidermal
equivalents of filaggrin null keratinocytes do not show impaired skin barrier function. J
Allergy Clin Immunol. 139(6):1979-1981 e1913.
NIOSH. 2021. Niosh strategic plan: Fys 2019-2024. Version 5: October 2021 ed. Atlanta, GA:
Centers for Disease Control and Prevention.
National occupational research agenda for immune, infectious and dermal disease prevention
(iid). 2019. [accessed 2022 May]. https://www.cdc.gov/nora/councils/iid/agenda.html.
Pendaries V, Le Lamer M, Cau L, Hansmann B, Malaisse J, Kezic S, Serre G, Simon M. 2015.
In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper
cornification. Cell Death Dis. 6:e1656.
Pendaries V, Malaisse J, Pellerin L, Le Lamer M, Nachat R, Kezic S, Schmitt AM, Paul C,
Poumay Y, Serre G et al. 2014. Knockdown of filaggrin in a three-dimensional
reconstructed human epidermis impairs keratinocyte differentiation. J Invest Dermatol.
134(12):2938-2946.
Pfaff CM, Marquardt Y, Fietkau K, Baron JM, Luscher B. 2017. The psoriasis-associated il-17a
induces and cooperates with il-36 cytokines to control keratinocyte differentiation and
function. Sci Rep. 7(1):15631.
Rietz Liljedahl E, Johanson G, Korres de Paula H, Faniband M, Assarsson E, Littorin M,
Engfeldt M, Liden C, Julander A, Wahlberg K et al. 2021. Filaggrin polymorphisms and
the uptake of chemicals through the skin-a human experimental study. Environ Health
Perspect. 129(1):17002.
Savage JH, Johns CB, Hauser R, Litonjua AA. 2014. Urinary triclosan levels and recent asthma
exacerbations. Ann Allergy Asthma Immunol. 112(2):179-181 e172.
Savage JH, Matsui EC, Wood RA, Keet CA. 2012. Urinary levels of triclosan and parabens are
associated with aeroallergen and food sensitization. J Allergy Clin Immunol. 130(2):453460 e457.
Tsilingiri K, Fornasa G, Rescigno M. 2017. Thymic stromal lymphopoietin: To cut a long story
short. Cell Mol Gastroenterol Hepatol. 3(2):174-182.
Weatherly LM, Shane HL, Friend SA, Lukomska E, Baur R, Anderson SE. 2020. Topical
application of the antimicrobial agent triclosan induces nlrp3 inflammasome activation
and mitochondrial dysfunction. Toxicol Sci. 176(1):147-161.
Wu Y, Beland FA, Chen S, Fang JL. 2015. Extracellular signal-regulated kinases 1/2 and akt
contribute to triclosan-stimulated proliferation of jb6 cl 41-5a cells. Arch Toxicol.
89(8):1297-1311.

106

Chapter 4
Exposure to the immunomodulatory chemical triclosan differentially impacts
immune cell populations in the skin of haired (BALB/c) and hairless (SKH1)
mice

Toxicology Reports 2022 9: 1766-1776
https://doi.org/10.1016/j.toxrep.2022.09.005

107

Exposure to the immunomodulatory chemical triclosan differentially impacts
immune cell populations in the skin of haired (BALB/c) and hairless (SKH1)
mice

Rachel Baur, Hillary L. Shane, Lisa M. Weatherly, Ewa Lukomska, Michael Kashon, Stacey E.
Anderson

Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute
for Occupational Safety and Health, 1000 Frederick Lane, Morgantown, WV 26508

Please address all correspondence to Rachel Baur, National Institute for Occupational Safety and
Health,

1000

Frederick

Lane,

Morgantown,

WV

26508.

(T)

rms0051@mix.wvu.edu

Running Title: Exposure to triclosan differentially impacts immune cells
Key Words: triclosan, skin, neutrophils, dendritic cells, ILC2s

108

304-285-5822

(E)

Abstract
Workers across every occupational sector have the potential to be exposed to a wide
variety of chemicals, and the skin is a primary route of exposure. Furthermore, exposure to
certain chemicals has been linked to inflammatory and allergic diseases. Thus, understanding the
immune responses to chemical exposures on the skin and the potential for inflammation and
sensitization is needed to improve worker safety and health. Responses in the skin
microenvironment impact the potential for sensitization; these responses may include
proinflammatory cytokines, inflammasome activation, barrier integrity, skin microbiota, and the
presence of immune cells. Selection of specific mouse strains to evaluate skin effects, such as
haired (BALB/c) or hairless (SKH1) mice, varies dependent on experimental design and needs of
a study. However, dermal chemical exposure may impact reactions in the skin differently
depending on the strain of mouse. Additionally, there is a need for established methods to
evaluate immune responses in the skin. In this study, exposure to the immunomodulatory
chemical triclosan was evaluated in two mouse models using immunophenotyping by flow
cytometry and gene expression analysis. BALB/c mice exposed to triclosan (2%) had a higher
number and frequency of neutrophils and lower number and frequency of dendritic cells in the
skin compared to controls. Although these changes were not observed in SKH1 mice, SKH1
mice exposed to triclosan had a higher number and frequency of type 2 innate lymphoid cells in
the skin. Taken together, these results demonstrate that exposure to an immunomodulatory
chemical, triclosan, differentially impacts immune cell populations in the skin of haired and
hairless mice. Additionally, the flow cytometry panel reported in this manuscript, in combination
with gene expression analysis, may be useful in future studies to better evaluate the effect of
chemical exposures on the skin immune response. These findings may be important to consider
during strain selection, experimental design, and result interpretation of chemical exposures on
the skin.
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Introduction
The CDC estimates that over 32 million workers in the United States are employed in
industries with potential chemical exposures and are at risk of occupational skin diseases (BLS
2022; NIOSH 2021). Furthermore, over 42,000 chemicals are currently in use and more are
being added each year (EPA 2022). The skin is one of the most common occupational routes of
chemical exposure and adverse reactions may occur, depending on the type of chemical (NORA
IID Cross-Sector Council 2019). Exposure to chemicals can result in the increased incidence of
inflammatory and allergic diseases such as irritant contact dermatitis (ICD), allergic contact
dermatitis (ACD), urticaria, and asthma (Anderson and Meade 2014). The microenvironment of
the barrier site can influence the development of disease and a variety of events; these events
may be involved in inflammation and sensitization, including release of danger signals,
inflammasome signaling, upregulation of proinflammatory cytokines, alterations in the
microbiota, decreases in skin integrity, and changes in immune cell populations (Shane et al.
2019a).
Hundreds of chemicals have been associated with inflammatory and allergic diseases
(Anderson and Meade 2014; Anderson and Meade 2018; Jarvis, et al. 2005). However, the
mechanism of how chemical exposure induces these immune responses is an area of active
investigation. Immune cells play an essential role in the development of inflammatory and
allergic responses in both the skin and draining lymph nodes (dLNs); signals and mediators in
the microenvironment of the skin are more recently being recognized as key mediators in these
processes. For example, type 2 innate lymphoid cells (ILC2s) have emerged as important players
in the type 2 helper T cell (Th2)-skewing response and the development of allergic disease
(Hammad

and

Lambrecht

2015).

Dermal

exposure

to

the

antimicrobial

chemical

didecyldimethylammonium chloride (DDAC) has been demonstrated to activate ILC2s; these
cells have been shown to be involved in Th2 cytokine production in mice (Shane et al. 2019b).
Dendritic cells (DCs), basophils, and eosinophils are also recruited through Th2 responses and
chemokine signaling (Hammad and Lambrecht 2015). Neutrophils are involved in inflammation
and are thought to be important in sensitization by promoting a proinflammatory response and
the activation and migration of DCs to the dLNs (Silvestre et al. 2018; Weber et al. 2015). Taken

110

together, these findings demonstrate that changes in immune cells in the skin influence the
inflammatory and sensitization process and development of disease.
BALB/c mice have commonly been used in investigations of asthma and allergic disease
due to their Th2 bias (Anderson et al. 2016; Woolhiser et al. 2000). In addition to activation of
the innate immune system and proinflammatory cytokines, the microbiome and skin barrier
integrity have been demonstrated to influence the immune microenvironment following chemical
exposure (Baur et al. 2021; Shane et al. 2019a). SKH1 hairless mice are a common model for
studies investigating the skin microbiome and skin barrier integrity (Baur et al. 2021; Fluhr et al.
2006; SanMiguel et al. 2017). The SKH1 mouse strain has also been used in studies investigating
dermal and immunological responses following exposure to sulfur mustard on the skin (Mouret
et al. 2015). SKH1 hairless mice are immunocompetent and have similar immune responses
compared to C57Bl/6 mice, which have a Th1 bias (Schaffer et al. 2010). There are several
advantages of using hairless mice in skin microbiome and skin integrity research including the
larger surface area available for microbial assessment and ability to measure skin integrity
without interference of hair. Previous investigations in our lab have shown differences between
BALB/c ear skin and SKH1 dorsal skin in expression of immune-related genes (e.g., Tslp)
following dermal chemical exposure (Anderson et al. 2020; Baur et al. 2021). However, the
immune cell differences between BALB/c mice and SKH1 mice in response to chemical
exposures on the dorsal skin have not been determined.
Triclosan is an immunomodulatory, antimicrobial chemical that is associated with
adverse health effects, including food allergy, aeroallergy, and asthma exacerbation (Savage et
al. 2014; Savage et al. 2012). Although triclosan has not been identified as a sensitizer in mice
(Anderson et al. 2016), dermal exposure to triclosan has been shown to augment the allergic
response in a mouse model of asthma (Anderson et al. 2013). Additionally, studies have
demonstrated the involvement of the Th2-skewing thymic stromal lymphopoietin (TSLP)
pathway (Marshall et al. 2015) and the S100 calcium-binding protein A8 and A9
(S100A8/S100A9)/ Toll-like receptor (TLR4) signaling pathway (Marshall et al. 2017) following
triclosan exposure on mice. The initiating factors involved in these Th2-skewing pathways are an
area of interest, including the potential involvement of the inflammasome, skin microbiome, and
skin barrier (Shane et al. 2019a). Recently, we have demonstrated that dermal exposure to
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triclosan on mice activates the NLRP3 inflammasome (Weatherly et al. 2020), decreases the
integrity of the skin barrier, and alters the skin microbiota composition (Baur et al. 2021).
Together, these studies demonstrate a change in responses within the skin microenvironment that
correlate with changes in the Th2-skewing immune responses. Historically, our lab has used
BALB/c mice in evaluations of immune responses following triclosan exposure on the skin
(Anderson et al. 2013; Anderson et al. 2016; Marshall et al. 2015; Marshall et al. 2017).
However, more recently, our lab used SKH1 hairless mice to investigate the skin barrier and skin
microbiota (Baur et al. 2021). Additionally, while the contribution of the skin in allergic
respiratory reactions is an active area of research, established methods to evaluate the immune
effects in the skin are lacking. Here we report the use of an extensive immunophenotyping flow
cytometry panel in addition to gene expression analysis to better characterize immunological
effects in the skin following dermal exposure to a representative immunomodulatory chemical.

Materials and Methods
Animals
Female SKH1 mice (6-8 weeks old, Charles River) and BALB/c mice (8 weeks old,
Taconic) were purchased and acclimated for at least one week. Mice were randomly assigned to
an exposure group and identified with tail markings made with a permanent marker. Mice were
housed (5/cage; same exposure group; 5 mice/exposure group) in ventilated plastic shoebox
cages with autoclaved bedding and crinkle nest material. Harlan NIH-31 modified 6% irradiated
rodent diet and tap water were available ad libitum. Housing facilities were maintained with a
12-hour light/dark cycle. All animal experiments were performed in the AAALAC International
accredited National Institute for Occupational Safety and Health (NIOSH) animal facility in
accordance with an animal protocol (19-003) approved by the CDC-Morgantown Institutional
Animal Care and Use Committee.
Triclosan Exposures
Triclosan (CAS# 3380-34-5) was purchased from Calbiochem (EMD Millipore Corp.)
and acetone (CAS# 67-41-1) was purchased from Sigma-Aldrich. Dorsal hair on BALB/c mice
was shaved using electric clippers one time, prior to the first exposure. Mice (5/group) were
exposed once per day for 2, 4, and 7 consecutive days to acetone (0%, vehicle control) or to
triclosan (2%) dissolved in acetone (w/v) on the entire dorsal back skin (100 µL/mouse). An
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additional experiment was included to mock shave SKH1 mice (5/group) prior to 4 days of
triclosan (2%) exposure to evaluate the effects of shaving. The concentrations were selected
based on previous study findings where immune changes were observed following 2% triclosan
exposure on SKH1 dorsal skin (Baur, et al. 2021). Acetone was selected as the vehicle based on
solubility and historical control data for triclosan studies (Anderson et al. 2013; Anderson et al.
2016; Marshall et al. 2015). Endpoints were evaluated following 7-day exposures because
previous kinetic studies have demonstrated that multiple immune changes occurred during this
triclosan exposure duration in mice (Anderson et al. 2020).
Euthanasia and Skin Collection
Animals were euthanized by CO2 inhalation 24 hours after the final exposure. Back skin
(~1 cm2) was collected, fat removed, and weighed. For immune phenotyping analysis, skin was
placed into tubes containing 2 mL RPMI and kept on ice. For gene expression analysis, skin was
placed into tubes containing 500 µL RNAlater (Invitrogen) and frozen at -80 °C until processed.
Immune Phenotyping Analysis
Skin was minced and then digested with 0.5 mg/mL Liberase TL (Roche) in RPMI
containing 100 µg/mL DNase I (STEMCELL Technologies) and for 2 hours at 37 °C in a
shaking water bath. Following incubation, samples were transferred to ice and 2 mL RPMI with
10% FBS was added to each tube to stop digestion. Cells were passed through a 70 µm cell
strainer and washed with RPMI with 10% FBS. Live cells were counted on a Cellometer using
acridine orange and propidium iodide solution (Nexcelom). Cells were incubated with antimouse CD16/32 anti-FcγII and FcγIII Fc Block (Invitrogen) for 10 min. on ice and then washed.
For staining, cells were incubated with a cocktail of fluorochrome-conjugated mouse antibodies.
For the innate/DC panel: Superbright-780 CD45 (30-F11), PerCP-Cy5.5 CD11b (M1/70), PECy7 F4/80 (BM8) (Invitrogen), BV510 Ly6G (1A8), PE-Dazzle594 CD207 (4C7), BV711
CD103 (2E7), BV605 CD11c (N418), APC-Fire750 CD24 (M1/69), AF488 SIRP-α (P84)
(BioLegend), PE SiglecF (E50-2440) (BD Pharmingen), AF700 MHCII (M5/114.15.2)
(eBioscience). For the lymphocyte panel: Superbright-780 CD45 (30-F11), APC KLRG1 (2F1),
PE-eFluor610 CD25 (PC61.5) (Invitrogen), FITC CD3 (145-2C11) (BD Pharmingen), BV711
CD4 (RM4-5), V500 CD8 (53-6.7), BV421 TCR-γδ (GL3) (BD Horizon), BV605 NKp46
(29A1.4), PE-Cy7 ICOS (C398.4A) (BioLegend), PerCP-Cy5.5 Lineage Gate (CD11b (M1/70)
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(Invitrogen), CD11c (N418), Ter119 (TER-119), CD19 (eBio1D3), Ly6G (RB6-8C5)), APCeFluor780 CD90.2 (53-2.1), PE CD127 (A7R34) (eBioscience). Following incubation, cells were
washed and then fixed in Cytofix buffer (BD Biosciences). Cells were resuspended in phosphate
buffered saline containing 1% bovine serum albumin and 0.1% sodium azide and events were
collected on an LSR II flow cytometer (BD Biosciences) within 24 hours. Compensation controls
were prepared with UltraComp eBeads (Invitrogen). Data was analyzed using FlowJo v10. Cell
populations were defined as shown in Table 4.1. DC subsets were determined based on
expression of certain cell surface markers (https://www.rndsystems.com/resources/cellmarkers/immune-cells/dendritic-cells/mouse-tissue--specific-dendritic-cell-subset-markers).
Gating strategies for immune cell populations are shown in Supplemental Figures 4.1-4.3, gates
were drawn based on fluorescence minus one (FMO) controls. Frequencies for all cell
populations are shown as % of CD45+ cells. Cell numbers were normalized to total cells/mg
skin tissue for each animal.
Gene Expression Analysis
Total RNA was isolated from the skin using the RNeasy kit per manufacturer’s
instructions (Qiagen). A QIAcube (Qiagen) automated RNA isolation machine was utilized in
conjunction with the RNA isolation kit. The concentration and purity of the RNA were
determined using a NanoDrop Spectrophotometer (Thermo Scientific). Reverse transcription was
performed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) per
manufacturer’s instructions. TaqMan Fast Universal PCR Master Mix (Applied Biosystems),
cDNA, and gene-specific primers (TaqMan Gene Expression Assays) were combined, and realtime quantitative PCR (qPCR) was performed per manufacturer’s instructions. MicroAmp Fast
Optical 96-Well Reaction Plates were analyzed on a 7500 Fast Real-Time PCR System (Applied
Biosystems) using cycling conditions per manufacturer’s instructions. Actb (Mm01205647_g1)
was used as the reference gene. Data was collected and relative fold change compared to acetone
(vehicle control) was calculated using the cycle threshold (Ct) and the 2-ΔΔCt method. Genes
involved in neutrophil responses were evaluated and include: Cxcl1 (Mm04207460_m1), Cxcl2
(Mm00436450_m1),

Tslp

(Mm01157588_m1),

(Mm00445259_m1).
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S100a8

(Mm00496696_g1),

and

Il4

Statistical Analysis
Data from each strain were analyzed independently from one another. All data were
analyzed using JMP version 16.4 (SAS Institute, Cary, NC). Two-way analyses of variance
(Exposure by Time) were conducted for each dependent measure, and relevant post-hoc pairwise
comparisons were calculated using Fishers LSD test. When examination of the residuals
indicated that the assumptions of the analysis were not met, particularly heterogenous variance
among the groups, a log transformation was performed and the analysis was repeated. All
differences were considered significant at p < 0.05.
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Table 4.1. Types of immune cells and their significance.
Immune Cell Type

Significance

Gating

Reference

Neutrophils

Involved in inflammation and sensitization

CD45+, CD11b+, Ly6G+, SiglecF-

(Silvestre et al. 2018; Weber et al. 2015)

Eosinophils

Promote type 2 allergic responses

CD45+, CD11b+, Ly6Gint, SiglecF+

(Hammad and Lambrecht 2015)

DCs

Migrate to dLNs and present antigen

CD45+, CD11c+, MHCII+

(Koppes et al. 2017)

Double negative dermal DCs, minor population, no defined

CD45+, CD11c+, MHCII+, CD11b-, CD207-, CD24-,

(Malissen et al. 2014)

CD207-CD11b- DCs

function

CD207-CD11b+ DCs

Type 2 conventional DCs (cDC2s), most abundant type

CD207+CD103- DCs

Langerin+ dermal DCs, may be involved in sensitization

CD207+CD103+ DCs

SIRP-α , CD103

-

CD45+, CD11c+, MHCII+, CD11b+, CD207-, CD24-,

(Guilliams et al. 2014; Malissen et al. 2014)

F4/80+, SIRP-α+, CD103CD45+, CD11c+, MHCII+, CD11b-, CD207+, CD24+,
CD103

(Honda et al. 2013)

-

Type 1 conventional DCs (cDC1s), may be involved in

CD45+, CD11c+, MHCII+, CD11b-, CD207+, CD24+,

(Bursch et al. 2007; Guilliams et al. 2014; Honda

sensitization

CD103+

et al. 2013)

CD45+, CD11c+, MHCII+, CD11b+, CD207+, CD24+,

Epidermal
Langerhans cells

-

+

+

(Malissen et al. 2014)

-

Reside in epidermis, crosstalk with keratinocytes

F4/80 , SIRP-α , CD103

Various functions; includes CD4+ T cells, CD8+ T cells, γδ+

CD45+, SSClow

(Niec et al. 2021)

(LCs)
Lymphocytes

T cells, ILC2s, NK cells

CD4+ T cells

Helper T cells, mediate type 2 allergic responses

CD45+, SSClow, Lin-, CD3+, CD4+

(Hammad and Lambrecht 2015)

CD8+ T cells

Cytotoxic functions

CD45+, SSClow, Lin-, CD3+, CD8+

(Niec et al. 2021)

γδ+ T cells

Involved in skin homeostasis, role not well-defined

CD45+, SSClow, Lin-, CD3+, TCR-γδ+

(Cruz et al. 2018)

ILC2s

Promote type 2 allergic responses, early responders

CD45+, SSClow, Lin-, CD90+, CD3-, NKp46-, ICOS+,

(Hammad and Lambrecht 2015)

NK cells

Innate immune cell, involved in inflammation, wound

+

+

CD127 , CD25

CD45+, SSClow, Lin-, CD90+, CD3-, NKp46+
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(Kobayashi et al. 2020; Liu et al. 2012; Silvestre et

healing, and Th1 immunity

al. 2018)
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Results
Dermal exposure to triclosan increased neutrophils in BALB/c mouse skin
Neutrophils were significantly higher in BALB/c mouse dorsal skin exposed to triclosan
for 4 (number and frequency (% of CD45+ cells)) and 7 (number and frequency (% of CD45+
cells)) days (Figure 1A-B, Table 2) compared to vehicle control exposed BALB/c mice, but no
significant difference was observed between triclosan and vehicle exposed SKH1 mouse skin
(Figure 1C-D, Table 3). To further investigate the impact of triclosan on neutrophil function,
select chemokines were examined following exposure. Triclosan-exposed skin had higher gene
expression levels of a chemokine involved in neutrophil recruitment, Cxcl2, compared to vehicle
control exposed mice in BALB/c mouse skin but not SKH1 mouse skin (Figure 2B and 2D).
Expression of another neutrophil recruiting chemokine, Cxcl1, was significantly higher in
BALB/c mouse skin following 2 and 7 days of triclosan exposure (Figure 2A) and SKH1 mouse
skin following 7 days of exposure to triclosan (Figure 2C) compared to vehicle control exposed
mouse skin. To evaluate the potential effects due to shaving, SKH1 mice were shaved or not
shaved, and both groups were dermally exposed to 2% triclosan for 4 days. The number and
frequency of neutrophils in the SKH1 shaved skin was not significantly different compared to
unshaved SKH1 skin (Figure 1E-F). Additionally, no changes in expression of Cxcl1 or Cxcl2
were identified between the SKH1 mice that were shaved or not shaved (data not shown).
Triclosan-exposed BALB/c mouse skin (2 and 7 days) had a significantly lower frequency and
number of eosinophils compared to vehicle control-exposed BALB/c mice (Table 2), but no
significant difference was observed between SKH1 mouse skin exposed to triclosan or vehicle
(Table 3). Together this data demonstrates that dermal exposure to triclosan increases the number
and frequency of neutrophils in BALB/c mouse skin and suggests that this occurs through
CXCL2 signaling. However, these effects were absent in the SKH1 mice.
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Figure 4.1. Dermal exposure to triclosan increased neutrophils in BALB/c mouse skin. Number
(A) and frequency (% of CD45+ cells) (B) of neutrophils in BALB/c mouse skin following
dermal exposure to 0% or 2% triclosan. Number (C) and frequency (% of CD45+ cells) (D) of
neutrophils in SKH1 mouse skin following dermal exposure to 0% or 2% triclosan. Number (E)
and frequency (% of CD45+ cells) (F) of neutrophils in SKH1 mouse skin following shaving or
no shaving and 4 days of dermal exposure to 2% triclosan. Bars represent the mean (± SEM) of 5
mice/group. *p < 0.05 vs. 0% triclosan on each corresponding day.
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Figure 4.2. Dermal exposure to triclosan increased expression of chemokines in mouse skin.
Fold change in gene expression of Cxcl1 (A) and Cxcl2 (B) in BALB/c mouse skin compared to
vehicle control (0% triclosan) following dermal exposure to 0% or 2% triclosan. Fold change in
gene expression of Cxcl1 (C) and Cxcl2 (D) in SKH1 mouse skin compared to vehicle control
(0% triclosan) following dermal exposure to 0% or 2% triclosan. Bars represent the mean (±
SEM) of 5 mice/group. *p < 0.05 vs. 0% triclosan on each corresponding day.
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Table 4.2. BALB/c skin phenotyping (innate/DCs) following dermal triclosan exposure.
Exposure Duration

2 Days

4 Days

7 Days

Triclosan (w/v)

0%

2%

0%

2%

0%

2%

Neutrophils (#)

82 ± 16

349 ± 100

198 ± 137

3089 ± 728*

76 ± 8

3662 ± 298*

Neutrophils (%)

0.36 ± 0.04

2.59 ± 1.04

0.70 ± 0.45

20.22 ± 4.53*

0.39 ± 0.03

41.20 ± 6.04*

Eosinophils (#)

1303 ± 193

597 ± 79*

951 ± 195

791 ± 175

995 ± 86

313 ± 46*

Eosinophils (%)

5.84 ± 0.61

3.86 ± 0.29*

3.69 ± 0.41

4.99 ± 0.68

5.04 ± 0.27

3.30 ± 0.15*

DCs (#)

4134 ± 559

1603 ± 211*

4242 ± 587

2205 ± 405*

4928 ± 646

937 ± 235*

DCs (%)

18.18 ± 0.71

10.26 ± 0.74*

16.78 ± 0.54

13.90 ± 0.82*

24.46 ± 1.00

9.48 ± 1.16*

CD207-CD11b- DCs (#)

7±1

6±1

5±2

6±1

5±1

2±1

CD207-CD11b- DCs (%)

0.03 ± 1.32e-003

0.04 ± 0.01

0.02 ± 0.01

0.04 ± 1.14e-003*

0.02 ± 2.68e-003

0.02 ± 4.93e-003

Immune phenotyping of the skin following 2, 4, and 7 days of triclosan exposure. Numbers represent the mean (± SEM) of 5
mice/group. * p < 0.05 vs. 0% on corresponding day.
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Table 4.3. SKH1 skin phenotyping (innate/DCs) following dermal triclosan exposure.
Exposure Duration

2 Days

4 Days

7 Days

Triclosan (w/v)

0%

2%

0%

2%

0%

2%

Neutrophils (#)

466 ± 96

474 ± 115

552 ± 154

352 ± 71

377 ± 57

638 ± 259

Neutrophils (%)

1.77 ± 0.39

1.90 ± 0.48

2.10 ± 0.46

2.80 ± 0.91

1.27 ± 0.15

3.54 ± 1.71

Eosinophils (#)

969 ± 185

1258 ± 138

620 ± 164

523 ± 187

874 ± 132

769 ± 75

Eosinophils (%)

3.58 ± 0.65

4.93 ± 0.49

2.35 ± 0.49

2.98 ± 0.35

2.86 ± 0.13

3.96 ± 0.55

DCs (#)

4221 ± 243

4209 ± 259

4854 ± 328

4175 ± 1081

5798 ± 545

3614 ± 457*

DCs (%)

15.50 ± 0.48

16.62 ± 1.34

19.34 ± 1.17

24.78 ± 0.39*

19.44 ± 0.95

17.78 ± 1.08

CD207-CD11b- DCs (#)

16 ± 3

18 ± 2

13 ± 2

12 ± 4

6±1

5±1

CD207-CD11b- DCs (%)

0.06 ± 0.01

0.07 ± 0.01

0.05 ± 0.01

0.07 ± 0.01

0.02 ± 2.20e-003

0.03 ± 0.01

CD207-CD11b+ DCs (#)

2250 ± 88

1958 ± 183

2836 ± 260

2070 ± 535

3142 ± 407

1780 ± 211*

CD207-CD11b+ DCs (%)

8.29 ± 0.26

7.79 ± 0.99

11.29 ± 0.93

12.61 ± 0.79

10.41 ± 0.57

8.79 ± 0.42

CD207+CD103- DCs (#)

62 ± 13

47 ± 7

39 ± 6

41 ± 12

48 ± 6

39 ± 6

CD207+CD103- DCs (%)

0.22 ± 0.04

0.18 ± 0.02

0.15 ± 0.02

0.23 ± 0.05

0.16 ± 0.03

0.19 ± 0.02

CD207+CD103+ DCs (#)

353 ± 91

304 ± 22

178 ± 38

162 ± 63

343 ± 46

224 ± 49

CD207+CD103+ DCs (%)

1.28 ± 0.31

1.19 ± 0.07

0.69 ± 0.15

0.81 ± 0.17

1.14 ± 0.08

1.07 ± 0.16

Epidermal LCs (#)

95 ± 20

207 ± 62

216 ± 24

133 ± 58

377 ± 32

177 ± 71*

Epidermal LCs (%)

0.34 ± 0.06

0.77 ± 0.17*

0.85 ± 0.08

0.62 ± 0.17

1.30 ± 0.16

0.83 ± 0.30

Immune phenotyping of the skin following 2, 4, and 7 days of triclosan exposure. Numbers represent the mean (± SEM) of 5
mice/group. * p < 0.05 vs. 0% on corresponding day.
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Dermal exposure to triclosan decreased DCs in BALB/c mouse skin
DCs (frequency and number) were significantly lower in BALB/c mouse skin exposed to
triclosan for 2, 4, and 7 days compared to vehicle control exposed mice (Table 2). SKH1 mice
had a higher frequency of DCs (% of CD45+ cells) in the skin following 4 days of triclosan
exposure and a lower number of DCs in the skin following 7 days of triclosan exposure
compared to vehicle exposure (Table 3). CD207-CD11b+ dermal DCs, CD207+CD103- dermal
DCs, and CD207+CD103+ dermal DCs were all significantly decreased in both number and
frequency in BALB/c dorsal skin following 2, 4, and 7 days of triclosan exposure compared to
vehicle control (Figure 3). Epidermal LCs (number and frequency) were also decreased
following 4 and 7 days of triclosan exposure compared to vehicle control (Figure 3). However,
these DC subsets were unchanged in triclosan-exposed SKH1 mouse skin compared to vehicleexposed SKH1 mouse skin, except for a significant decrease in number of CD207-CD11b+
dermal DCs and epidermal LCs after 7 days of triclosan exposure and increase in frequency of
epidermal LCs after 2 days (Table 3). The small population of CD207-CD11b- dermal DCs was
significantly increased (frequency) following 4 days of triclosan exposure on BALB/c mice
compared to vehicle control (Table 2), but this subset of cells was unchanged in triclosanexposed SKH1 mice compared to vehicle-exposed SKH1 mice (Table 3). Together these results
show that exposure to triclosan on the skin decreases the number and frequency of dermal DCs
in BALB/c mouse dorsal skin with minimal effects in SKH1 mice.
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Figure 4.3. Dermal exposure to triclosan decreased DC subsets in BALB/c mouse skin. Number
(A) and frequency (% of CD45+ cells) (B) of CD207-CD11b+ DCs, number (C) and frequency
(% of CD45+ cells) (D) of CD207+CD103- DCs, number (E) and frequency (% of CD45+ cells)
(F) of CD207+CD103+ DCs, and number (G) and frequency (% of CD45+ cells) (H) of epidermal
LCs in BALB/c mouse skin following dermal exposure to 0% or 2% triclosan. Bars represent the
mean (± SEM) of 5 mice/group. *p < 0.05 vs. 0% triclosan on each corresponding day.
Dermal exposure to triclosan increased ILC2s in SKH1 mouse skin
Dermal exposure to triclosan significantly decreased lymphocyte frequency (% of CD45+
cells) in BALB/c mouse skin after 2, 4, and 7 days (Table 4) and SKH1 mouse skin after 4 days
(Table 5) compared to vehicle exposure on each corresponding day. Additionally, triclosan
exposure on the skin decreased the frequency of CD4+ T cells in BALB/c mouse skin after 2 and
7 days compared to vehicle exposure (Table 4). Furthermore, dermal exposure to triclosan
decreased the frequency of γδ+ T cells in BALB/c mouse skin after 4 and 7 days compared to
vehicle exposure (Table 4), although no change was observed in SKH1 mouse skin between
exposure groups (Table 5). No significant differences in CD8+ T cells were identified following
triclosan exposure in BALB/c mouse skin (Table 4) and in SKH1 mouse skin (Table 5)
compared to controls.
ILC2s in SKH1 mouse skin were significantly increased following 4 days (frequency and
number) and 7 days (frequency) of triclosan exposure compared to vehicle exposure (Table 5),
but not in BALB/c mouse skin following triclosan exposure (Table 4). Additionally, ICOS (days
2, 4, and 7) and CD25 (days 4 and 7) were elevated on ILC2s and CD127 was decreased (days 2,
4, and 7) on ILC2s in SKH1 dorsal skin exposed to triclosan compared to vehicle exposure
(Figure 4D, F, H). In BALB/c dorsal skin, KLRG1 (day 7), CD25 (day 2), and CD127 (day 7)
were increased on ILC2s following triclosan exposure compared to vehicle (Figure 4A, E, G).
The frequency (days 2, 4, and 7) and number (day 2) of natural killer (NK) cells in triclosanexposed BALB/c mouse skin was lower compared to vehicle-exposed BALB/c mouse skin
(Table 4), but the frequency (day 7) of NK cells in triclosan-exposed SKH1 mouse skin was
higher compared to vehicle-exposed SKH1 mouse skin (Table 5), although NK cells are a small
population. Genes known to be involved in Th2 responses were also evaluated in the dorsal skin
following triclosan exposure. BALB/c mice exposed to triclosan for 2, 4, and 7 days had higher
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expression of S100a8 and Tslp in their skin compared to vehicle exposed mice and BALB/c mice
exposed to triclosan for 4 and 7 days had higher Il4 in their skin compared to vehicle exposed
mice (Figure 5A-C). SKH1 mice exposed to triclosan for 7 days also had higher expression of
S100a8 and Il4 in their skin compared to vehicle exposed mice, although mice exposed to
triclosan for 4 days had higher Tslp expression in their skin compared to vehicle exposed mouse
skin (Figure 5D-F). No changes in expression of S100a8, Tslp, or Il4 were identified between
SKH1 shaved and unshaved mice (data not shown). Together these results show that exposure to
triclosan alters lymphocyte populations in mouse skin and increases ILC2s in SKH1 mouse skin.
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Figure 4.4. Dermal exposure to triclosan altered the expression of activation markers on ILC2s
in mouse skin. Relative median fluorescence intensity (MFI) of KLRG1 (A), ICOS (C), CD25
(E), and CD127 (G) on ILC2s in BALB/c mouse skin following dermal exposure to 0% or 2%
triclosan. Relative MFI of KLRG1 (B), ICOS (D), CD25 (F), and CD127 (H) on ILC2s in SKH1
mouse skin following dermal exposure to 0% or 2% triclosan. Bars represent the mean (± SEM)
of 4-5 mice/group. *p < 0.05 vs. 0% triclosan on each corresponding day.

Figure 4.5. Dermal exposure to triclosan increased expression of Th2 cytokines in mouse skin.
Fold change in gene expression of S100a8 (A), Tslp (B), and Il4 (C) in BALB/c mouse skin
compared to vehicle control (0% triclosan) following dermal exposure to 0% or 2% triclosan.
Fold change in gene expression of S100a8 (D), Tslp (E), and Il4 (F) in SKH1 mouse skin
compared to vehicle control (0% triclosan) following dermal exposure to 0% or 2% triclosan.
Bars represent the mean (± SEM) of 5 mice/group. *p < 0.05 vs. 0% triclosan on each
corresponding day.
Impact of shaving on immune cell populations
To evaluate the potential effects of shaving in combination with chemical exposure,
SKH1 mice were mock shaved and exposed to triclosan for 4 days. Mice in the shaved group had
a lower number of CD4+ T cells and ILC2s in their dorsal skin (Table 4.6). Furthermore, these
mice had a lower number and frequency of NK cells in the dorsal skin (Table 4.6). Shaving did
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not alter lymphocytes, CD8+ T cells, and γδ+ T cells (Table 4.6) or number or frequency of
neutrophils, eosinophils, or DCs (data not shown). Together these results suggest that shaving in
combination with chemical exposure may impact select immune cell populations in the skin,
notably NK cells.
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Table 4.4. BALB/c phenotyping (lymphocytes) following dermal exposure to triclosan.
Exposure Duration

2 Days

4 Days

7 Days

Triclosan (w/v)

0%

2%

0%

2%

0%

2%

Lymphocytes (#)

407 ± 91

232 ± 85

241 ± 48

207 ± 32

174 ± 43

114 ± 64

Lymphocytes (%)

38.08 ± 1.21

31.84 ± 2.80*

29.98 ± 0.76

23.08 ± 0.85*

39.82 ± 1.89

25.12 ± 0.76*

CD4+ T cells (#)

87 ± 20

40 ± 19

49 ± 11

54 ± 11

57 ± 15

38 ± 28

CD4+ T cells (%)

8.30 ± 0.55

5.12 ± 1.10*

5.84 ± 0.25

5.87 ± 0.51

12.68 ± 0.71

6.21 ± 1.17*

CD8+ T cells (#)

1 ± 4e-001

0±0

4e-001 ± 2e-001

0±0

1 ± 2e-001

2e-001 ± 2e-001

CD8+ T cells (%)

0.06 ± 0.02

0.06 ± 0.03

0.06 ± 0.01

0.03 ± 4.55e-003

0.17 ± 0.05

0.11 ± 0.01

γδ+ T cells (#)

30 ± 8

17 ± 7

15 ± 5

6±1

14 ± 3

6±5

γδ+ T cells (%)

2.70 ± 0.13

2.26 ± 0.45

1.72 ± 0.32

0.62 ± 0.07

3.64 ± 0.73

0.89 ± 0.26*

ILC2s (#)

6±1

5±2

2±1

2 ± 2e-001

1 ± 2e-001

1±1

ILC2s (%)

0.57 ± 0.02

0.55 ± 0.14

0.29 ± 0.02

0.17 ± 0.02

0.25 ± 0.02

0.19 ± 0.02

NK cells (#)

7±2

2 ± 1*

4±1

2 ± 5e-001

2±1

1±1

NK cells (%)

0.61 ± 0.09

0.24 ± 0.08*

0.45 ± 0.04

0.26 ± 0.03*

0.56 ± 0.07

0.25 ± 0.04*

Immune phenotyping of the skin following 2, 4, and 7 days of triclosan exposure. Numbers represent the mean (± SEM) of 5
mice/group. * p < 0.05 vs. 0% on corresponding day.
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Table 4.5. SKH1 phenotyping (lymphocytes) following dermal exposure to triclosan.
Exposure Duration

2 Days

4 Days

7 Days

Triclosan (w/v)

0%

2%

0%

2%

0%

2%

Lymphocytes (#)

572 ± 87

732 ± 105

667 ± 76

493 ± 104

612 ± 85

606 ± 146

Lymphocytes (%)

41.78 ± 1.11

37.92 ± 2.27

33.16 ± 2.17

26.08 ± 2.09*

40.44 ± 2.67

34.60 ± 1.18

CD4+ T cells (#)

116 ± 25

138 ± 29

129 ± 11

92 ± 20

151 ± 24

170 ± 41

CD4+ T cells (%)

8.23 ± 0.97

6.79 ± 0.94

6.46 ± 0.25

4.91 ± 0.49

9.76 ± 0.79

9.58 ± 0.45

CD8+ T cells (#)

1 ± 4e-001

1 ± 4e-001

9±3

5±3

5±1

3±1

CD8+ T cells (%)

0.07 ± 0.03

0.04 ± 0.02

0.42 ± 0.13

0.29 ± 0.13

0.34 ± 0.06

0.15 ± 0.05

γδ+ T cells (#)

176 ± 44

196 ± 38

94 ± 49

110 ± 40

139 ± 63

106 ± 45

γδ+ T cells (%)

12.44 ± 1.56

11.20 ± 3.38

4.77 ± 2.45

5.26 ± 1.42

9.37 ± 3.53

5.28 ± 1.69

ILC2s (#)

4±1

5±1

7±1

15 ± 5*

4±1

10 ± 1

ILC2s (%)

0.26 ± 0.08

0.25 ± 0.03

0.33 ± 0.07

0.74 ± 0.13*

0.25 ± 0.02

0.67 ± 0.11*

NK cells (#)

3 ± 5e-001

4±1

5±1

4±1

4 ± 3e-001

6±1

NK cells (%)

0.25 ± 0.03

0.24 ± 0.05

0.22 ± 0.04

0.22 ± 0.02

0.26 ± 0.02

0.37 ± 0.04*

Immune phenotyping of the skin following 2, 4, and 7 days of triclosan exposure. Numbers represent the mean (± SEM) of 4-5
mice/group. * p < 0.05 vs. 0% on corresponding day.
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Table 4.6. SKH1 phenotyping following mock shaving and dermal exposure to triclosan.
Triclosan (w/v)

No Shave

Mock Shave

Lymphocytes (#)

787 ± 139

457 ± 42

Lymphocytes (%)

23 ± 0.84

25 ± 0.73

CD4+ T cells (#)

221 ± 47

104 ± 11*

CD4+ T cells (%)

6.3 ± 0.30

5.5 ± 0.26

CD8+ T cells (#)

0.4 ± 0.2

1 ± 0.5

CD8+ T cells (%)

0.015 ± 0.0028

0.076 ± 0.038

γδ+ T cells (#)

44 ± 16

35 ± 7

γδ+ T cells (%)

1.2 ± 0.42

1.8 ± 0.25

ILC2s (#)

5 ± 0.7

3 ± 0.2*

ILC2s (%)

0.15 ± 0.020

0.14 ± 0.021

NK cells (#)

11 ± 2

3 ± 0.4*

NK cells (%)

0.32 ± 0.026

0.15 ± 0.0073*

Immune phenotyping of the skin following mock shaving and 4 days of triclosan exposure. Numbers represent the mean (± SEM) of 5
mice/group. * p < 0.05 vs. no shaving.
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Discussion
Although the skin provides a physical barrier to pathogens and certain environmental
exposures, some chemicals can be absorbed through the skin and result in adverse outcomes
including allergic disease (Fang et al. 2016; MacIsaac et al. 2014). Immune cells play an
important role in transporting agents and communicating messages from barrier sites to dLNs.
Additionally, recruitment of immune cells to the barrier site is critical for activities such as
crosstalk to other immune cells, elimination of the foreign molecule, and tissue healing. In
immunotoxicological studies, animal models are important to evaluate the movement of immune
cells to and from the barrier sites and throughout the body. In this study, flow cytometry and
gene expression analysis were used to evaluate immune responses in the skin between two
mouse strains (BALB/c and SKH1) following dermal exposure to a representative
immunomodulatory chemical, triclosan.
Triclosan-exposed BALB/c mouse skin had a lower number and frequency of DCs
compared to vehicle-exposed BALB/c mouse skin, but no change was observed between
triclosan and vehicle exposed SKH1 mouse skin. Specifically, triclosan exposure decreased
CD207-CD11b+ DCs, CD207+CD103- DCs, CD207+CD103+ DCs, and epidermal LCs in
BALB/c skin. These DC subsets may be involved in the process of sensitization (Table 1).
Although triclosan itself is not a sensitizer, exposure to triclosan may increase the trafficking of
DCs from skin to dLNs and increase the risk of sensitization through the increase of Th2
mediators. Additionally, our lab has previously shown that 4 days of dermal triclosan exposure
increases DCs in the dLNs (Marshall et al. 2015; Marshall et al. 2017). Although in the studies
described in this manuscript BALB/c and SKH1 mice have been shown to have similar levels of
CD103+ and CD11b+ DCs in the skin, BALB/c mice have been shown to have higher uptake of
ovalbumin by dermal DCs through hair follicles and increased transportation of ovalbumin to
dLNs via DCs compared to SKH1 mice (Tordesillas et al. 2018). Due to their abnormal hair
follicles, SKH1 mice may have reduced uptake of molecules through their skin (Benavides et al.
2009), which presents a potential explanation for the current findings. Hair follicles are also a
site of absorption of chemicals (Nayak et al. 2014) and hairless mice have been shown to have
reduced permeation of benzo[a]pyrene compared to haired mice, potentially due to the increased
passage of this chemical through hair follicles in haired mice (Kao et al. 1988). Together this
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suggests that SKH1 mice may have reduced absorption of triclosan and subsequently less
migration of DCs out of the skin. Collectively, these results demonstrate that dermal triclosan
exposure decreases DCs in BALB/c skin specifically and suggest that BALB/c mice may be a
more useful strain compared to SKH1 in the investigation of DCs and their trafficking patterns in
the context of chemical exposures on the skin.
Lymphocytes play a role in skin homeostasis, although their mechanism of action is not
well understood (Cruz et al. 2018). Certain subsets, such as Th2 cells and ILC2s, play a central
role in allergic responses (Hammad and Lambrecht 2015). BALB/c mouse skin exposed to
triclosan had a lower frequency (but not number) of lymphocytes, specifically CD4+ T cells and
γδ T cells, compared to vehicle exposed skin. Because the ratio and not number was decreased,
the large influx of neutrophils into the skin could be a potential explanation for this finding. In
contrast, triclosan exposure increased the number and frequency of ILC2s in the skin of SKH1
mice, but not BALB/c mice. ILC2s are thought to play an important role in allergic disease
because of their Th2-skewing properties and are influenced by the cytokines IL-25, IL-33, and
TSLP (Hammad and Lambrecht 2015). Interestingly, dermal exposure to triclosan only
significantly increased Tslp gene expression in SKH1 mice on day 4, but not day 2 or 7 (Figure
5). The lack of change on day 7 is in agreement with a previous study by our lab that showed that
7 days of dermal exposure to triclosan did not change Tslp gene expression in SKH1 dorsal skin
(Baur et al. 2021). In contrast, although in the absence of increases in ILC2s, triclosan exposure
has been demonstrated to increase Tslp in BALB/c mouse dorsal skin at multiple timepoints in
this study and in the ears of BALB/c mice as shown previously by our lab (Anderson et al. 2020;
Marshall et al. 2017). Although ILC2s have been shown to be activated following dermal
exposure to the antimicrobial chemical DDAC by measuring the expression of KLRG1, ICOS,
CD25, and CD127, the number of ILC2s was unchanged with exposure (Shane et al. 2019b). In
the present study, total ILC2 numbers were increased and the expression of ICOS and CD25
activation markers on ILC2s was increased. CD127 expression on ILC2s was decreased in SKH1
dorsal skin at all timepoints and indicates activation of ILC2s (Poposki et al. 2017). Further
investigations are needed to explore the biological significance of increased ILC2 numbers.
These results demonstrate that exposure to triclosan increases ILC2s in the skin of SKH1 mice,
but not BALB/c mice. ILC2s in SKH1 mice are not well understood; this strain has previously
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been compared to the Th1-biased C57Bl/6 strain and studies directly comparing with the Th2biased BALB/c strain are limited. The effects of dermal triclosan exposure on the immune
response of C57Bl/6 mice has not been evaluated. The difference between SKH1 and BALB/c
responses following chemical exposure could be due to the hairless gene or differences in
immune bias. However, the underlying mechanism of this differential finding is not yet
understood. Future research could explore the role of the hairless gene on a BALB/c background
to better control for immune differences.
Barrier-disruptive activities such as scratching and tape stripping of the skin have been
shown to be involved in neutrophil recruitment to the skin (Oyoshi et al. 2012). Shaving may
also have a disruptive and inflammatory effect in the skin. Although mock shaving in
combination with triclosan exposure did not impact the number of neutrophils in the skin, mock
shaving SKH1 mouse dorsal skin significantly decreased the number and frequency of NK cells
in the skin. This result is surprising, because NK cells have been shown to increase in
inflammatory skin diseases (Silvestre et al. 2018) and have been shown to be involved in wound
healing (Liu et al. 2012). However, the biological significance of this finding is unknown given
the small size of this population.
Exposure to chemicals on the skin can lead to inflammatory reactions and sensitization,
contributing to the development of allergic diseases. Investigating the immune cell changes in
response to chemical exposures on the skin is important to improve understanding of
mechanisms of allergic disease. Although haired mice (BALB/c) are typically used in studies
evaluating allergic responses, hairless (SKH1) mice are useful in certain experimental designs
such as investigations of the skin microbiota and skin integrity. In this study, exposure to the
representative immunomodulatory chemical triclosan differentially impacted immune cell
populations in haired and hairless mice, demonstrating that selection of mouse strain is an
important factor to consider during experimental design of skin chemical exposure studies.
However, the extensive immune flow cytometry panels in addition to gene expression analysis
described here can be utilized in future studies to better characterize immunological effects in the
skin following dermal exposure.
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Chapter 5
General Discussion
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Introduction
Millions of workers in health care, manufacturing, and other industries have the potential
for exposure to chemicals that can cause occupational skin diseases (BLS 2022; NIOSH 2021).
Health care workers frequently use antimicrobial chemicals which in some cases have been
shown to be sensitizers contributing to ACD or asthma (Table 1.1) (Anderson and Meade 2014).
One particular antimicrobial chemical used by health care workers, triclosan, is positively
associated with food allergy, aeroallergy, and asthma exacerbation (Savage et al. 2014; Savage et
al. 2012). Triclosan is not directly sensitizing in mice (Anderson et al. 2016) but has been shown
to augment the allergic response in a mouse model of asthma (Anderson et al. 2013), suggesting
that triclosan acts as an adjuvant. Previous studies have shown that triclosan is
immunomodulatory through the Th2-skewing cytokine TSLP and the DAMP S100A8 (Marshall
et al. 2015; Marshall et al. 2017), factors that are involved in the sensitization process, the first
step in the development of an allergic disease. Breakdown of the skin barrier integrity and
disruption of the composition of the microbiome have also been suggested to contribute to
immunomodulation (Shane et al. 2019a). In our studies, we demonstrate that dermal exposure to
triclosan decreases the skin barrier integrity, alters the expression patterns of skin barrier genes
and cytokines, and alters the composition of the microbiome. Overall, these results suggest that
there is an interplay between the skin barrier integrity, skin microbiome, and immune system in
response to dermal triclosan exposure.

Triclosan exposure alters the skin barrier
The largest organ in the body, the skin, is essential as a physical barrier from pathogens
and is immunologically active. The epithelial cells, immune cells and microbiome of the skin
closely interact with one another (Flowers and Grice 2020). However, a decrease in the integrity
of the skin barrier is associated with disease, including AD (Kelleher et al. 2015), food allergy
(Kelleher et al. 2016), and aeroallergen sensitization (Boralevi et al. 2008), suggesting the
importance of the skin integrity in maintaining health. Decreased skin integrity can result from
genetic mutations or environmental exposures and many products from the environment have
been shown to cause skin damage (Celebi Sozener et al. 2020). The skin barrier is mainly
comprised of the cornified envelopes in the stratum corneum and the tight junctions in the
stratum granulosum of the epidermis (Goleva et al. 2019). Many of the genes involved in
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formation of the cornified envelopes are encoded in the EDC, such as Flg, and have been studied
in the context of barrier integrity (Goleva et al. 2019). Other genes in the EDC that are also
involved in skin integrity through formation of the cornified envelope include Flg2, Ivl, and Lor
(Albérola et al. 2019; Goleva et al. 2019; Pendaries et al. 2015). In addition to the cornified
envelope, tight junctions are also important in maintaining skin barrier integrity (Goleva et al.
2019; Kirschner et al. 2013). Intermediate filaments, which are comprised of keratins, are also
critical for promoting skin integrity (Pan et al. 2013). Although there are over 50 keratins (Pan et
al. 2013), KRT14/KRT5 have been shown to be primarily expressed by proliferating
keratinocytes in the epidermis and KRT10/KRT1 are expressed by differentiating keratinocytes
(Moll et al. 2008). Together the cornified envelopes, tight junctions, and keratins are involved in
maintaining the structure and function of the skin. The results from our studies show that
exposure to the immunomodulatory chemical triclosan decreases the integrity of the skin barrier
both in vivo and in vitro. Additionally, we found that exposure to triclosan alters the expression
patterns of these genes involved in barrier integrity.
In mice, we demonstrate that repeated (5-7 days) exposure to 2% triclosan on mouse skin
significantly increased TEWL levels (Figure 2.1) (Baur et al. 2021). TEWL is a direct way to
measure water evaporation and higher TEWL levels indicate greater disruption of the skin
barrier (Fluhr et al. 2006). To investigate potential contributors of skin barrier disruption, we
investigated the expression of genes involved in the cornified envelope (Flg, Flg2, Ivl, Lor), a
tight junction gene (Tjp1), and keratins (Krt10, Krt14) following dermal triclosan exposure. We
demonstrated that 7 days of dermal 2% triclosan exposure on mice had no impact on Flg gene
expression and increased FLG protein levels in mouse skin (Figure 2.2) (Baur et al. 2021). In
contrast, dermal triclosan exposure had no effect on FLG2 protein, but decreased the Flg2 gene
expression in mouse skin (Figure 2.2) (Baur et al. 2021). Exposure to triclosan on mice had no
significant impact on Ivl, Lor, nor Tjp1 gene expression (Supplemental Figure 2.3) (Baur et al.
2021). Our studies also show that 7 days of 2% triclosan exposure on SKH1 hairless mouse skin
decreased Krt10 gene expression (Figure 2.3), but increased Krt14 expression at the gene and
protein level (Figure 2.4) (Baur et al. 2021). Together these studies show that repeated exposure
to triclosan on mouse skin decreases barrier integrity and alters expression of barrier genes.
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Decreased barrier integrity has previously been connected with alterations in the
expression of these barrier genes. Mice with Flg deficiency (flaky tail mouse model) have been
demonstrated to have elevated TEWL levels (Moniaga et al. 2010), suggesting that Flg plays a
role in maintaining barrier integrity. Additionally, this study showed that the Flg deficient mice
developed dermatitis and epidermal hyperplasia, had an elevated number of lymphocytes and
mast cells in the skin, increased skin permeability, increased serum IgE, and an exacerbated
response to irritants, haptens, and allergens (Moniaga et al. 2010). However, other studies have
demonstrated that mice with Flg deficiency (flaky tail mouse model) either have age-dependent
elevated TEWL levels (Scharschmidt et al. 2009) or do not have any alterations in TEWL levels
(Fallon et al. 2009). Flaky tail mice also have a mutation in Tmem79 (Saunders et al. 2013),
therefore additional studies have been conducted to investigate the effects of Flg knockout alone.
These studies have shown that Flg knockout alone does not change TEWL levels (Kawasaki et
al. 2012) or that TEWL changes are age-dependent (Muhandes et al. 2021). Therefore, although
FLG plays an important role in maintaining skin integrity, other skin genes may be involved as
well. Our results do not show that increased TEWL levels occurred at the same time as decreased
Flg gene expression, suggesting that other changes in the skin contributed to the increased
TEWL levels and skin barrier disruption.
Interestingly, exposure to triclosan increased FLG protein levels in the skin. Increased
expression of EDC genes has been well-studied in the context of the AHR. AHR signaling in
keratinocytes is known to upregulate the expression of the skin barrier genes FLG, IVL, and LOR
(Fernandez-Gallego et al. 2021) and overexpression of Ahr in mouse skin has been shown to
elevate TEWL and expression of Tslp and Flg (Hidaka et al. 2017). This result suggests a
connection between AHR signaling, elevated TEWL, and increased Flg expression.
Additionally, mice overexpressing Ahr under the control of Krt14 in the skin develop skin
lesions (Tauchi et al. 2005). However, too little AHR signaling may be a problem too, because
mice lacking AHR develop skin lesions (Fernandez-Salguero et al. 1997). Thus, proper
regulation and a careful balance of AHR signaling in the skin is critical for maintaining skin
homeostasis. Both endogenous and exogenous ligands are known to activate AHR (Napolitano et
al. 2021). Exposure to the chemical 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been shown
to increase the expression of skin barrier genes FLG and FLG2 through increased AHR activity
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(Sutter et al. 2011). Triclosan has a chemical structure similar to TCDD and is known to
breakdown into dioxins (Fang et al. 2010), suggesting that triclosan or its breakdown products
could activate AHR. In support of this idea, a previous study has shown that triclosan exposure
activates AHR in cultured mouse neurons (Szychowski et al. 2016). Although AHR activation
was not examined in our studies, this pathway would be an interesting area for future
investigations. AHR activation may be one way that triclosan exposure increases TEWL levels in
connection with increased FLG protein levels. S100A7 stimulation has also been shown to
increase expression of several barrier genes (e.g., FLG, IVL, LOR, KRT10) in human
keratinocytes (Hattori et al. 2014; Nakamura et al. 2021) and this pathway could also be involved
in upregulating the expression of EDC genes in response to triclosan exposure.
Although Flg has been widely investigated, other genes are also important in the structure
and function of the skin. Exposure to triclosan was shown to decrease the expression of Flg2 and
Krt10 genes in mouse skin, but increase Krt14 gene and protein expression. Flg2 has been
suggested to play a role in maintaining skin integrity (Albérola et al. 2019; Pendaries et al.
2015). However, the function of Flg2 is not well-studied. Mice with skin barrier disruption due
to a deficiency in essential fatty acids have been demonstrated to have decreased Flg2 expression
but increased Flg expression (Hansmann et al. 2012). This study suggests that Flg2 plays a role
in barrier integrity and that Flg and Flg2 may have different expression or regulation patterns.
Additional research is needed to better understand the relationship between Flg2 and barrier
integrity. As mentioned previously, Krt10 is expressed by differentiating keratinocytes and Krt14
is expressed by proliferating keratinocytes (Moll et al. 2008). Decreased Krt10 expression
suggests that keratinocyte differentiation is impaired. Previously, Krt10 knockout mice have
been demonstrated to have increased TEWL levels (Jensen et al. 2000), suggesting that Krt10
plays a role in barrier integrity. Our observations of decreased Krt10 gene expression occurs in
concert with increased TEWL following triclosan exposure. Interestingly, we showed that
exposure to triclosan increased Krt14 expression at the gene and protein levels. This result
suggests that keratinocyte proliferation is increased.
In addition to mouse models, RHE models have been used to study the skin barrier and
diseases associated with the skin (Figure 1.4) (Niehues et al. 2018; Rademacher et al. 2018). In
RHE tissues, a single exposure of triclosan (0.1% and 0.2% triclosan) increased the permeability
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of a fluorescent molecule (Lucifer Yellow) through the epidermal tissue (Figure 3.3), although
repeated triclosan exposure had no significant impact on permeability of RHE tissues (Figure
3.6). A single triclosan exposure also increased FLG, FLG2, IVL, LOR, TJP1¸ and KRT10 gene
expression (Figure 3.1 and Supplemental Figure 3.1) but repeated triclosan exposure had no
significant impact of expression of barrier genes in RHE tissues (Figure 3.4). In contrast, a single
exposure to triclosan on RHE tissues decreased KRT14 gene expression (Figure 3.1). Repeated
exposure to triclosan had no significant impact on KRT14 gene expression (Figure 3.4).
Permeability of the fluorescent molecule Lucifer Yellow has previously been used to assess
barrier integrity of RHE tissues and knockdown of FLG was shown to increase tissue
permeability (Mildner et al. 2010; Pendaries et al. 2014). Additionally, FLG knockdown
decreased FLG2, KRT10, and LOR expression (Pendaries et al. 2014). However, in our studies,
we found that increased FLG expression occurred at the same time as increased tissue
permeability and increased expression of other barrier genes (FLG2, IVL, LOR, TJP1, KRT10).
This result may be due to timing because some of these increases in barrier genes occurred just 6
hours post a single exposure to triclosan and barrier permeability was only assessed at 24 and 48
hours post triclosan exposure. Additionally, other studies have shown that FLG deficiency does
not result in increased barrier permeability (Niehues et al. 2017; van Drongelen et al. 2013),
suggesting that other factors in the skin may be at play and can influence barrier permeability. As
mentioned previously, AHR signaling has been shown to increase the expression of FLG, IVL,
and LOR (Fernandez-Gallego et al. 2021). AHR signaling could also be involved in the response
to triclosan exposure in the RHE model.
Taken together, our results show that triclosan exposure alters the expression pattern of
genes involved in skin barrier integrity, but that there are differential impacts dependent on the
model (in vivo vs. in vitro) and length of exposure (single vs. repeated) (Figure 5.1).
Additionally, different concentrations of triclosan were used between these models (2% triclosan
in the mouse model; 0.2% triclosan in the RHE model). These concentrations were selected
based on previous investigations in mice and RHE models (Marshall et al. 2015). Our results
also suggest that skin integrity was decreased due to triclosan exposure in both models. Although
a change in tissue permeability is not a direct comparison to TEWL, a decrease in barrier
integrity may lead to increased passage of other chemicals/potential allergens and this increased
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exposure to allergens may contribute to allergic disease. Previous studies have shown that barrier
disruption (indicated by increased TEWL) leads to increased skin permeability to sucrose,
caffeine, and hydrocortisone (Tsai et al. 2001). Additionally, damage to keratinocytes may also
contribute to the production of proinflammatory cytokines, which are involved in communication
with immune cells. Overall, disruption of the barrier integrity may be one mechanism by which
triclosan exposure is immunomodulatory and augments the allergic response.

Figure 5.1. Comparison of skin barrier gene expression changes following triclosan exposure
between mice and RHE models.
Multiple researchers have suggested decreased barrier integrity as a potential mechanism
for immunomodulation and allergic disease. Children with elevated TEWL levels have been
shown to be more at risk for development of AD, food allergy, and aeroallergen sensitization
(Boralevi et al. 2008; Kelleher et al. 2015; Kelleher et al. 2016). Although skin barrier disruption
alone may not result in AD or allergic disease, the skin barrier is likely a contributing factor.
Previous studies have also shown that exposures can decrease barrier integrity and increase
immune system responses. In mice, exposure to sulfur mustard increased TEWL, indicating skin
barrier disruption, while also increasing the number of mast cells, neutrophils, and
proinflammatory cytokines (TNF-α, IL-6, IL-1β, CXCL1, CXCL2) in the skin (Mouret et al.
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2015). Exposure to TNCB has been shown to increase TEWL while also leading to redness and
scaling, epidermal hyperplasia, increased number of CD4+ T cells and mast cells, and increased
serum IgE (Matsumoto et al. 2004). Repeated exposure to another hapten, oxazolone, on mouse
skin has also been shown to increase TEWL and alter skin lipid composition at the same time as
increasing eosinophils in the skin and serum IgE levels (Man et al. 2008). These studies show
that chemical exposures alter the skin barrier in concert with changes in immune factors.
Exposure to the irritant sodium lauryl sulfate has also been shown to increase TEWL and
increase erythema scores (Soltanipoor et al. 2018), although immune factors were not measured.
In addition to the skin barrier’s influence on immune responses (Hammad and Lambrecht 2015),
immune factors such as cytokines can influence barrier integrity. Specific cytokines have been
shown to influence keratinocytes (Gutowska-Owsiak and Ogg 2013; Jiang et al. 2020) including
TSLP (Kim et al. 2015), IL-22 (Gutowska-Owsiak et al. 2011) and Th2 cytokines (IL-4, IL-13)
(Howell et al. 2009). Our studies show that expression of some of these cytokines increase,
specifically in BALB/c mice, as early as 2 days of triclosan exposure on the skin (Figure 4.5).
These early changes in immune-related genes suggest that changes in the immune system may
occur prior to changes in barrier integrity. Overall, these studies suggest that there is an interplay
between chemical exposures, barrier integrity, and the immune system. Further research should
explore the timing of these responses and the specific influence of cytokines on barrier integrity.

Interplay of the skin barrier and microbiome
The microbiome plays an important role in maintaining human health, including immune
system development and maintenance (Belkaid and Harrison 2017). The skin microbiome, while
less studied compared to the gut microbiome, is an emerging area of interest and has been shown
to be involved in developing skin immune responses and resisting colonization to pathogens such
as Staphylococcus aureus (Belkaid and Harrison 2017). Our studies show that 7 days of triclosan
exposure on mouse skin alters the composition of the skin and gut microbiome (Figure 2.6 and
2.7) (Baur et al. 2021). Specifically, we found that Firmicutes (families Lachnospiraceae and
Clostridiales vadinBB60 group) were enriched on the skin but depleted (family
Ruminococcaceae) in the gut following triclosan exposure (Baur et al. 2021). Several studies
have previously explored the role of the microbiome on skin barrier integrity. Mice lacking a
microbiome, germ-free mice, have altered expression patterns of skin barrier genes and increased
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proliferation of keratinocytes (Meisel et al. 2018), suggesting that the microbiome is important in
regulating skin barrier integrity. Additionally, the microbiome has been shown to be important in
repairing the skin barrier (Uberoi et al. 2021). Mice deficient in Flg also have an altered skin
microbiome with decreased alpha diversity and reduced levels of Lachnospiraceae,
Ruminococcaceae, and Muribaculaceae (Muhandes et al. 2021). These studies suggest an
interplay between the skin barrier and skin microbiome. Certain groups of bacteria have also
been shown to have a differential impact on the skin barrier integrity. Mice colonized with
bacteria from patients with AD had elevated TEWL but mice colonized with bacteria from
healthy controls did not (Myles et al. 2016). However, relatively few studies have investigated
the specific roles of bacterial species in the families Lachnospiraceae and Clostridiales
vadinBB60 group on the skin. In the gut, species within the family Lachnospiraceae are diverse
(Sorbara et al. 2020) and additional research is needed to understand the role of these species on
the skin barrier.

Exposure to triclosan impacts cytokines and immune cells
Cytokines play a critical role in communicating between epithelial and immune cells in
barrier tissues and in mediating allergic diseases (Dainichi et al. 2018). The cytokine milieu is
important because it impacts the specific immune responses that occur following chemical
exposures. For example, TSLP is a central cytokine in the Th2 immune response and can be
produced by keratinocytes (Dainichi et al. 2018; Goleva et al. 2019; Hammad and Lambrecht
2015). Previously, repeated dermal exposure to triclosan has been shown to elevate expression of
Th2-related genes (Tslp, Il4) (Marshall et al. 2015). Additionally, exposure to triclosan has been
shown to increase the DAMP S100a8 (Marshall et al. 2017).
We also investigated these immune-related genes in the present study and found that 7
days of dermal exposure to 2% triclosan in SKH1 hairless mouse dorsal skin increased S100a8
and Il4 gene expression (Figure 2.5) (Baur et al. 2021). This result aligns with previous work
showing that S100a8 (1, 2, 4, and 7 days) and Il4 (2, 4, and 7 days) expression are increased
following repeated triclosan exposure on BALB/c mouse ears (Anderson et al. 2020). However,
7 days of dermal triclosan exposure has no significant impact on Tslp expression in SKH1 mouse
dorsal skin (Figure 2.5) (Baur et al. 2021). Due to changes observed at earlier timepoints in other
studies, we investigated the expression of immune-related genes in the dorsal skin of SKH1 and
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BALB/c mice following exposure to triclosan (2, 4, and 7 days of repeated, daily exposure).
Exposure to triclosan increased expression of S100a8 (2, 4, and 7 days) and Il4 (4 and 7 days) in
BALB/c dorsal skin (Figure 4.5). In SKH1 mouse dorsal skin, 7 days of dermal exposure to
triclosan increased the expression of S100a8 and Il4 (Figure 4.5). Additionally, in BALB/c
dorsal skin, exposure to triclosan for 2, 4, and 7 days increased expression of Tslp (Figure 4.5).
Interestingly, 4 days of triclosan exposure on SKH1 mouse skin increased expression of Tslp
(Figure 4.5). In RHE tissues, a single exposure to triclosan increased expression of TSLP (Figure
3.2) although repeated triclosan exposure had no significant impact on TSLP expression (Figure
3.5). Taken together, these results show that dermal exposure to triclosan increases the
expression of immune-related genes in mouse skin and RHE tissues but that these changes are
dependent on mouse strain and length of exposure.
Chemokines, a specific class of cytokines that are involved in the recruitment of immune
cells to tissues, are also involved in the immunomodulatory response to dermal triclosan
exposure on mice (Weatherly et al. 2020). Specifically, 2 and 4 days of triclosan exposure on
BALB/c mouse ears increased the expression of the neutrophil-recruiting chemokines Cxcl1 and
Cxcl2 (Weatherly et al. 2020). CXCL1 and CXCL2 are specifically involved in neutrophil
recruitment (De Filippo et al. 2008) and neutrophils may be involved in promoting sensitization
(Silvestre et al. 2018; Weber et al. 2015). Triclosan exposure significantly increased the gene
expression of Cxcl2 in BALB/c mouse dorsal skin but not SKH1 mouse dorsal skin (Figure 4.2).
Expression of Cxcl1 was significantly higher in BALB/c mouse skin following 2 and 7 days of
triclosan exposure and SKH1 mouse skin following 7 days of exposure to triclosan (Figure 4.2).
In RHE tissues, a single exposure to triclosan increased CXCL1 and CXCL2 gene expression
(Figure 3.2). Taken together, these results demonstrate that exposure to triclosan increases the
expression of neutrophil-recruiting chemokines (e.g., Cxcl1, Cxcl2) in the skin, which may be
important for neutrophil recruitment and the immunomodulation that occurs following exposure
to triclosan on the skin.
The changes in these neutrophil-recruiting chemokines and other cytokines suggest that
immune cells may also be altered in the skin following exposure to triclosan. Neutrophils were
significantly increased in BALB/c mouse dorsal skin exposed to triclosan but not in SKH1
mouse skin (Figure 4.1). The increased levels of Cxcl2 gene expression in BALB/c skin
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following triclosan exposure, but not SKH1 skin, may explain the elevation in neutrophils in
BALB/c skin only. To evaluate the potential effects of shaving the BALB/c mice, SKH1 mice
were shaved or not shaved, and both groups were dermally exposed to triclosan for 4 days. The
neutrophils and neutrophil-recruiting chemokines in the SKH1 shaved skin was not significantly
different compared to unshaved SKH1 skin, suggesting that effects on neutrophils are due to
strain differences rather than shaving. Taken together, the increase in chemokines in BALB/c
mouse skin aligns with the finding that neutrophils are recruited to the skin.
ILC2s have emerged as important players in allergic disease (Hammad and Lambrecht
2015) and exposure to the antimicrobial, sensitizing chemical DDAC on mouse skin has
previously been shown to activate ILC2s (Shane et al. 2019b). Additionally, exposure to the
sensitizer TDI has been shown to activate ILC2s in mouse skin (Shane et al. 2019a). ILC2s are
also known to be influenced by TSLP (Hammad and Lambrecht 2015). As previously
mentioned, exposure to triclosan on mouse skin increases Tslp expression (Figure 4.5),
suggesting that ILC2s may also be impacted due to triclosan exposure. ILC2s (CD45+, SSClow,
Lin-, CD90+, CD3-, NKp46-, ICOS+, CD127+, CD25+) in SKH1 mouse skin were significantly
increased following 4 days (frequency and number) and 7 days (frequency) of triclosan exposure
(Table 4.5), but not in BALB/c mouse skin following triclosan exposure (Table 4.4). Expression
of cell surface markers KLRG1, ICOS, CD25, and CD127 have previously been used to identify
activation of ILC2s (Shane et al. 2019b). ICOS (days 2, 4, and 7) and CD25 (days 4 and 7) were
elevated on ILC2s and CD127 was decreased (days 2, 4, and 7) on ILC2s in SKH1 dorsal skin
(Figure 4.4). In BALB/c dorsal skin, KLRG1 (day 7), CD25 (day 2), and CD127 (day 7) were
increased on ILC2s following triclosan exposure (Figure 4.4). Taken together, in SKH1 mice,
total ILC2 numbers were increased and the expression of ICOS and CD25 activation markers on
ILC2s was increased with triclosan exposure. CD127 expression on ILC2s was decreased in
triclosan-exposed SKH1 dorsal skin at all timepoints and indicates activation of ILC2s (Poposki
et al. 2017). Further investigations are needed to explore the biological significance of increased
ILC2 numbers in concert with these activation markers. Interestingly, the number of ILC2s was
unchanged in BALB/c mice with triclosan exposure. The underlying mechanism of this
differential finding is not yet understood.

151

Together our results show that repeated dermal exposure to triclosan increases the
expression of immune-related genes and immune cells in the skin (Figure 5.2). However, these
changes are dependent on mouse strain. BALB/c mice have a Th2 bias (Anderson et al. 2016;
Woolhiser et al. 2000) and this may contribute to the increased expression of Th2-related
cytokines observed at multiple timepoints following triclosan exposure (Figure 5.2). There is
limited research comparing the immunocompetent hairless mouse strain SKH1 to the BALB/c
mouse strain. However, one study shows that SKH1 mice have similar immune responses to
C57Bl/6 mice, which have a Th1 bias (Schaffer et al. 2010). The effects of triclosan exposure on
the immune response of C57Bl/6 mice has not been investigated. The difference between SKH1
and BALB/c responses following triclosan exposure could be due to the hairless gene or
differences in immune bias. Additional research is needed to understand the effects of strain
differences in response to chemical exposure. One potential direction is to explore the role of the
hairless gene, which is responsible for the hairless phenotype in SKH1 mice, on a BALB/c
background. A hairless mouse strain with a BALB/c background could be used to evaluate Th2
immune responses in concert with the skin barrier and skin microbiome following exposure to
chemicals on the skin.

Figure 5.2. Summary of gene expression and immune cell changes in haired (BALB/c) and
hairless (SKH1) mice following dermal exposure to triclosan.
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Comparison between mouse and RHE models
There are many differences between mice and RHE models, but both models are useful
for investigating the impact of chemical exposures. Mice are widely used as an in vivo model in
research. RHE tissues are comprised only of keratinocytes and the interactions between the
immune system and microbiome, which are present in vivo, are lacking in this model.
Differences observed in our studies between models may also be due to single vs. repeated
exposure and differences in concentration of triclosan used. In the RHE model, we observed
differences in expression patterns of barrier genes between a single triclosan exposure compared
to the 5-day exposure to triclosan (Figure 5.1). One explanation is the cytotoxicity levels
observed following triclosan exposure. Both a single (Figure 3.1) and repeated (Figure 3.4)
exposure to triclosan was cytotoxic in the RHE model. Additionally, the repeated exposure may
have an accumulated effect that impacts the expression of genes more so compared to the single
exposure. This difference in a single vs. repeated exposure in the RHE model, as well as the
cytotoxic effects, should be taken into consideration during future studies of chemical exposure
and toxicological effects using the RHE model.
Another difference between animal models and the RHE model is the lack of an immune
system and microbiome in the RHE model. Immune cells can interact with skin epithelial cells
by producing cytokines; for example, T cells produce IL-4 and IL-13 and these cytokines have
been shown to decrease the expression of the skin barrier gene FLG (Howell et al. 2009).
However, T cells, IL-4, and IL-13 are not naturally present in the RHE model, therefore this
influencing factor is lacking in the RHE model used in our studies. The microbiome is also
known to influence expression of barrier genes (Meisel et al. 2018). The RHE model is typically
sterile; however, select microorganisms can be added to the RHE model to evaluate their effects
(Holland et al. 2008). Although not evaluated in our studies, previous work has shown that
adding bacteria to the media in the RHE model influences the expression of skin barrier genes
(Duckney et al. 2013). This method could be useful to evaluate the effects of specific species of
microorganisms of interest. However, the skin microbiome is complex and many of the
microorganisms have not been cultured in the lab environment. Taken together, animal models
are a valuable tool to evaluate the interactions between the skin barrier, skin microbiome, and
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immune system. The advantage of in vitro studies is that select components can be evaluated
using the RHE model to better understand specific interactions and mechanisms.

Endocrine disruption and the immune response
Triclosan has been identified as an endocrine disruptor and alterations in the endocrine
system may be involved in immunomodulation. Sex hormones are known to impact the immune
system (Taneja 2018). In rats, triclosan exposure has been shown to reduce the levels of
progesterone, estradiol, testosterone, human chorionic gonadotropin, and prolactin (Stoker et al.
2010; Feng et al. 2016). In mice, exposure to triclosan has been shown to increase spontaneous
abortion rates and reduce estrogen sulfotransferase activity, an enzyme important in estrogen
metabolism (Wang et al. 2015). Additionally, abortion patients exposed to triclosan have been
shown to have lower levels of sex hormones (progesterone and β-human chorionic gonadotropin)
compared to controls (Wang et al. 2015). Together these studies support the role of triclosan as
an endocrine disruptor that inhibits sex hormones. Additionally, in humans, triclosan has been
positively associated with polycystic ovary syndrome (Ye et al. 2018). However, some studies
have shown conflicting results. In vitro, exposure to triclosan on primary rat granulosa cells
increased production of estradiol and progesterone (Chen et al. 2019). Differences between in
vivo and in vitro studies and cellular targets may account for these differences. For example,
exposure to TCDD, a dioxin with a similar chemical structure to triclosan, has been shown to
reduce estrogen signaling in the liver and kidney but increase estrogen signaling in the pituitary
glands of mice (Yoshida et al. 2020). This finding highlights the potential differences between
tissue responses and cell type.
In addition to the impact on sex hormones, triclosan exposure has also been shown to
impact levels of thyroid hormones. Triclosan exposed mice have been demonstrated to have
lower levels of triiodothyronine (T3) and thyroxine (T4) compared to controls (Wang et al.
2015). Rats exposed to triclosan have also been shown to have lower T4 levels (Stoker et al.
2010; Louis et al. 2017). These studies further support the findings that triclosan is an endocrine
disruptor. However, human studies are conflicting. One study showed that elevated urinary
triclosan levels in humans were positively associated with total T3 levels in adolescents,
although no association was identified in adults (Koeppe et al. 2013). Additional studies are
needed to better understand differences in responses between animals and humans and to further
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elucidate mechanisms. Future studies should also explore the impact of sex differences and the
immune response. Overall, these studies support the role of triclosan as an endocrine disruptor
and this may have consequences on the immune response.

Conclusions
In summary, we demonstrated that dermal exposure to the antimicrobial chemical
triclosan altered the expression patterns of skin barrier genes, decreased the integrity of the skin
barrier, disrupted the composition of the microbiome, and increased the expression of
proinflammatory and Th2-related genes in the skin (Figure 5.3). Specifically, in chapter 2, we
showed that repeated exposure to triclosan on SKH1 dorsal skin increased TEWL, increased skin
thickness, increased KRT14 gene and protein expression, decreased Krt10 gene expression,
increased FLG protein expression, decreased Flg2 gene expression, increased S100a8 and Il4
gene expression, increased skin alpha diversity and phylum Firmicutes, and decreased gut alpha
diversity and phylum Firmicutes (Figure 5.4). In chapter 3, we demonstrated that a single
exposure to triclosan on a RHE model increased expression of skin barrier genes (FLG, FLG2,
TJP1, OCLN, KRT10), decreased expression of a proliferation marker (KRT14), increased gene
expression of cytokines (TSLP, IL1A, IL1B, TNF, CXCL1, CXCL2, CXCL8), increased protein
expression of cytokines and a growth factor (IL1α, IL36, VEGF), and increased LDH and tissue
permeability (Figure 5.4). Additionally, repeated exposure to triclosan on a RHE model
increased gene expression of cytokines (TNF, CXCL8), increased LDH, and increased IL36 and
EGF protein while S100A8 gene expression and CXCL8 and VEGF protein were decreased
following triclosan exposure (Figure 5.4). In chapter 4, we compared the immune cell response
to triclosan on dorsal skin between two mouse strains (BALB/c and SKH1). Dermal exposure to
triclosan increased neutrophils and expression of immune-related genes (Cxcl1, Cxcl2, S100a8,
Tslp, Il4) in BALB/c skin (Figure 5.4). In SKH1 dorsal skin, triclosan exposure increased ILC2s
and immune-related genes (Tslp, Cxcl1, S100a8, Il4) at select timepoints (Figure 5.4).
Previous studies have suggested that decreased skin barrier integrity and altered
composition of the skin microbiome play a role in promoting allergic diseases. Taken together,
our studies suggest that exposure to triclosan alters the immune system and may influence
allergic disease through disruptions in the skin barrier and microbiome. Future studies should
explore the mechanisms by which an altered skin barrier and microbiome influence the immune
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system, particularly in the context of antimicrobial chemical exposures such as triclosan. Overall,
a better understanding of mechanisms of allergic disease and the role of immunomodulatory
chemical adjuvants in disease may aid in the prevention and treatment of occupational allergic
diseases.

Figure 5.3. Summary of changes occurring in the skin following dermal exposure to triclosan.

156

Figure 5.4. Detailed schematic showing the changes occurring in the skin following dermal exposure to triclosan.
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Chapter 2: Supplemental Information

Supplemental Figure 2.1. Representative negative control images of secondary antibody
staining only in the skin following 7 days of dermal exposure to vehicle (A) or 2% triclosan (B)
on mice. Scale bar = 50 µm. Line indicates basement membrane.
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Supplemental Figure 2.2. Total protein detected in immunoassay. Total protein detected in
immunoassay for (A) FLG, (B) FLG2, (C) KRT10, and (D) KRT14 in skin following 7 days of
dermal exposure to vehicle or 2% triclosan on mice. Points represent the individual mice and
bars represent the mean (± SEM) of 5 mice/group.
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Supplemental Figure 2.3. No change in additional skin barrier genes tested following 7 days of
dermal triclosan exposure. Fold change in gene expression compared to vehicle control of (A)
Ivl, (B) Lor, (C) Tjp1, (D) Ocel1, and (E) Itgbl1 in skin following 7 days of dermal exposure to
vehicle or 2% triclosan on mice. Points represent the individual mice and bars represent the mean
(± SEM) of 6 mice/group.
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Chapter 3: Supplemental Information

Supplemental Figure 3.1. Exposure to triclosan on EpiDerm tissues increased expression of
additional select skin barrier genes. (A) RNA yield (ng/µL) following 6, 24, and 48 hours of 0%
triclosan (acetone vehicle) or 0.05-0.2% triclosan. Bars represent the mean (± SEM) of 2
samples/group. *p < 0.05 vs. 0% triclosan. Fold change in gene expression compared to vehicle
control of (B) IVL, (C) LOR, and (D) CDH1 following 6, 24, and 48 hours of 0% triclosan
(acetone vehicle) or 0.05-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group.
*p < 0.05 vs. 0% triclosan.
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Supplemental Figure 3.2. Expression of additional select skin barrier genes following repeated
triclosan exposure on EpiDerm tissues. (A) RNA yield (ng/µL) following 5 days of 0% triclosan
(acetone vehicle) or 0.1-0.2% triclosan. Bars represent the mean (± SEM) of 2 samples/group. *p
< 0.05 vs. 0% triclosan. Fold change in gene expression compared to vehicle control of (B) IVL,
(C) LOR, and (D) CDH1 following 5 days of 0% triclosan (acetone vehicle) or 0.1-0.2%
triclosan. Bars represent the mean (± SEM) of 2 samples/group. *p < 0.05 vs. 0% triclosan.
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Supplemental Table 3.1
Cytokine
IL-1α

IL-36

CXCL8

VEGF

EGF

Exposure

1 day

2 days

3 days

4 days

5 days

No Exposure

37.4

32.2

23.9

19.9

25.2

Acetone

87.3

127.7

147.4

154.3

192.9

No Exposure

155.5

104.4

68.73

50.9

50.4

Acetone

208.1

128.3

90.20

78.5

71.4

No Exposure

331.4

184.2

129.1

102.7

104.5

Acetone

520.5

330.7

248.8

217.4

213.3

No Exposure

425.5

383.2

358.0

313.3

362.2

Acetone

452.5

404.0

380.5

356.2

401.1

No Exposure

25.5

24.1

22.5

22.5

20.9

Acetone

25.0

24.7

23.5

24.3

23.8

Cytokines and growth factors (pg/mL) released following 5 days of acetone exposure on
EpiDerm.
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Chapter 4: Supplemental Information

Supplemental Figure 4.1. Gating strategy for neutrophils and eosinophils.
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Supplemental Figure 4.2. Gating strategy for subsets of DCs.
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Supplemental Figure 4.3. Gating strategy for lymphocytes.
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